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Abstract 
Zebrafish embryos have become one of the most popular model systems in biomedical and 
environmental research. However, current testing protocols using conventional multiwell 
plates rely heavily on time-consuming and labour-intensive manual handing. Static culture 
environments and low-throughput data collection are outdated with regards to meet the 
requirements of modern compound library screening. Herein, this research presents steps 
towards the development of a miniaturised and automated system for manipulating 
zebrafish embryos by using both innovative microfluidic lab-on-a-chip technologies and 
three-dimensional printing technologies.  
Four steps were taken to achieve this goal: (i) 3D printing technologies were explored to 
fabricate the lab-on-a-chip device. While 3D printing provided rapid manufacture of devices 
with high definition and optical transparency, as evidenced by SEM and confocal microscopy 
results, it caused significant toxicity in fish embryos after long-term exposure. (ii) The 
toxicity profile of a selection of 3D printing polymers was then extensively investigated using 
standard biotests. A chemical analysis was performed to reveal the compounds contributing 
to the toxicity. (iii) To avoid the use of toxic materials, a chip-based embryo trapping array 
was fabricated using biocompatible material PMMA. The chip allowed for automatic embryo 
loading, continuous reagent perfusion, and convenient image acquisition. The device was 
validated using both CFD simulations and biological experiments using reference toxicants. 
In addition, the embryo chip device was further developed to enable real-time metabolic 
level detection.  (iv) A miniaturised and automated imaging platform, together with the 
high-throughput embryo trapping array and customised fluidic actuators, were prototyped.  
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1 Introduction 
 
1.1 Small model organism bioassays 
Bioassays, or biological assessments, are one of the standardised scientific experiments 
used in drug discovery and ecotoxicology. They are used for a range of biological specimens 
from cells or tissues (in vitro) to live plants or animals (in vivo), to determine the activity or 
toxicity of a substance, such as a drug, protein, or unknown toxicant.  
Whilst in vitro bioassays are simple, fast, and cheap, their test results are usually 
inconsistent with the human clinic trials. On the other hand, animal testing using mouse and 
chicken produce trustworthy results, but they are too expensive to screen a large number of 
samples. Therefore, small model organisms have merged to bridge the existing gap.  
1.1.1 A brief introduction of small model organisms  
In general, small model organisms are multicellular animals ranging in size from 50 µm to 
2000 µm, including invertebrates and small vertebrates1. Commonly used invertebrate 
organisms are nematodes (Caenorhabditis elegans) and fruit flies (Drosophila 
melanogaster)2. They have been serving in biomedical laboratories for many decades and 
are still being actively used in high-throughput screening2. Being invertebrate animal 
models, they are low in cost, allow for easy genetic modification, and have no concerns of 
animal ethics. However, they bear some intrinsic disadvantages in that they do not have 
certain genes and organs for specific human disease studies. They are also evolutionarily 
distant from mammals, which has led to some false results.  
Crustaceans, such as brine shrimp (Artemia sp.) and fresh water daphnids (Daphnia sp.), are 
aquatic invertebrate animal models extensively used for acute and chronic toxicity tests in 
ecotoxicology3-5. Bioassays testing on such organisms feature low cost, simple test 
procedures, and require a low degree of expertise. These bioassays also have relatively high 
adaption and sensitivity in various test conditions. In addition, with off-the-shelf test kits 
availability, these animals can be culture and maintenance free, which is a huge advantage 
for researchers5. Sub-lethal and behavioural responses could also be detected for different 
research purposes6-9.  
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Zebrafish (Danio rerio) and clawed African frogs (Xenopus sp.) are vertebrate small model 
organisms with more complex organs, such as kidneys and a cardiovascular system, that 
invertebrate organisms lack. They also have a higher genetic similarity to human, compared 
to invertebrates. Moreover, recent advances in developing genetic tools has broaden their 
applications in biomedical research10-13. Also, development of behaviour analysis 
technologies has facilitated behaviour investigations in these species on a molecular basis14-
19.  
Among all the small model organisms, zebrafish has become one of the most popular.  
Within only a few decades, it has gone from being a hobby fish to a mainstream model 
organism employed by scientists in a wide variety of scientific research20. Nevertheless, in 
recent years, there has been increasing concern with regard to animal welfare and research 
ethics, so that using adult fish for research experiment is largely discouraged. Fortunately, 
using early stage zebrafish, namely embryo and larvae, involves fewer ethical concerns and 
thus they are replacing adult zebrafish in many bioassays. 
 
1.1.2 Zebrafish embryos as an animal model 
Zebrafish embryos are only slightly larger in size than many invertebrate organisms, making 
them easy to handle manually in the laboratory, as well as capable of performing well in 
automated high-throughput screenings. They also survive with simple and cost effective 
husbandry and exhibit a large brood size that facilitates rapid and efficient bioassays. As a 
replacement of adult fish, zebrafish embryos can be effectively applied in many type of 
research. For example, zebrafish embryos are widely used in identifying lead compounds for 
biological targets during drug discovery21, 22 and bio-active natural compound discovery23-27; 
they also play an important role in drug discovery preclinical toxicity tests28-31, and in 
tumour studies using transgenic zebrafish reporter lines32-39. In addition, zebrafish embryo 
bioassays have remarkable applications in environmental research, particularly for 
assessment of aquatic toxins40-43. 
In fact, using zebrafish embryos is not only an excellent alternative to using adult fish, they 
also have their own advantages over adult fish. For instance, zebrafish embryos have 
transparent chorions and skins that enables non-evasive observation of most important 
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organs and cardiovascular systems.  Furthermore, embryos are in early developmental 
stages, which are believed to be more sensitive to most chemical compounds.  
Standard chemical test protocols for using zebrafish embryos have recently been 
established by OECD44, also known as the Fish Embryo Acute Toxicity (FET) test. Zebrafish 
embryos have been validated as being able to test a variety of substances with diverse 
solubilities, volatilities, and hydrophobicities44.  
 
1.1.3 Challenges in current FET assays 
In spite of the importance of zebrafish embryo models, standard FET tests are conducted on 
24-well microtitre plates, which demand iterative manual manipulation of specimens and 
fluids1, 45, 46. Using such a method is time-consuming and labour intensive due to iterative 
manual pipetting. Fragile embryos can also easily be damaged during manual transferring. 
Moreover, static culture conditions require a substantial amount of compound solution, 
which is very costly for some applications, e.g. testing new therapeutic drugs. Furthermore, 
culturing embryos in a static environment can unfavourably bias the toxicity test results due 
to, for example, toxicant adsorption to the test chamber and bystander effects. Lastly, it is 
rather difficult to precisely position and immobilise specimens for high-resolution imaging in 
a microtitre plate. All above, these factors act as hurdles for high-throughput testing and 
lead to analytical error.  
 
1.2 Microfluidics and Lab-on-a-Chip 
Not surprisingly, many efforts and achievements have already been made to reform the 
current testing protocols. Apart from simple modifications of conventional multiwell 
plates47, novel designs using microfluidic Lab-on-a-Chip (LOC) technologies have proven to 
greatly elevate laboratory automation and analysis. This section introduces lab-on-a-chip 
technologies and their applications in manipulation of zebrafish embryos.  
1.2.1 A brief introduction to lab-on-a-chip  
Lab-on-a-chip is a miniaturisation technology that integrates several laboratory functions 
onto a small piece of chip, which is only a few square centimetres in size. The core of a lab-
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on-a-chip device is a microfluidic system that manipulates a tiny amount of fluid (usually 
tens of microliters) to perform chemical and biological analyses.  
There are many benefits that lab-on-a-chip devices can offer us. Firstly, the consumption of 
reagents is greatly reduced. By using miniaturised animal culturing chambers with close-
loop fluid circuits, a few hundred microliters of compound is usually enough for the entire 
assay, which is very favourable for high-throughput screenings. Secondly, lab-on-a-chip 
devices provide a flow-through condition for animal culture, which overcomes the 
drawbacks of testing in a static condition, such as adsorption or evaporation. Thirdly, micro 
channels in the chip device can be designed to function as many essential laboratory 
equipment, including pumps, valves, and mixers. By integrating these features, chip devices 
become miniaturised, portable, and convenient for clinical and environmental studies in the 
field.  
Moreover, lab-on-a-chip devices are usually associated with microelectrical mechanical 
systems (MEMS) that allow various sensors to be embedded to monitor fundamental 
parameters, including pressure, light, and conductivity. Embedded electrical or hydraulic 
actuators allow users to manipulate small droplets of reagents, air bubbles, and even small 
live organism. Apart from micro techniques, integrating robotic actuators with 
computational vision technologies has been attempted to automate the whole experimental 
process from reagent preparation to image analysis.  
 
Figure 1.2.1 Microfluidics and lab-on-a-chip. A) A conceptual image describing a microfluidic lab-on-
a-chip device. Several laboratory functions are integrated onto a miniaturised chip through micro 
fluidic flows. The Image is sourced from a website48. B) An example of a lab-on-a-chip device. The size 
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of this chip was exactly same as a conventional glass microscope slide. The Image is sourced from a 
website49.  
1.2.2 Lab-on-a-chip and zebrafish embryos 
The applications of microfluidic lab-on-a-chip technologies in zebrafish embryo laboratory 
automation have been extensively explored by many researchers. Herein, I summarise the 
current and upcoming lab-on-a-chip devices and platforms that greatly improved specimen 
manipulation, fluidic regulation, and imaging acquisition. I present a brief introduction for 
each device in terms of their features, fabrication approaches, and utilities, as well as their 
limitations. 
Segmented flow microculture 
One of the earliest designs was the micro fluid segment technique50. This system comprised 
of a Teflon (PTFE) tubing coil, an integrated camera, and a PC controlled syringe pump50 
(Figure 1.2.2 A-B). It introduced zebrafish embryos by carrying medium 
(perfluoromethyldecalin, PP9) from an assay plate into the tube for imaging, where fluid 
flow and image recording were controlled by software50. In this way, zebrafish embryos 
were trapped in each fluidic segment and thus could be imaged individually inside the 
tubing. Despite of iterative dipping of the tube into the assay plate to alternatively aspirate 
embryos and carrying medium, the flow system and imaging system can work continuously, 
which can be applied for automation50. Interestingly, air bubbles that are inevitably 
introduced when changing the dipping wells were also useful for providing segment 
stability50. The limitation of this design was inadequate image quality due to the images 
being taken through a curved surface (the tubing). 
Digital EWOD microfluidics 
In addition to hydraulic force, a microfluidic device using electrokinetic force for 
transporting zebrafish embryos has been presented51 (Figure 1.2.2 C-D). This device used 
electrowetting-on-dielectric (EWOD) techniques that could move an embryo-contained 
droplet in a gap between two plates51: the top plate acted as a common ground electrode; 
and the bottom plate had electrodes beneath a dielectric layer to manipulate droplet 
movement51. The surface of both plates were coated with hydrophobic material for easier 
movement51. Furthermore, a droplet-based on-chip dechorionation was performed by 
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mixing an embryo-contained droplet with a digestive agent (Pronase) droplet51. In addition, 
such mixing techniques were also useful for mixing laminar flows on microfluidic devices52, 
53. 
  
Figure 1.2.2 Microfluidic technologies for manipulating zebrafish embryos. (A) ‒ (B) Segmented flow 
microculture platform for zebrafish embryo development studies50. (Reproduced from Ref 50 with 
permission from The Royal Society of Chemistry). (C) – (D) Electrowetting device for moving zebrafish 
embryos51. (Reproduced from Ref 51 with permission from The Royal Society of Chemistry). 
Chip-based device for embryo culture 
Using lab-on-a-chip technologies in design and fabrication, miniaturised chip-based devices 
have been applied to zebrafish embryo manipulation and on-chip embryo culture. Such 
techniques could also provide versatile functions and utilities for specific studies. Shen and 
co-workers presented a microfluidic chip to immobilise zebrafish embryo, with only a 
limited surface area of the embryo exposed to test compounds for growth factor 
experiments54. The chip was made of two layers of polydimethylsiloxane (PDMS). The top 
layer had a funnel-shaped aperture to immobilise the embryo; and the bottom layer 
contained a micro channel to deliver fluidic samples54. During operation, the chip was 
submerged in a Petri dish containing fish medium, and a gravity-driven pump was used to 
deliver test compounds via the micro channel54. When the embryo docked into the 
aperture, it could separate two phases of liquid54. While maintaining embryo viability, only 
the bottom part of the embryo was exposed to the test compounds. Although such a device 
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worked well in proof-of-concept experiments, it had limitations in high-throughput 
feasibility, namely embryos had to be manually positioned at the aperture using 
conventional pipetting. Furthermore, the design using two layers of PDMS had difficulties to 
be converted to a high-throughput device because the alignment would be a big issue, due 
to large pieces of PDMS layer bonding together, especially when both layers contain small 
features. 
A microfluidic flow-through system was developed by Wielhouwer and co-workers (Figure 
1.2.3 A). It featured an embedded heating system55. The device was made from three layers 
of bonded borosilicate glass55. It had two sets of flow-through systems: one for buffering 
solutions in on-chip embryo culture and the other for warm water keeping the desired 
temperature for embryo growth55. The embryo culturing chambers were smaller than the 
wells in conventional 96-well microtitre plates, but they were large enough for a hatched 
larvae to swim around55. This device facilitated on-chip flow-through culturing without an 
incubator meanwhile it provided real-time imaging accessibility. In particular, during the 
proof-of-concept culturing test, the authors observed that a high flow rate (6 µL per well per 
minute) can suppress the hatching rate of the embryo55, however, a substantial flow rate (2-
4 µL per well per minute) was necessary to deliver oxygen55.  
A chip-based microfluidic embryo array integrated with a concentration gradient generator 
was reported by Yang and co-workers56 (Figure 1.2.3 B). This chip was made of three 
bonded glass plates – the top plate contains micro channel networks that were fabricated 
by photolithography; the middle plate contained seven embryo culture chambers that were 
drilled with a drill-bit; and the bottom layer simply acts as a base56. In experiment, embryos 
were manually transferred into the culturing chambers and each chamber can hold several 
embryos56. Interestingly, the chip was designed to lean around 20° to discharge waste and 
gain enough oxygen prior to applying drug solutions so that no tubing was required for the 
device56. Two syringe pumps can deliver drug and medium solution via concentration 
gradient micro channels to the chamber inlets, providing a series of concentrations over the 
culturing chambers56. For continuously flow-through on-chip culture, the chip needs to lean 
20° again for the same reasons56. The device was designed for rapid drug toxicity tests, 
however, one chamber for each concentration is not optimal. Although each chamber can 
host multiple embryos, an overcrowded chamber is not ideal for culturing, nor for imaging. 
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In addition, the chip fabrication that using photolithography is complicated and 
uneconomical. Fabrication also involves using the dangerous chemical hydrofluoric acid 
(HF), which is unfavourable.  
There was another chip-based microfluidic perfusion platform presented together with an 
embedded concentration gradient generator57 (Figure 1.2.3 C). This prototype described by 
Choudhury et al. was similar to the device reported by Yang and co-workers56, but differed 
in fabrication method and some other details. The chip device consisted of three different 
layers – an oxygen permeable and removable polyurethane membrane as a cover; a crystal 
silicon wafer with fluidic channels and embryo culturing chambers as a core; and a glass 
bonded to a silicon layer as a base57. Drug solution and media solution from syringe pumps 
created gradient concentration via microfluidic mixing channels; different mixing ratios 
generated different concentrations of drug solution57. There were eight chambers for 
embryo culture; each chamber had an independent inlet and outlet with specified drug 
concentration57. The culture chambers were rather small, which constrained embryos from 
moving freely, but was readily used for high magnification imaging. The inner surface of the 
micro channels were hydrophilic to minimise potential air bubbles57. Such a device was 
ready for flow-through culturing and real-time high resolution imaging, and could be used 
for dose-dependent chemical screenings. However, the chip only provided one embryo 
chamber per concentration, that is insufficient for bioassays. The fabrication for the core 
layer using photolithography was complicated and involved using hydrofluoric acid (HF), a 
method that is rather dangerous. Device set-up was also inconvenient, including manually 
dispensing embryos for loading and handling a 100 µm thick membrane as a cover for the 
chip at every use.  
Another novel device with enhanced fluidic actuation capabilities was reported in a brief 
communication by Zheng and co-workers58. This device was fabricated using elastomeric 
PDMS layers to form embryo culture chambers. In addition to functioning as a microwell 
plate, it featured an embedded monolithic micro-valve system that was controlled 
pneumatically by actuators (Figure 1.2.3 D)58. This flow manipulation system can 
dynamically renew the medium within 10 second58. The device was still short of completion, 
but the monolithic micro-valve design has potential for many applications, including drug 
and anaesthetic solution delivery. 
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Figure 1.2.3 Microwell chip-based embryo culture devices. (A) Microwell based microfluidic flow-
through system55. (Reproduced from Ref 55 with permission from The Royal Society of Chemistry). (B) 
Microfluidic embryo array integrated with a concentration gradient generator from Yang et al56. 
(Reproduced from Ref 56 with permission from AIP Publishing LLC) (C) Microfluidic embryo array 
integrated with a concentration gradient generator from Choudhury et al57. (Reproduced from Ref 57 
with permission from The Royal Society of Chemistry) (D) The schematic diagram of the microwell 
chip with embedded valves that enable instant fish medium exchange58. (Reproduced from Ref 58 
with permission from The Royal Society of Chemistry). 
Hydrodynamic fluid trap embryo arrays 
All the designs discussed above involve manually transferring embryos into the culturing 
chamber. For high-throughput screening processes, this is undesirable as the embryos are 
fragile and can be easily damaged during pipetting. To solve this issue, a miniaturised 
embryo array was reported for automated trapping, immobilisation, and on-chip perfusion 
using only hydrodynamics59, 60 (Figure 1.2.4 A-B). The design concept was based on an 
anterior work reported by Tan and Takeuchi61 for single cells trapping and immobilisation 
using hydrodynamic forces. Here, the chip was made of two layers: the top layer was a 
PDMS block containing fluidic channels and 48 embryo traps; the bottom layer was a 
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conventional microscope glass slide59. The PDMS layer was made through replica moulding. 
Afterwards, the PDMS layer was bonded to a glass microscope slide using oxygen plasma 
surface activation59. A peristaltic pump connected to the outlet of the channel, providing a 
passive hydrodynamic force; meanwhile the channel inlet was connected to PTFE Teflon 
tubing that can aspirate embryos from a reservoir59. All the embryo traps were sequenced 
along the main loading channel so that once an embryo docks to a trap, the following 
embryo would skip the occupied trap and move towards the next available trap59. After 
loading, test compounds could be introduced into the channel in the same manner as 
embryo loading59. Such hydrodynamic designs facilitate rapid and automatic loading, 
immobilisation and perfusion. The constrained embryo traps also enabled high 
magnification imaging. Based on this chip design, an automatic image analysis algorithm was 
presented to detect embryo anomalies during their on-chip development62.  
Actively actuated 3D embryo arrays 
Akagi and co-workers also developed a microfluidic device for real-time analysis of 
transgenic zebrafish embryos63, 64 (Figure 1.2.4 C). This multi-layer chip was made of four 
poly(methyl methacrylate) (PMMA) sheets, comprises of loading and suction channels, 20 
embryo traps, and a heating manifold64. All the channels and traps were laser cut or 
engraved separately and then thermally bonded together in an oven64. The embryo loading 
and trapping combines hydrodynamic and gravitational forces: embryos were aspirated 
from a reservoir via a tubing, and then they were driven along the loading channel using 
suction force that was created at the outlet of the chip using a piezoelectric ultrasonic 
pump.  When embryos flowed above the traps, they gravitationally sank into the traps 
assisted by suction force from micro suction channels that were located beneath the traps64. 
The trapped embryo acted as a spacer so that the following embryo could not enter into a 
same trap. Following trapping, compound solution can be delivered from the loading 
channel to each docked embryo64. The U shaped heating manifold that surrounds the 
embryo traps introduces flowing warm water and provides the proper temperature for 
embryo on-chip culture64. This design facilitated rapid device fabrication, automated 
embryo loading, trapping, and perfusion.  
Based on this work, an integrated automation platform was then presented65. Apart from 
the microfluidic chip, the authors integrated a microfluidic actuator, a temperature 
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regulator, and image acquisition units65. All the units were controlled by a Field 
Programmable Gate Array (FPGA)-based embedded microcontroller65, which made the 
system approach a higher level of automation. Another modification and development of 
the original design was focused on achieving a higher degree of integration66. The authors 
added a drug delivery manifold with another piezoelectric pump to the chip so that embryo 
loading and drug delivery were controlled separately with an integrated servo pinch valve66. 
Furthermore, they used an optically transparent indium tin oxide (ITO) heater to replace the 
previous flow-through heating manifold66. Moreover, a USB fluorescent microscope (Dino-
lite) was also integrated for imaging together with a LED illumination and polarisation 
base66. In addition, a motorised rack and pinion drive was embedded into the stage that 
drives the chip for imaging66. All the units were controlled by PC and microcontrollers66. 
Together with embedded sample and waste bottles, the author managed to minimise the 
size of the platform to as large as a restaurant tray, which means it was portable for field 
studies (Figure 1.2.4 D).  
 
Figure 1.2.4 Hydrodynamically and actively actuated embryo trapping array. (A) A twisted channel 
hydrodynamic embryo trapping array59(Reproduced from Ref 59, no permissions were required). (B) 
A modified twisted channel embryo trapping array for Xenopus oocytes67(Reproduced from Ref 67, 
no permissions were required). (C) A 3D multilayer linear embryo trapping array embedded with a 
heating manifold64. (Reproduced from Ref 64 with permission from Elsevier) (D) A highly integrated 
platform for zebrafish embryo bioassays66 (Reproduced from Ref 66, no permissions were required).  
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Letamendia and co-workers developed and presented a fully automated high-throughput 
zebrafish embryo screening system68. This robotic system comprised of a master PC, an 
embryo sorter, two liquid handling devices, an automatic incubator, a plate feeder, a plate 
transporter, and an imaging system with software68. Such fully motorised and automated 
system offered comprehensive functions for high-throughput screening, including embryo 
dispensation, compound delivery, culturing, imaging, and data analysis68. After sorting, 
embryos could be dispensed into a multiwell microtitre plate within 3-5 minutes68. Then the 
two liquid handling devices were capable of operating in parallel to deliver test samples for 
screening68. Afterwards, a microscope with a camera scanned the microtitre plate well by 
well and acquires images by imaging software68. Finally, a customised image analysis 
software processed the images and generates the results directly in Excel and Word 
formats68. 
Vertebrate automated screening technology (VAST) 
Recently an advanced innovative vertebrate automated screening technology (VAST) was 
reported for fully automated high throughput screening69, 70 (Figure 1.2.5). This highly 
integrated platform could load zebrafish larvae from either a multiwell microtitre plate or a 
reservoir into a detection tube, where the system could recognise larvae from air bubbles 
and debris69. Afterwards, the larvae moved into a capillary tube that was capable of 
automatically adjusting larvae’s position and orientation from any angles for automated 
imaging.  After experiments, the larvae could be recovered either into a multiwell plate or a 
reservoir69. Because of the precise positioning and orientating system, the image resolution 
could reach to cellar level70. The ultimate completion platform was also motorised with a 
multi-thread system that could process multiple animals simultaneously70. The authors also 
optimised the capillary tube material with ultra-thin borosilicate that facilitates confocal and 
fluorescent imaging70. This technology greatly facilitated in vivo specimen manipulation and 
subcellular organ imaging. 
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Figure 1.2.5 VAST platform for high-throughput zebrafish larvae manipulation and image detection70. 
(A) The schematic diagram of the Vertebrate Automated Screening Technology (VAST) system. (B) ‒ 
(D) in a microcapillary tube, larvae orientation can be easily adjusted for imaging. (Reproduced from 
Ref 76 with permission from The Royal Society of Chemistry) 
1.2.3 Challenges in lab-on-a-chip 
Despite the growing interest and demand of lab-on-a-chip technologies in small model 
organism assays, lab-on-a-chip has not yet been widely adopted in practice compared with 
other flourishing fields using LOC technologies. This phenomenon is referred to as the 
workshop-to-bench gap71. One of the major reasons is that prototyping and fabrication of 
millilitre scale lab-on-a-chip devices for accommodating small model organisms are 
expensive and difficult to achieve using standard fabrication methods, such as mechanical 
machining and lithography. Another important reason is that many of the lab-on-a-chip 
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devices or systems are not user-friendly, and require substantial know-how and an 
engineering background to operate and maintain the system.  
The way to solve the problems is to develop a simple and affordable fabrication methods for 
making lab-on-a-chip devices. A significant amount of work needs to be accomplished in 
exploring optimal approaches utilising advanced technologies, including those derived from 
microelectronics industry72.  
 
1.3 Fabrication of lab-on-a-Chip devices 
Not all microfabrication methods are suitable for making a lab-on-a-chip devices. Firstly, lab-
on-a-chip devices or microfluidic devices are meant to be miniaturised. Fabrication methods 
with high feature definitions are required. Secondly, the devices usually contain three 
dimensional structures with over hanging fluidic channels in an enclosed configuration, 
which many conventional subtractive manufacturing methods cannot achieve. Thirdly, the 
fabrication process needs to be relatively simple and inexpensive as most lab-on-a-chip 
devices are developed in laboratories with limited engineering resources.  
In this section, I briefly discuss rapid microfabrication methods for making lab-on-a-chip 
devices, and emphasise on a cutting-edge technology: 3D printing.  
Photolithography and Softlithography 
Photolithography was one of the most successful technologies in microfabrication of 
industrial semiconductors and microelectronics. It can fabricate features below 1 µm. 
Nevertheless, for most microfluidic lab-on-a-chip devices, this resolution is overkill. 
Furthermore, the fabrication is very time-consuming when making large features (> 250 
µm).  
To improve the fabrication process, soft lithography was introduced by Qin and co-workers 
73-75. In their protocol, photolithography was only used to make a master mould with 
patterned structures on the stamp. Afterwards the authors used elastomeric material 
polydimethylsiloxane (PDMS) for replica moulding. The cast PDMS blocks can be bonded to 
other PDMS blocks, as well as other silicon-based surfaces such as glass. Because the mould 
can be reused and the PDMS is very cheap to obtain, the fabrication time and cost were 
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greatly reduced (Figure 1.3.1). This technology is so good that after nearly two decades, 
despite some disadvantages, including the complexity of making a master mould and multi-
layer assembly, soft lithography is still a widely used technique in prototyping lab-on-a-chip 
devices.  
 
Figure 1.3.1 Principle of PDMS soft lithography76. A casing is placed around the master mould, and 
liquid PDMS is poured over the mould. The PDMS is degassed under vacuum, and is later heated in an 
oven to harden. Cast PDMS is peeled off the master and then bonded to a flat substrate to enclose 
the microchannels to form a complete microfluidic device. The mould can be reused, and thus new 
devices can easily be made repetitively and quickly. (Reproduced from Ref 76 with permission from 
Nature Publishing Group) 
Laser beam machining  
Cutting, grinding, and punching are essential techniques for fabrication. However, 
conventional machining methods using mechanical force to remove unwanted materials 
may influence the fabrication accuracy through the deposition of waste materials on the 
surface72. The feature resolution is also limited by the spot size of the tools. Hence new 
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technologies using non-contact machining methods have been developed. For example, 
electrical discharge machining (EDM) is a well-developed fabrication process based on 
melting and vaporisation of materials by electrical sparks generated between the parts and 
the tools72. The drawback of this technology is that it can only function effectively with 
conductive materials such as metals. The fabrication process is also time-consuming and 
expensive.  
Laser beam machining (LBM) melts and vaporises materials by heat generated from a high 
energy laser source72. The beam shape is controlled by optical lenses to sharply focus on a 
small spot on the surface of the object. The optical lenses also determine the resolution and 
the precision of the laser. The laser power can easily fabricate with wood, fabric, and 
plastics and a high energy laser source is also able to fabricate with metals (Figure 1.3.2).  
 
Figure 1.3.2 Principle of direct laser micromachining77. A laser beam scans throughout the material. 
The laser creates a small heated area where the material will be evaporated. In this way, the 
unwanted material is expelled from the fabrication area in gaseous form, preventing the risk of 
material re-deposition on the surfaces and the resulting increase in surface roughness. (Reproduced 
from Ref 77 with permission from The Royal Society of Chemistry) 
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Apart from two-dimensional fabrication, such as cutting and grinding, laser-fabricated 
plastic sheets can be assembled and thermally bonded together and form three dimensional 
structures. Furthermore, such a technique can be used to fabricate master moulds for soft 
lithography59.  
1.3.1 Three dimensional (3D) printing 
Three dimensional printing, a.k.a. 3D printing, is an additive manufacturing process. The 
name is sometimes misleading because many other additive manufacturing technologies are 
also capable of creating three dimensional structures by stacking two-dimensional planes 
and assembling them in a third dimension. Yet, they are often called as 2.5-dimensional 
(2.5D) manufactures. The main feature that stands out the genuine 3D printing is that it can 
make an object with arbitrary shaping in all dimensions77. The widely accepted definition of 
3D printing specifically refers to the technology that selectively solidifies materials on a 
three-dimensional building stage. With few exceptions, most of them are building on a 
layer-on-layer basis. The 3D printing technology has been commercially available for more 
than two decades, but only recently, when the original patent expired, were great advances 
in developing 3D printing technologies achieved. At present, there are several different 3D 
printing types on the market.  
Stereolithography (SLA) 
Stereolithography is the classical method of 3D printing developed by Hull in 198678. In 
practice, fabrication takes place in a container filled with photosensitive resin. A radical 
stimulation (usually a UV laser) is used to scan and cure the resin at the surface of the 
building platform in the resin tank. After the surface layer hardens, the building platform 
will shift one layer so the laser will be focused on curing the next layer of the object. This 
process is repeated until the entire structure is cured.  
Currently, there are two different types of SLA printers: the bath configuration and the bat 
configuration77. The bath configuration is the conventional set-up. The laser is sourced from 
the top while the building platform submerges in the resin bath. The platform continuously 
moves downwards during the printing. In this method, however, the printable height of the 
object is limited to the depth of the resin tank. In contrast, the bat configuration is more 
advanced and widely accepted77. In this printing method, the laser comes from the bottom 
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of the resin tank and the printing pad is hanged over and pulled away from the resin tank 
during the printing. By this way, the printed object is positioned upside down when finish, 
but the height of the object is independent from the depth of the resin tank79, 80 (Figure 
1.3.3).  
SLA features high resolution, smooth surfaces, and acceptable printing speed. It is now 
globally applied in industrial prototyping processes. Many 3D printing technologies are 
derived from SLA and are often compared with it.  
 
Figure 1.3.3 Principle of Stereolithography (SLA) with bath configuration. The figure is adapted from 
a webpage81. 
Digital micromirror device-based projection printing (DMD-PP) 
This is a technology similar to the SLA, however, instead of using a laser to scan the shape of 
the printing object, it uses a projection system together with a digital mirror that can reflect 
the light to cure an entire layer simultaneously, where unwanted printing areas are digitally 
masked82. Besides, it is sometimes unnecessary to move the printing stage in DMD-PP 
because the focus depth can be automatically adjusted by tilting the convex lens equipped 
with the printer83. As a result, this technology can greatly reduce the printing time and it is 
believed to be the next generation of SLA77.  
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Two photon polymerisation (2PP) 
Two photon polymerisation is a direct writing technology. During the printing, two photons 
are absorbed by the photo initiator for the polymerisation reaction to begin from both sides 
directly within the volume of the resin82, 84. Because the resin is transparent, the focus of the 
laser beam can be controlled by adjusting the laser beam energy and the number of applied 
pulses84. Despite the fact that printing speed is decreased in 2PP, the printing resolution is 
greatly improved by avoiding contact to the oxygen and having a much smaller laser spot 
size84.  
Multi-jet modelling (MJM) 
Also known as Inkjet (Polyjet) 3D printing, MJM is a technology that is similar to 
conventional paper printers. The MJM printer usually has cartridges that contain printing 
materials, including photosensitive resins, plastic granules, or wax. The print head embeds 
multiple nozzles that are capable of jetting tiny drops of resins, melted plastics, or wax on to 
the printing pad. Once the droplets are cured by UV or thermally hardened on the printing 
platform, the printing stage moves downwards a step for building of the next layer on top of 
the previous one. By using multiple nozzles jetting picolitre droplets, this printing method 
gains high resolution and printing speed82. It also uses wax (which can be melted away later) 
as a support material for printing over hung structures, rather than print an additional 
supportive structure (which could to be manually removed later) in SLA technology. The 
only drawback for MJM is that cleaning out the wax is tedious and troublesome when 
printing certain structures. Although there are some water soluble support materials 
available now, the cleaning procedure is actually still difficult. The so-called water soluble 
supports also require some special solvents provided by the manufacturer to be dissolved, 
with the assist of constant tumbling in a specifically designed support cleaning apparatus.  
Fused deposition modelling (FDM)  
Also known as Fused filament fabrication (FFF), FDM is one of the most widely used 3D 
printing technologies at present. It uses a heating nozzle to melt thermoplastic filaments 
that are continuously fed into the extruder. Because there is only one nozzle for each 
polymer, melted polymers are dropped as threads onto the printing platform and then 
solidified on top of each another layer. After one layer is finished, the printing stage moves 
down one step for building the next layer. Depending on the manufacturer of the printer, it 
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also can have more than one nozzle to be able to print different materials together. This 
straightforward printing rational welcomes an extensive selection of materials 
(thermoplastics) for use in fabrication, as well as making itself relatively inexpensive. Its 
resolution, however, is also restricted by this printing method as it creates gaps formed 
from two adjacent molten polymer threads. The gaps result in a rough surface when finish 
and often cause leakage when containing liquids (Figure 1.3.4).  
 
Figure 1.3.4 Principle of Fused deposition modelling (FDM). The figure is adapted from a webpage85.  
Selective laser sintering (SLS) 
Selective laser sintering is a powder 3D printing technology77. There is powder reservoir 
filled with metal, ceramic, or polymer powders, continuously feeding a powder slider. On 
the printing platform, the slider spreads a thin layer of material powder smoothly and 
evenly. A laser is then used to selectively heat and fuse the powder particles into a bulk 
object. The most advantageous feature of technology over others is that it can print metals 
and ceramics, while other 3D printings can only work with plastics. Unlike resins or 
thermoplastics, metal and ceramic powders are not compressible, so there is no support 
structure needed to printing over hanging structures. The residue powder, however, is still 
difficult to remove from small and narrow structures.  
Bioprinting 
Bioprinting provides a solution that allows cells and biomaterials to be arranged together in 
a specific structure82. The printing methods, as well as materials, vary between different 
printer manufacturers, but they typically use combinations of other 3D printing technologies 
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(such as DMD-PP86 and MJM87) together with cells, hydrogels, or other viscous 
biocompatible materials in fabrications. 
To sum up, each of the 3D printing technologies has its highlights and drawbacks and there 
are different applications for each technology. The table below outlined the characteristics 
of each aforementioned 3D printing technology (Table 1-1): 
Table 1-1 Comparison of 3D printing technologies 
Type Material(s) Resolution Speed Cost Feature(s) 
SLA Photoresist resin <100 µm Medium Medium High resolution 
DMD-PP Photoresist resin <100 µm Fast Medium Rapid fabrication 
2PP Photoresist resin <100 nm Slow High Ultra-resolution; 
Truly 3D structure 
MJM Photoresist resin;        
Thermal polymer 
<100 µm Medium Medium Use of multiple 
materials together 
FDM Thermal polymer >200 µm Fast Low Simple and cheap; 
multiple materials; 
without support 
SLS Metal; Ceramics  <100 µm Medium Medium Use of metal as 
material 
BIO Cell; Hydrogel <100 µm Slow High Use of cells as 
material 
 
1.3.2 Applications of 3D printing in making lab-on-a-chip devices 
Comparing all major microfabrication techniques, 3D printing features high resolution, 
capability for making complex structures, and a simple and inexpensive fabrication process. 
Recent advances of 3D printing technologies have gained a growing interest in the biological 
and biomedical communities, and the applications of this technology in making microfluidic 
and lab-on-a-chip devices are being explored. 
Master mould fabrication 
The first application for microfluidics that used 3D printing involved making master moulds 
for elastomer casting. Back in 2002, McDonald and co-workers attempted to produce 
master moulds for microfluidic device fabrications with PDMS88. A Thermojet 3D printer (3D 
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Systems) using multi-jet moulding (MJM) technology was used in this study. At that time, 
however, the resolution for the printer was only 250 µm, which was not enough to make 
normal microfluidic devices, so only large channels (>250 µm) were tested in printing. As a 
result, the printed surface was so rough that the optical transparency was limited. The 
mould was also too soft, especially after being thermally cured with PDMS. Despite all these 
disadvantages, many positive prospects were foreseen, including simplicity in fabrication, 
large scale manufacturing, and fast but not labour intensive operation.  
Eight years after MJM was well developed, Bonyar and co-workers once again investigated 
the difficulty, resolution, and fabrication speed of using a new MJM 3D printer to construct 
moulds for PDMS replica moulding89, 90. In computer aided designs (CAD), they drew a few 
rectangular channels and then printed them out by using an Objet Geometries Eden 250 
printer. This 3D printer had two printing modes, namely “glossy” and “matt”. They found 
that although the “glossy” mode printed fully transparent parts with smoother surfaces, the 
printing accuracy was actually very poor, and vice versa for the “matt” mode. Interestingly, 
despite the manufacturer’s claims that the 3D printer had a sub 100 µm resolution, in 
practice, only those structure that are larger than 200 µm (for “matt”) and 400 µm (for 
“glossy”) were reliably built with accuracy. However, neither of these modes were actually 
useful for making complex microfluidic channels or devices directly (Figure 1.3.5).  
 
Figure 1.3.5 3D printing for making master moulds. A) From left to right: A 3D printed master mould; 
a negatively moulded PDMS layer; and a positively moulded epoxy mould90. (Reproduced from Ref 90 
with permission from Springer). B) A PDMS microfluidic cell lysis chamber moulded from 3D printed 
master moulds89. (Reproduced from Ref 89 with permission from Elsevier) 
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3D printed microfluidic interconnections 
Dealing with leakage is an instinctive problem in microfluidics. Three dimensional printing is 
capable of solving the issue by printing a fluidic interface with embedded connectors. Han 
and co-workers first reported a so-called microfluidic-system-interface (MSI) technology 
that can interconnect to complex microfluidic systems91. They used a SLA 3D printer to make 
an interface layer containing O-ring ports and fluid manifolds. This layer was then glued to 
the top surface of a glass microfluidic device. With this set-up, the system withstood up to 
116 psi during testing. Unfortunately, by using glue to irreversibly bond the interface onto 
the chip, the fabrication method became complicated again, which lost the advantage from 
using 3D printing.  
Paydar and co-workers also reported a 3D printed interface that contained a flexible gasket, 
an embedded O-ring, and a rigid clamp92. Tubing were directly connected to the interface 
and docked to the chip device by clamping the interface at the connection port. This design 
was tested with the goal of being able to hold a dead-end pressure up to 60 psi. However, in 
a subsequent test with the same prototype, the interface failed at 36 psi in a 12 hour test. 
This suggested that the clamping mechanism has its limitation for use in long-term 
experiments. This problem would be magnified further for applications such as long-term 
culture of small model organisms.  
Au and co-workers attempted to solve this problem by directly integrating 3D printed Luer 
connectors into the design of chip devices93. They made their microfluidic chips with female 
Luer connector embedded while the tubing was connected to commercially available male 
Luer connectors. Thanks to modern SLA technology, the printing resolution was high enough 
to create the three dimensional helix structures on the Luer connectors. From their test, the 
desired dimensions fit very well to the practically measured sizes (Figure 1.3.6). The authors 
also demonstrated acceptable optical transparency of 3D printed channels compared with 
glass microscope slides using fluorescent cells. Interestingly, the authors stated that the 
“resolution” defined as minimum printable feature, is not equivalent to the minimum 
printable channel in microfluidics. Despite the convincing report, the capabilities of desktop 
3D printers to fabricate complex microchannels still require more investigations on different 
microfluidic devices.  
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Figure 1.3.6 3D printing for making fluidic interconnectors93. A) Male Luer connectors interconnecting 
with 3D printed microchannels. B) 3D printed female Luer connectors integrated on the chip device. 
(Reproduced from Ref 93 with permission from The Royal Society of Chemistry) 
Monolithic lab-on-a-chip devices 
Using 3D printing technologies to fabricate monolithic lab-on-a-chip devices was reported 
by many research groups. Compared to conventional PDMS casting technology, although 3D 
printing has many advantages during the fabrication process, in practice, it still has issues 
such as low resolution, rough surface, and difficulties in post processing procedures. Thus 
the current 3D printing technologies are well suited to make devices in millimetre scale, 
rather micrometre scale. Also, it is critical to choose a suitable 3D printing technology for 
different device designs.  
Preechaburana and Filippini pioneered a feasibility study for printing monolithic microfluidic 
devices94. In this report, a series of microfluidic manifolds in arbitrary positive, negative, and 
suspended 3D geometries were created. The authors described the substantial capabilities 
of 3D microfabrication methodology to fabricate 3D micro structures in a concise and 
affordable way. In a highlight of this study, the authors managed to 3D print a cantilever 
structure for fluid mixing purposes in a stream of flow. By using a DMD-PP 3D printer, all the 
microstructures were fabricated within 5 minutes. Unfortunately, the printing system only 
supported a maximum working area of 4 mm2 at the highest resolution mode, which is 
insufficient for most monolithic microfluidic devices.   
Bonyar and colleagues presented a monolithic fluid mixer and homogeniser for 
gynaecological cervical sample storage and pre-processing89. The authors took full 
advantages of 3D printing to make microfluidic device that were inexpensive and 
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disposable, so the device was capable of separating deoxyribonucleic acid (DNA) and protein 
from cervical samples and delivering them from a clinic to a laboratory. In addition, the 
authors also showed some flexibilities in using 3D printing technologies; they customised a 
holder platform for a surface Plasmon resonance imaging instrument. The process from the 
design all the way through the fabrication occurred within a day, which avoided tedious 
purchase order procedures from the original manufacturer. However, the authors failed to 
provide any biological assay results from the bio device, thus its actual functionality is still 
unknown.  
Shallan and co-workers demonstrated how to use DMD-PP 3D printing technology to 
fabricate microfluidic devices with different functions95. The authors fabricated their devices 
by using a miniaturised DMD-PP 3D printer with a printable stage of merely 43 mm × 27 mm 
× 180 mm (x × y × z), specialised for making microfluidic devices. Apart from mixing the 
fluids, the devices fabricated with high resolution were able to generate concentration 
gradients, extract droplets, and even undertake electrophoresis (Figure 1.3.7 A). 
Unfortunately, no topological studies of the printing surface were conducted in this paper. It 
is rather crucial to show these important parameters when using and testing cheap 3D 
printers.  
Kitson and co-workers reported a few 3D printed microfluidic “reactionware” devices for 
chemical synthesis96. The devices were printed on a desktop 3D printer using FDM 
technology. By using polypropylene (PP) as the printing material, the devices were tolerant 
to a wide range of organic and inorganic chemical reactions, including reductive amination, 
alkylation, and large polyoxometalate synthesis. This methodology allows customised 
reaction wares’ design and fabrication so that it offers greater freedom to the chemistry 
communities (Figure 1.3.7 B). This work proved that chemical reagents were stable when 
exposed with 3D printed materials. However, the compatibility of using such devices for 
containing biological samples has not yet been tested.  
Rogers and co-workers presented a 3D printed microfluidic device with membrane based 
valves97. The membrane was printed together with the chip device and functioned well at 
20 psi. Interestingly, the fabrication was performed on a normal SLA 3D printer, but the 
authors used a tailored resin formula for specific hydrophilicity requirements. Moreover, 
such 3D printed devices allowed direct bonding with a range of commonly used materials, 
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including glass and PDMS, which broaden the application of this device even further. 
Unfortunately, the material selected for 3D printing was not optically transparent. This 
largely limited its application in biological assays.  
 
Figure 1.3.7 3D printing for making monolithic chip devices. A) A 3D printed device filled with 
coloured solutions to show the different fluidic layers95. (Reproduced from Ref 95 with permission 
from ©  2014 American Chemical Society). B) A 3D-printed reactionware used for polyoxometalate 
syntheses96. (Reproduced from Ref 96 with permission from The Royal Society of Chemistry) 
3D printed lab-on-a-chip device with integrated features 
Apart from making monolithic devices, 3D printing also help fabrication with integrated 
features. For example, a 3D printed helix thread structure on the chip device provides 
capability of interconnecting additional parts easily but without leaking. Being able to 
integrate fine parts patches the weak point of not being able to precisely fabricate complex 
small features in current 3D printing technologies. Lab-on-a-chip devices become more 
versatile with integration of mechanic, electronic, and photonic parts for different research. 
Anderson and co-workers fabricated a 3D printed high-throughput fluidic device for 
studying drug transport and cell viability in a parallel manner98. The device comprised eight 
parallel channels. Each channel had independent fluidic controls enabling eight independent 
tests in the same time. The device was also designed to allow integration of commercially 
available membrane inserts for different drug delivery test during dynamic flow through the 
system (Figure 1.3.8 A). On the other hand, the author pointed out that among the 17 
available materials for the Object Connex 3D printer, only one was tested as being 
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biocompatible with medical approval. The need for a comprehensive biocompatibility test 
on commercially available 3D printing materials is thus extremely urgent.  
Begolo and co-workers introduced a miniaturised pumping mechanism for microfluidic 
studies99. This 3D printed device not only served as a fluidic interface, but also could 
produce positive or negative pressure flow by compression or expansion of gases. In 
practice, up to 300 µL of reagent could be pumped into a chip device by using the pumping 
mechanism. In response to criticisms regarding the complexity of using lab-on-a-chip 
devices, the authors herein demonstrated that this device was so user-friendly that even a 
six-year-old child was able to operate the device after minimal training (Figure 1.3.8 B). 
Unfortunately, this design could only manipulate a small amount of fluid (20 µL), which is 
not enough for a normal bioassay on small model organisms.  
Erkal and colleagues reported two 3D printed microfluidic devices with integrated 
electrodes for oxygen level measurement and ATP detection100. In both cases, the 
electrodes were encapsulated in cured epoxy resin and inserted into plastic fitting bolts. The 
bolts were then screwed into a 3D printed device with embedded threads. With different 
electrodes and coatings, the first device successfully detected dopamine and nitric oxide 
concentrations in flow injection analyses. The second device managed to detect oxygen 
levels in a stream of flowing biological samples (Figure 1.3.8 C). Again, this work lacked 
biological experiment verification and its reliability was also not demonstrated.  
Walczak and Adamski explored the use of MJM technology to fabricate microfluidic 
structures101. They investigated several printers for their printing quality and optimised 
printing protocols. Although the authors managed to fabricate a chip device with integrated 
optical fibre and a spectrophotometric chip that is capable of detecting UV/VIS spectra of 
loaded fluids, they found that the minimum dimension for a microfluidic channel to be 3D 
printed properly was around 200 µm. This proved that current 3D printing technologies are 
only applicable for making fluidic devices in millimetre scales, rather than micrometre 
scales, which is suitable for devices accommodating small model organisms.  
Bhargava and co-workers developed a microfluidic system with 3D printed discrete 
components102. Much like LEGO blocks, each 3D printed part had male and female 
connectors, together with fluid channels. They could be easily assembled into a fully 
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functional device in any desired configuration. The drawback of this concept is that the final 
assembly could be very complex for certain fluidic manifolds and leakage could also be a 
problem as the final assembly size becomes larger (Figure 1.3.8 D).  
 
Figure 1.3.8 3D printing for making microfluidic complexes. A) A 3D printed device with inserted 
membrane98. (Reproduced from Ref 98 with permission from ©  2013 American Chemical Society). B) 
A 3D printed device with a self-pumping lid delivering coloured fluid99. (Reproduced from Ref 99 with 
permission from The Royal Society of Chemistry).  C) A 3D printed device with integrated Pt-electrode, 
electrode leads and interconnectors100. (Reproduced from Ref 100 with permission from The Royal 
Society of Chemistry). D) A fluidic system combined with discrete elements102. (Reproduced from Ref 
102, no permissions were required) 
1.3.3 Challenges in 3D printing  
3D printing technologies have been extensively studied with regard to fabrication of 
microfluidic lab-on-a-chip devices. Despite promises of rapid and user-friendly fabrication 
processes, using 3D printing is still challenging for most microfluidics applications. The 
printing quality, especially the surface roughness, has not yet been properly evaluated. It is 
known that different 3D printers using different materials result in various finish qualities 
and optical transparencies. As microfluidic chip-devices require high quality fabrication, a 
comprehensive assessment in printing quality is necessary. Moreover, despite the fact that 
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most 3D printed lab-on-a-chip devices are designed for biological studies, the general 
toxicity profile of 3D printing materials remains largely unknown. As many 3D printing 
materials are developed by individual companies and their chemical composites are 
protected, the assessment could be performed using bioassays on selected model 
organisms.  
 
1.4 Thesis aim and objectives 
The presented research is aimed to address all the challenges described above, namely: 
i) Evaluation of the feasibility of using 3D printing to fabricate a lab-on-a-chip device for 
zebrafish embryo bioassays.  
ii) Investigation of the toxicity profile of a range of common 3D printing materials and 
finding the compounds contributing to the toxicity 
iii) Design and development of a new microfluidic lab-on-a-chip device that allows 
automated zebrafish embryo arraying and long-term culturing, without material toxicity 
issues. 
iv) Integration of technologies and prototyping a miniaturised, automated, and multi-
functioned system to manipulate zebrafish embryos for high-throughput bioassays.  
In particular, Chapter 2 provides general methods used throughout the thesis, including 
chemistries, animal cultures, and fabrications. Each objective listed above is completed and 
described in Chapter 3 to Chapter 6, where experimental results and discussions are 
presented. The thesis is concluded in Chapter 7 with an outlook of future research 
directions.  
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2 Materials and Methods   
This chapter describes the materials used in the experiments, including reagents for 
biological tests, as well as materials for device fabrication. This chapter also presents 
methods in prototyping, animal culture, and data acquisition and analysis. 
 
2.1 Chemicals and materials 
2.1.1 Chemicals for toxicity test 
Copper sulphate pentahydrate (CuSO4·5H2O) and caffeine were purchased from Sigma-
Aldrich, Australia as solid powders. Solutions were prepared by dissolving solids in E3 
medium in volumetric flasks, followed by serial dilutions.  
1-Hydroxycyclohexyl phenyl ketone (1-HCHPK; Sigma-Aldrich, Australia) was dissolved in 
dichloromethane (Sigma-Aldrich, Australia) at a ratio of 600:1 (w/v) as a stock solution. 
Working solution was prepared by serial dilutions using E3 medium.  Vehicle control was 
prepared by adding dichloromethane into E3 medium.  
Dimethyl sulfoxide (DMSO), phenol, ethanol, and nicotine were purchased from Sigma-
Aldrich, Australia as liquids. Solutions were prepared by adding test chemicals into E3 
medium in volumetric flasks, followed by serial dilutions.  
Anti-angiogenesis drugs AV951 (Tivozanib; Symansis Ltd., Auckland, New Zealand) and 
Sunitinib (Sutent; Sapphire Bioscience Ltd., New South Wales, Australia) were dissolved in 
DMSO as stock solutions. Working solutions were prepared by serial dilution using E3 
medium. Vehicle control was prepared by adding DMSO into E3 medium. 
2.1.2 Biological culture media 
Algae culture medium (MLA medium) was prepared as shown below in Table 2-1. The final 
culture medium (working solution) was then autoclaved.  
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Table 2-1 MLA medium formulation103 
 
 
Duckweed culture medium (Hoagland’s E-medium) was prepared as demonstrated below in 
Table 2-2. The final culture medium (working solution) was then autoclaved.  
Table 2-2 Hoagland’s E-medium formulation 
 
Constituents Working solution (mg/L)
1. MgSO4·7H2O 49.1
2. NaNO3 170
3. K2HPO4 34.8
4. H3BO3 2.4
5. Na2EDTA 4.56
6. FeCl3·6H2O 1.58
7. NaHCO3 18
8. MnCl2·4H2O 0.36
9. CuSO4·5H2O 0.01
10. ZnSO4·7H2O 0.022
11. CoCl2·6H2O 0.01
12. Na2MoO4·2H2O 0.006
13. H2SeO3 0.0012
14. CaCl2·2H2O 29.4
15. Na2SO3 12.6
16. Thiamine HCl 0.1
17. Biotin 0.0005
18. Cyanocobalamin (Vitamin B12) 0.0005
Constituents Working solution (mg/L)
1. MgSO4·7H2O 246
2. Ca(NO3)2·4H2O 542.8
3. KH2PO4 68
4. KNO3 252.5
5. H3BO3 1.43
6. MnCl2·4H2O 0.91
7. ZnSO4·7H2O 0.11
8. Na2MoO4·2H2O 0.045
9. CuSO4·5H2O 0.045
10. FeCl3·6H20 9.68
11. EDTA 30
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Daphnia culture medium contained NaHCO3 (67.75 mg/L), CaCl2·2H2O (294 mg/L), 
MgSO4·7H2O (123.25 mg/L), and KCL (5.75 mg/L) in Milli-Q water.  
Rotifer culture medium contained NaHCO3 (96 mg/L), CaSO4·2H2O (120 mg/L), MgSO4·7H2O 
(123 mg/L), and KCL (4 mg/L) in Milli-Q water.  
Ceriodaphnia culture medium contained NaHCO3 (96 mg/L), CaSO4·2H2O (60 mg/L), MgSO4 
(60 mg/L) and KCL (4 mg/L) in Milli-Q water.  
Zebrafish embryo culture medium (E3) contained NaCl (292.5 mg/L), KCl (12.67 mg/L), CaCl2 
(36.62 mg/L), MgSO4 (39.72 mg/L), and methylene blue (0.002% v/v) in Milli-Q water. 
 
2.2 Biological specimens  
2.2.1 Plant culture and biotests 
Microalgae 
Fresh water microalgae Selenastrum capricornutum (a.k.a Pseudokirchneriella subcapitata) 
beads were obtained from the Algaltoxkit-F TM (MicroBioTest Inc., Belgium) biotest kit. 
Tubes containing storage medium and algal beads were kept in a refrigerator at 4 °C until 
use. When preparing the algae stock, algal beads were dissolved in the “Matrix dissolving 
medium” provided in the test kit. To assist this de-immobilising process, vigorous hand 
shaking was exercised followed by centrifugation at 3000 rpm for 10 minutes. After pouring 
out the supernatant, the remaining algae were resuspended homogenously in the algal 
culture medium. The resultant algal suspension was incubated in a 500 mL Erlenmeyer flask 
filled with 100 mL of culture medium placed on a rotatory mixer and illuminated 
continuously by LED light under 10,000 lux at 22 °C for 72 hours.  
Prior to the experiment, the concentration of algae stock was determined using a TC-20 TM 
automated cell counter (Bio-rad, Australia). The algal suspension was then diluted at least 
10 times by the respective test compound solutions, and were then pipetted into standard 
24-well plates with 2 mL per well. Each concentration had 5 replicates. From each well, 100 
µL of algae test solution was transferred into standard 96-well plates to measure the optical 
density (OD) at 670 nm using a microplate reader (PolarStar Omega, BMG Labtech, 
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Offenburg, Germany). The culturing 24-well plate was placed on a rotatory mixer and 
illuminated continuously by LED light under 10,000 lux at 22 °C for up to 96 hours. Every 24 
hours, 100 µL of algae test solution was transferred into standard 96-well plates to measure 
the OD as described above.  
Duckweed 
Duckweed (Lemna minor) was obtained from a culture collection held in the RMIT University 
Bundoora West Campus, Victoria, Australia. Collected plants were transferred into a 
container filled with duckweed culture medium and illuminated continuously by LED light 
under 10,000 lux at 25 °C.  Test plants were acclimated in this condition for at least three 
weeks before experiments.  In the tests, duckweed with a same number of fronds were 
transferred into 250 mL beakers filled with 100 mL medium/test compound solutions. Each 
concentration had 3 replicates. The beakers were then wrapped in aluminium foil and 
covered by a transparent thin plastic film. All the beakers were illuminated continuously by 
LED light under 10,000 lux at 25 °C for up to 7 days. At the end of days three, five, and 
seven, the number of frond in each beaker was manually counted. At the end of 
experiment, the fresh weight of the duckweed from each beaker was measured.  
2.2.2 Invertebrate culture and biotests 
Artemia cysts and larvae 
Marine crustacean Artemia franciscana cysts were obtained from the Artoxkit-MTM 
(MicroBioTest Inc., Belgium) biotest kit. Vials containing dry cysts were kept at 4 °C until use. 
When hatching, cysts were incubated in a Petri dish filled with filtered sea water (pH= 8.0 ± 
0.5) and illuminated continuously by LED light under 3000 lux at 25 °C for 30 hours. After 23 
hours of incubation, hatched larvae were manually selected and kept incubating, while 
unhatched cysts were discarded. In experiments, artemia larvae were pipetted into 
standard 24-well plates. Each plate contained 1 mL of medium/test compound solution and 
10 artemia larvae. Each concentration had 5 replicates. The test plate was then incubated in 
darkness at 25 °C for 24 hours. At the end of the test, animal mortality was manually 
counted under a stereomicroscope.  
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Daphnia ephippia and neonates 
Fresh water crustacean Daphnia magna ephippia were obtained from the Daphtoxkit-F 
Magna TM (MicroBioTest Inc., Belgium) biotest kit. Vials containing storage medium and 
ephippia were kept in a refrigerator at 4 °C until use. When hatching, ephippia were rinsed 
by pre-aerated daphnia culture medium to remove any storage medium. Rinsed ephippia 
were then incubated in a hatching Petri dish filled with daphnia culture medium and 
illuminated continuously by LED light under 6000 lux at 22 °C for 80 hours. After 72 hours of 
incubation, spirulina powder was sprinkled into the hatching Petri dish for pre-feeding. In 
experiments, neonates were pipetted into a special 24-well plate provided in the test kit. 
Each test well contained 10 mL of medium/test compound solution and 5 neonates. Each 
concentration had 4 replicates. The plate was then covered with Parafilm and incubated in 
darkness at 20 °C for up to 48 hours. Every 24 hours, animal mortality was manually counted 
under a stereomicroscope. 
Rotifer cysts and neonates 
Fresh water rotifer Brachionus calyciflorus cysts were obtained from the Rotoxkit-F TM 
(MicroBioTest Inc., Belgium) biotest kit. Vials containing dry cysts were kept at 4 °C until use. 
When hatching, cysts were incubated in a special 36-well plate obtained from the test kit. 
The hatching wells were filled with pre-aerated rotifer culture medium and illuminated 
continuously by LED light under 3000 lux at 25 °C for 18 hours. After 16 hours of incubation, 
hatched neonates were manually selected and kept incubating, while unhatched cysts were 
discarded. The experiments started within 18 hours of incubation. In experiments, rotifers 
were pipetted from the hatching wells into the test wells of the 36-well plate. Each test well 
contained 0.3 mL of medium/test compound solution and 5 neonates. Each concentration 
had 6 replicates. The plate was then covered with Parafilm and incubated in darkness at 
25 °C for 24 hours. At the end of the test, animal mortality was manually counted under a 
stereomicroscope. 
Ceriodaphnia ephippia and neonates 
Fresh water crustacean Ceriodaphnia dubia ephippia were obtained from the 
Ceriodaphtoxkit-F Acute TM (MicroBioTest Inc., Belgium) biotest kit. Vials containing storage 
medium and ephippia were kept in a cool dry place at 20 °C until use. When hatching, 
ephippia were rinsed with pre-aerated ceriodaphnia culture medium to remove any storage 
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medium. Rinsed ephippia were then incubated in a hatching Petri dish filled with culture 
medium and illuminated continuously by LED light under 6000 lux at 25 °C for 80 hours. In 
experiments, neonates were pipetted into standard 24-well plates. Each test well contained 
1 mL of medium/test compound solution and 10 neonates. Each concentration had 3 
replicates. The plate was then covered with Parafilm and incubated in darkness at 25 °C for 
24 hours. At the end of the test, animal mortality was manually counted under a 
stereomicroscope. 
Amphipod 
Adult amphipods Allorchestes compressa were collected from ashore sea grass in Swan Bay, 
Victoria, Australia. Collected animals were maintained in glass tanks filled with filtered sea 
water at temperature of 20 ± 1 °C with a 12 hour light/dark cycle. Amphipods were left to 
acclimate for at least two weeks prior to experiments. In the test, amphipods were pipetted 
into standard 24-well plates. Each test well contained 2 mL of medium/test compound 
solution and 2 amphipods. Each concentration had 5 test wells. The plate was then 
incubated at 20 ± 1 °C with a 12 hour light/dark cycle for up to 72 hours. Every 24 hours, 
animal mortality was manually counted under a stereomicroscope. 
2.2.3 Vertebrate culture and biotests 
Vertebrate animal experiments were conducted with approvals from the University of 
Auckland Animal Ethics Committee, the RMIT University Animal Ethics Committee, and the 
Monash University Animal Ethics Committee. 
Zebrafish husbandry and embryo culture 
Adult wild type zebrafish were kept in a circulating aquatic system on a 14 hour light and 10 
hour dark cycle. The environmental temperature was maintained at 27.5 ± 0.5 °C and the pH 
was held at 7.5-8.0. Fish were fed twice daily, once with live crustaceans Artemia sp. and 
once with dry fish food granule.  Daily monitoring was exercised and standard water quality 
parameters (pH, ammonia, nitrite, nitrate, carbon hardness, and general hardness) were 
measured.  
Zebrafish embryos were obtained from pair-wise mating and natural spawning of the adult 
zebrafish. Adult fish were randomly grouped in a 1:1 male to female ratio in a separate fish 
tank and left overnight. Female adult fish naturally spawned eggs when the light was turned 
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on the following morning. Embryos were harvested within an hour of spawning and were 
transferred to embryo culture medium (E3).  
Wild type embryos were incubating at 28 °C in a Petri dish filled with E3 medium until use. 
Any debris and unfertilised embryos were manually removed at 3 hour post fertilisation 
(hpf). When using transgenic Tg(fli1:EGFP) embryos, harvested embryos were incubated at 
22 °C for 16 hours. Prior to experiments, homozygous-recessive and heterozygous embryos 
were manually removed. The density of embryos held in the Petri dish was kept around 50 
per dish. Besides, culture medium (E3) that contained 0.003% 1-phenyl-2-thioures (PTU; Life 
technologies Corp., California, USA) was used to inhibit the natural formation of the pigment 
that optically blocks the observation of inter-segmental vessel (ISV). At the end of 
experiments, 0.2 mg/mL of Tricaine mesylate (TMS) was added into the culture medium to 
temporarily anaesthetise the embryo from spontaneous movement inside the chorion.  
Static fish embryo toxicity (FET) tests were performed according to the OECD animal test 
protocol44. In experiments, 20 fertilised embryos at 5 hour post fertilisation (hpf) were 
dispensed into 24-well plates with one embryo per well. Test compound, positive control, or 
negative control solutions were then pipetted into the test wells with 2 mL per well. The 24-
well plate were covered by Parafilm-M and incubated in darkness at 28 ± 1°C for up to 48 
hours.  
Chip-based fish embryo toxicity (µFET) tests were conducted with a slight modification from 
the FET test protocol44. In experiments, 21 embryos at 5 hour hpf were loaded into each 
culturing chamber on the microfluidic chip made of PMMA. The device was connected to a 
fluid reservoir containing 40 mL of test compound, positive control, or negative control via 
PUR tubing.  Such system was continuously perfused in a closed-loop regimen at flow rate of 
400 μL/min. Embryos were immobilised on the chip device and incubated in darkness at 28± 
1°C for up to 48 hours.  
In 3D printed chip device experiment, 24 embryos at 5 hour post fertilisation were loaded 
into each culturing chamber of the microfluidic chip made from different 3D printing 
materials. The device was connected to a fluid reservoir containing 40 mL of embryo 
medium via silicon tubing.  The system was continuously perfused in a closed-loop regimen 
at flow rate of 400 μL/min. Embryos were immobilised on the chip device and incubated in 
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darkness at 28± 1°C for up to 72 hours. At the end of experiments, embryos were unloaded 
from the chip device into a Petri dish where embryonic development was observed under a 
stereomicroscope.  
Zebrafish larvae 
Zebafish larvae were obtained from hatched zebrafish embryos. Zebrafish embryos normally 
hatch around 48 hpf under the incubation conditions described in section 2.5.1. Hatched 
larvae were kept incubating until use.  
In larval toxicity experiments, larval zebrafish at 5 days post fertilisation (dpf) were manually 
transferred into standard 24-well plates. Each test well of the 24-well plate contained 2 mL 
of medium/test compound solution and one zebrafish larvae. Each concentration had 5 
replicates. The plate was then covered with Parafilm and incubated in darkness at 28 ± 1 °C 
for up to 48 hours. Every 24 hours, the number of unviable animals was manually counted 
under a stereomicroscope. 
In zebrafish larvae behaviour tests, larval fish at 7 days post fertilisation (dpf) were used. 
The day prior to the experiment, test larvae were fed with live paramecium (Paramecium 
caudatum; Southern biological, Victoria, Australia) to keep them active. In experiments, 
larval fish were pipetted into standard 24-well plates with one larvae per well. Each test well 
contained 1 mL of embryo medium/test solution. Locomotion activity analysis was 
performed using the Zebrabox behaviour recording system and associated analysis software 
(ViewPoint, France). The tracking experiment was conducted on a 4 min light and 4 min dark 
cycle for 64 minutes at temperature of 25 ± 1 °C.  A LED light pad and an infrared camera 
were equipped for light stimulation and dark imaging, respectively. Assessment of sub-lethal 
behavioural effects was performed by tracking the movement (total distance moved) of 
each larvae during alternating periods of 240 seconds of light and dark.  
 
2.3 Scoring criteria for zebrafish embryo biotests 
Based on the OECD testing protocol (FET), four lethal end-points were recorded every 24 
hours: (i) coagulation; (ii) lack of somite formation; (iii) lack of tail detachment from the 
yolk; and (iv) lack of heartbeat44.  
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Furthermore, a new method (iFET) developed by Wigh and co-workers was applied to score 
sub-lethal biomarkers and teratogenicity104. This method introduced 9 new parameters:  (i) 
abnormal eye development; (ii) pericardial oedema; (iii) lack of pigmentation; (iv) defects in 
blood circulation; (v) head abnormalities; (vi) tail abnormalities; (vii) heart abnormalities, 
(viii) spine abnormalities; and (ix) yolk abnormalities104. These sub-lethal parameters were 
also checked every 24 hours. 
The iFET index integrated lethal and sub-lethal endpoints observed from the experiment. It 
can be quantitated using the following formula104: 
 
iFET index =  
(9 x ND) + ∑ 𝑁
𝑁
1 𝑆𝐿
9 x N
x100%  
 
Where N = total number of test embryos; ND = number of dead embryos (FET lethal 
endpoints); NSL = number of sub-lethal biomarkers recorded from each embryo (iFET sub-
lethal endpoints, a total of 9 for each embryo). The iFET index was expressed as a 
percentage of embryos that shows lethal and/or sub-lethal abnormalities. 
 
2.4 Design and fabrication 
2.4.1 Infrared laser machining 
The design and modelling of microfluidic lab-on-a-chip devices were performed using the 
CorelDraw X3 (Corel Corp., Ontario, Canada) software package. For multilayer devices, each 
layer was fabricated separately in poly(methyl methacrylate) (PMMA) – a transparent 
thermoplastic - using a non-contact 30W CO2 infrared laser machining system (VLS 3.50, 
Universal Laser Systems, Scottsdale, Arizona, USA). The system was equipped with high 
power density focusing optics (HPDFO) that has a 40 µm elliptical beam spot (Figure 2.4.1).  
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Figure 2.4.1 Laser cutting system. A) VLS 3.50 infrared CO2 laser cutting system. B) Lenses: left – High 
Power Density Focusing Optics (HPDFO) lens with a beam spot size of 40 µm; right – Standard lens 
with a beam spot size of 100 µm.  
Fabricated PMMA slides were manually aligned, sandwiched by, in the sequence of, 
standard microscope glass slides, metal slides, and C-clamps. It was then thermally bonded 
in a fan assisted oven at 120 °C for 1.5 hours. 
2.4.2 Soft lithography 
The master mould was designed and fabricated using laser machining as described in 
section 2.4.1. The mould was then used for replica moulding with poly(dimethylsiloxane) 
(PDMS; Sylgard 184; DowCorning Corp., Midland, Michigan, USA). The PDMS elastomer base 
and curing agent were mixed at a ratio of 10:1 (w/w). The mixture was poured onto a 
master mould, followed by the degassing process at 40 Torr to remove air bubbles 
completely.  
The de-bubbled PDMS mixture was cured thermally in a fan assisted oven at 70 °C for 1.5 
hours. The hardened PDMS layer was then carefully peeled off from the master mould. The 
inlet and outlet of the device were bored by a 3 mm diameter biopsy punch. The resulting 
PDMS block was bonded to a standard glass microscope slide using oxygen plasma 
generated by a reactive ion etching system (RIE; CS-1701 RIE Plasma Cleaning System, 
March, Concord, Massachusetts, USA) in a clean room. 
2.4.3 Three dimensional (3D) printing  
The design and modelling of 3D printed objects were performed using the SolidWorks 2013 
(Dassault Systems SolidWorks Corp., USA) software package. All designs were saved as STL 
file and were then processed by the respective 3D printers’ software.  
44 
 
Multi-jet moulding (MJM) fabrication 
HD3500 Plus (3D Systems, USA) high definition 3D printer was used for MJM fabrication. It 
features a 25 µm x-y resolution and 16 µm z-layer thickness. VisiJet Crystal (3D System, USA) 
resin together with VisiJet S300 Support Wax (3D System, USA) was used for fabrication 
according to the standard operating procedures. The following post-processing procedure 
was conducted to remove the support wax from the printed parts: (i) heating in the oven at 
65 °C to melt and scrap out large chunks of wax; (ii) soaking in warm vegetable oil in an 
ultrasonic bath at 55°C with a pumping flow at 70 mL/min; and (iii) rinsing and flushing with 
Decon90 detergent to clean out any residual wax and oil. Furthermore, to achieve a 
desirable level of optical transparency, the surface of the device was polished using 10.3 µm 
grit pads followed by 9 µm diamond paste (Mold Makers 9-STD GREEN; Boride Engineered 
Abrasives, USA) with high-quality modelling heads (Dremel, USA).  
Stereolithography (SLA) fabrication 
Multiple SLA systems were selected including: (i) Viper Pro (3D System, USA) using 
Watershed 11122XC (DSM Somos, USA) resin or Dreve Fototec 7150 Clear (Dreve Otoplastik 
GmbH, Germany) resin; (ii) ProJet 7000HD (3D Systems, USA) using VisiJet SL Clear (3D 
Systems, USA) resin, and (iii) Form 1 using Form Clear (FormLabs, USA) resin. The first two 
systems are characterised by 25 µm x-y resolution and 50 µm z-layer thickness, while the 
third system has 300 µm x-y resolution and 50 µm z-layer thickness.  All prototyping was 
performed according to manufacturer’s standard operating procedure, including flushing 
and resining with 99% isopropyl alcohol to remove un-polymerised resins. In addition, 
prototypes fabricated from the Form1 printer were exposed to UV light at emission 
wavelength of 350 nm in a standard tissue culture hood for 12 hours to harden the polymer. 
To achieve a desirable level of optical transparency, the surface of the device printed in 
Dreve Fototec 7150 Clear or Form Clear resins was mechanically polished by using 10.3 µm 
grit pads followed by 9 µm diamond paste polishing (Mold Makers 9-STD GREEN; Boride 
Engineered Abrasives, USA) with high-quality modelling heads (Dremel, USA).  
Fused Deposition Modelling (FDM) fabrication 
Makerbot Replicator 2 (MakerBot, Brooklyn, New York City, USA) desktop 3D printer with 
poly(lactic acid) (PLA) and uPrint SE (Stratasys, Edina, Minnesota, USA) with acrylonitrile 
butadiene styrene (ABS) were used for FDM fabrication. In addition to the standard 
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processing procedure, post-processing treatment was performed manually to remove any 
support materials and printing residues. 
 
Figure 2.4.2 3D printers used in this study. From left to right: ProJet 3500HD is a MJM 3D printer 
using VisiJet Crystal material together with VisiJet S300 support wax. ViperPro is a SLA 3D printer 
using Watershed 11122XC resin or Dreve FotoTec Clear resin. ProJet 7000HD is also a SLA 3D printer 
using VisiJet SL Clear resin. And Form 1 is a SLA 3D printer as well using Form Clear resin. All the 
printing materials are specifically used for only their designated 3D printers.  
 
2.5 Electricals and actuators 
Dynamixel MX-64T robotic actuators (Robotis Ltd., Irvine, California, USA) were used in 
making 3D printed peristaltic pumps. Each actuator was equipped with an on-board 32bit 72 
MHz Cortex M3 microcontroller, contact-less magnetic encoders and TTL 2.0 bus. The 
actuators were controlled by a CM-530 microcontroller (Robotis Ltd.) based on 32-bit ARM 
Cortex M3 architecture. The programing of the actuators was performed in a native 
RoboPlus environment (Robotis Ltd.). In addition, Dynamixel AX-12A servo actuators 
(Robotis Ltd.) were used in making a moving stage for imaging in the integrated device.  
Miniplus Evolution peristaltic pumps equipped with MFI pump heads (Gilson Inc., 
Middleton, Wisconsin, USA) was used in the device validation test. A water bath (Julabo 
Labortechnik GmbH, Seelbach, Germany) was used for incubation when hatching organisms.  
 
46 
 
2.6 Tubing 
Polyurethane (PUR) tubing, silicon tubing and luer connectors (John Morris Scientific Pty. 
Ltd., Australia) were used for connecting peristaltic pumps. They all have an inner diameter 
of 1/16” (1.58 mm) that allows zebrafish embryos to pass through. Polyvinyl chloride (PVC) 
tubing (Gilson Inc., Middleton, Wisconsin, USA) was used inside the peristaltic pumps. This 
flexible tubing has an inner diameter of 1.02 mm that provides the desired flow rates 
ranging from 0.1 mL/min to 7.0 mL/min. 
 
2.7 Imaging  
Stereomicroscopy and time-lapse imaging were conducted using Nikon SMX18 (Nikon Corp., 
Tokyo, Japan) equipped with a Retiga TM 4000DC cooled CCD camera and Nikon Eclipse TiE 
epifluorescence microscope equipped with a cooled DS-Qi1Mc CDD camera. A standard 
FITC/GFP filter cube (Nikon Corp.) was used to acquire fluorescence images of Tg(fli1a:EGFP) 
zebrafish embryos. The systems were controlled by a native NIS-Elements Ar software 
package.  
Confocal laser scanning microscopy was performed on a Leica SP5 (North Ryde, New South 
Wales, Australia) with a FLUOTAR 10x dry objective lens. Focus-stack imaging was 
performed in steps of 5 µm. Bidirectional scan was performed with 3 line average at 8 bit 
and 200 Hz scan speed. A 488 nm Argon laser was used at 30% power for excitation. The 
emission signals were received from 498 nm to 651 nm.  
Miniaturised USB microscopy (AM7013MT Dino-Lite Premier, Dino-Lite, AnMo Electronics 
Corp., New Taipei City, Taiwan) was used for brightfield imaging and video recording. This 
microscope was equipped with a 5 megapixal colour CMOS sensor and variable 
magnifications of up to 200x, supporting video acquisition up to 15 frame per second (fps). 
The illumination was supplied by 8 embedded LED lights, which were controlled by the 
operating software (DinoCapture2.0; AnMo Electronics Corp.). Time-resolved image 
acquisition was fully programmable through the software user interface.  
Scanning electron microscopy (SEM) was performed using a FEI Quanta 200 ESEM (2002) 
(FEI Company, Hillsboro, Oregon, USA) operated at 20.0 kV with a 5.0 Spot size in high 
vacuum. Before sampling into the SEM, samples were coated with Au/Pd using an in-house 
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sputter coater operating at 15 mA for 2 minutes. The object stage was tilted to 39° for 
stereoscopic imaging.  
Optical profilometry images were taken from BRUKER ContourGT-I 3D Optical Microscope 
(Bruker Corp., Billerica, Massachusetts, USA).  Stitching was enabled to obtain a final 
bounding box of 0.5 mm x 0.5 mm with 20% overlapping area. 
 
2.8 Oxygen gradient imaging 
Oxygen detection was accomplished by a Presens® VisiSens TM system (PreSens Precision 
Sensing GmbH, Germany) that receives fluorescence signals from sensor foils via a 
miniaturised digital microscope. Image acquisition was supported by native software 
(VisiSens Analytical 1, ver. 1.13) capable of capturing 1.3 megapixel images at up to 0.5 
frames per second (fps). The oxygen level was calculated by comparing the fluorescence 
readings from the calibration with signals detected from the oxygen sensor foil. 
 
2.9 Computational fluid dynamics (CFD) simulation 
The CFD simulation was conducted using the ANSYS 15.0 software package (ANSYS Inc., 
Canonsburg, PA, USA). Simulation was initiated after importing 3D models created from 
SolidWorks software into Fluent 15.0 software to generate mesh. Virtual zebrafish embryos 
were modelled as rigid spheres 1 mm in diameter. The flow rate was set at 400 µL/min from 
the inlet port. Trypan blue was virtually used as a model for mass transfer simulation. Flow 
velocity, pressure and shear stress on the surface of the embryos were calculated. 
 
2.10 Gas chromatography-mass spectrometry (GC-MS) 
The GC-MS experiment was performed on an Agilent HP 6890 Gas chromatography system 
with an Agilent 5973 Mass spectrometer (Agilent Technologies Australia Pty. Ltd., Forest 
Hill, Victoria, Australia). The system was controlled in a native ChemStation software 
environment. The instrumental conditions are listed below in Table 2-3: 
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Table 2-3 GC-MS instrumental conditions 
 
 
2.11 Data analysis and control 
Image analysis was conducted using ImageJ (Wayne Rasband, Research Services Branch, 
National Institute of Mental Health, Bethesda, Maryland, USA). Video processing was 
executed using Adobe Premiere Pro CC software (Adobe Systems Inc., San Jose, California, 
USA). Embryonic video analysis was performed on a Danio Scope 1 (Noldus, Wageningen, 
The Netherlands). Behavioural video analysis was performed on ZebraBox (ViewPoint, Lyon, 
France). Data analysis was done using GraphPad Prism 5 (GraphPad Software Inc., La Jolla, 
California, USA) and ToxRat (ToxRat Solutions GmbH, Alsdorf, Germany) software. A 
standard ANOVA model was applied to perform independent comparisons for each test 
compound concentration with significance set at p < 0.05.   
All experiments were performed in at least independent 3 replicates per concentration, 
unless otherwise indicated. All control measurements were provided in detail, where 
appropriate, for context and/or figure legends. 
  
Injection mode Split
Split ratio 20:1
Injection volume 1 µL
Injection port temperature 250 °C
Carrier flow Helium at 17.54 psi
Temperature ramp 40 °C for 1 min, 10 °C/min, 325 °C final for 4.30 min
Column DB-5ms, 0.25 mm x 30.0 m x 0.25 µm
Acquisition mode Scan
EMV Mode Relative
Relative voltage 47
Resulting EM Voltage 1035
Low mass 50
High mass 550
Mass source 230 °C, maximum 320 °C
GC
MS
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3 Three dimensional printed lab-on-a-chip device for zebrafish 
embryo biotest 
 
3.1 Introduction 
This chapter describes using high-definition 3D printing systems to fabricate optical-
transparent lab-on-a-chip devices with complex fluidic geometries for zebrafish embryo 
bioassays. As mentioned in Chapter 1, the spread of lab-on-a-chip technology is inhibited by 
complicated manufacture methods requiring significant engineering expertise. The main 
objective of this project was to investigate the feasibility of using 3D printing to simplify and 
accelerate fabrication of microfluidic lab-on-a-chip devices, with an equal or better 
fabrication quality. To compare with conventional fabrication methods, a design of a 
microfluidic zebrafish embryo trapping array fabricated in PDMS was selected as the 
control. The chip device was then prototyped using four off-the-shelf 3D printers and five 
associated printing materials.  
To assess the printing quality, I tested the printing accuracy and completion of complex 
geometries. Surface topology analysis was performed using scanning electron microscopy, 
optical profilometery, and atomic force microscopy. Optical transparency was tested with 
both bright field microscopy and fluorescence microscopy. The device functionality was 
examined by loading zebrafish embryos hydrodynamically. Lastly, I investigated the 
biocompatibility of 3D printed devices for live embryo cultures for an extended period of 
time.  
 
3.2 Design and fabrication 
The original lab-on-a-chip device was designed and fabricated by Akagi and co-workers 
(Figure 3.2.1)59. It was a 2D (one-layer) fluidic system fabricated from Polydimethylsiloxane 
(PDMS). It consisted of three major modules: (i) the twisted main loading channel, (ii) the 
array of embryo traps, and (iii) the array of suction channels.  
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Figure 3.2.1 A lab-on-a-chip device for zebrafish embryo trapping59. Key features are depicted. The 
body of the chip was made of polydimethylsiloxane (PDMS), with a bottom sealing layer made of 
glass. This chip will be converted to a 3D printed chip in this chapter.  
To convert the 2D chip into 3D, a computer aided design (CAD) was built (Figure 3.2.2). The 
dimensions of the fluidic system in the 3D chip were exactly same as the ones in 2D chip 
with total internal volume of approximately 825.9 μL. The corners of the 3D chip were 
rounded to reduce the usage of the materials. The top and bottom sealing layer were 
designed to be 500 µm in thickness, offering optical transparency and leaving an overhead 
of material to be removed in the post-printing polishing procedure. In addition to the 2D 
chip design, two barb connection ports were embedded to the 3D chip for leak-free and 
user-friendly tubing interconnections.  
To enable a detailed evaluation of the inner structure of the device, prototypes without the 
top sealing layer were also manufactured. An additional 2D control chip made of PMMA 
thermal plastic by infrared laser micromachining was also fabricated. The detailed 
manufacturing and post-processing procedures of all chips can be found in Chapter 2.  
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Figure 3.2.2 3D computer aided design (3D CAD) rendered model of the chip device. Left: a monolithic 
device with integrated interconnection ports; Right: An open-lid chip for analysing 3D printing quality 
assessments; Bottom: Magnified view of the microfluidic embryo trapping system. All theoretical 
dimensions are depicted. They were used as references when assessing the printing quality.  
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3.3 Appearance and accuracy 
First, I investigated the feature production quality of the chip device. Chip devices were 
printed in VisiJet Crystal (VJC), Watershed 11122XC (WXC), Dreve Fototec 7150 Clear (DFC), 
VisiJet SL Clear (VJSL), or Form Clear (FC) materials. The 3D printing of all chip devices were 
successful as monolithic devices with no further bonding needed, whereas the control chips 
made in PDMS and PMMA required plasma and thermal bonding, respectively. The finishes 
of 3D printed devices were comparable to the control chips, with minor surface polishing 
required in only the VJC, DFC, and FC chips. Although all 3D printing polymers were named 
“crystal” or “clear”, they all bear with some colour tint. For example, VisiJet Crystal (VJC) 
polymer was yellow; Watershed XC11122 (WXC) polymer was blue. However, after 
polishing, the colour of the chips changed to green because of the use of green polishing 
paste.  
 
Figure 3.3.1 A photograph depicting embryo trapping arrays from different fabrication methods. i) 
chips fabricated using soft lithography (PDMS, elastomer) and infrared laser micromachining 
(PMMA, thermoplastic) as controls; ii) 3D printed chips fabricated using Multi-Jet Modelling (MJM; in 
VisiJet Crystal resin) and Stereolithography (SLA; in Watershed 11122XC, Dreve Fototec 7150 Clear, 
VisiJet SL Clear and Form Clear resins).  
The printing accuracy was assessed by comparing the designated dimension with the actual 
dimension of a small feature on the chip. The smallest feature on the chip was the width of 
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the suction channel (500 µm) (Figure 3.2.2). In practice, despite some variations, the 
printing accuracy was satisfactory across most 3D printing chips with less than 10% variation 
(Figure 3.3.2). The exceptions were the chips made from PDMS and Form Clear (FC). PDMS 
is an elastic polymer so accuracy is lost during the moulding and de-moulding processes.  
However, the poor accuracy observed in the FC was considered to be related to the printing 
quality of the 3D printer.  
 
Figure 3.3.2 Comparison of the feature size deviations across different chips. The suction channel 
designed in CAD to be 500 µm in width was fabricated in all 3D prototyped chips. Apart from the 
chips made of PDMS and Form Clear, the fabrication of other chips were relatively accurate and 
precise.  
The printing quality of the embedded connection nozzles was also examined. Due to the 
thin wall of the connectors, some of them broke during attempts to connect hard tubing, 
such as Teflon (PTFE) or polyurethane (PUR) tubing (Figure 3.3.1). No difficulties were 
experienced when connecting soft tubing, like silicon or polyvinylchloride (PVC) tubings. This 
result indicates that these 3D printing polymers (epoxy resins) are hard and brittle.  
The embedded connectors offer user-friendly interconnections, but the quality of the 
sealing remained unclear. To elucidate the answer to this question, a dead-end pressure 
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holding test was performed. The connector was found to be able to withhold a fluidic 
maximum pressure of up to 30 psi (figure 3.3.3). This result demonstrates a seamless fluidic 
connection that is more than sufficient for a microfluidic perfusion system.  
 
Figure 3.3.3 An embedded barb connector fabricated during 3D printing allowed leak-free and 
convenient fluidic interconnections. The fluidic seal between the connector and silicon tubing was 
capable of withstanding a peak pressure of up to 30 psi. 
 
3.4 Surface properties 
The surface properties of the chip device are important because they heavily affect the 
microfluidic chip performance. For example, a rough surface has a significantly larger 
surface area that causes extra compound adsorption onto the surface. Moreover, a 
turbulent flow instead of a laminar flow will be created by the rough surface. Most 
importantly, a rough surface scatters light and thus reduces optical transparency. In this 
regard, a detailed topological assessment of 3D printed devices was performed. To improve 
the resolution and sensitivity, all chip devices had to be coated with gold, and thus only the 
chips without the lid layer were used here. 
3.4.1 Scanning Electron Microscopy 
The surface roughness of 3D printed lab-on-a-chip devices was first analysed under a 
scanning electron microscope (SEM), allowing us to visually compare the difference among 
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surfaces (Figure 3.4.1). The VJSL chips had a very smooth surface after printing and was 
comparable with the control PDMS chip. WXC and DFC chips had characteristic lattices 
patterns on their surface, as they were fabricated from a same 3D printer. The VJC was 
revealed to have a coarse surface. The surface of the FC chip was the worst with obvious 
gaps existing in the surface.  
 
Figure 3.4.1 Comparison of topographic surfaces of a single embryo trap in the chip using scanning 
electron microscope (SEM). Rough surfaces were observed in VisiJet Crystal and Form Clear chips. 
PDMS and VJSL chips presented smooth surfaces. Published in Ref 105. Reproduced with permission 
from AIP Publishing LLC. 
Next I magnified the view and looked at the vertical wall of the embryo trap (Figure 3.4.2). 
In the control PDMS chip, there is a large residue due to the moulding process during 
fabrication. In all 3D printed chips, traces from the building of each layer can be clearly 
observed. The VJSL chip had a smooth vertical surface without any residues, and the WXC 
and DFC chips again had a similar printing quality with minor unpolymerised residues. 
Because of the printing principles, the VJC chip fabricated in a MJM 3D printer had a rough 
surface caused by melting of the raw polymer. The FC chip had a problem with aligning each 
layer accurately. As a result, the finished structure was deformed and the surface looked 
very bumpy.  
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Figure 3.4.2 Comparison of topographic surfaces using SEM, showing the vertical surface of the 
embryo trap. Note that layer deposition can be observed in all 3D printed chips. Poor layer deposition 
in VisiJet Crystal chip was due to the printing principle (MJM); in the Form Clear chip it was because 
of poor layer alignment. Artefacts (unpolymerised resin) were left on Watershed XC and Dreve 
FotoTec chips.  
Afterwards I magnified the view of the top surface of 3D printed structures (Figure 3.4.3). 
Small dents as a result of air bubble residues were observed in the control PDMS chip. This 
was due to insufficient degassing time during the PDMS fabrication procedure. Residual 
resin materials were left on the top surfaces of WXC, DFC, and VJSL chips, making the top 
surfaces not as flat as the bottom surface. In particular, the building of the top surface in the 
FC chip was not successful, as the material collapsed in the centre of the structure, leaving a 
large indentation on a porous surface.  
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Figure 3.4.3 Comparison of topographic surfaces using SEM, showing the top surface of the embryo 
trap. Most 3D printed chips achieved a relatively smooth surface, with the exception of the Form 
Clear chip where structural deformation was observed.  
3.4.2 Optical profilometry 
To quantify the surface analysis, I applied 2D and 3D topographic surface mapping 
technology using optical profilometry. In practice, representative areas of 500 x 500 μm 
from the bottom and top surfaces of the chip devices were scanned by a laser beam. As a 
result, the surface roughness was presented as a heat map where the areas in green were 
set as a reference panel, the red areas were peaks and the blue areas were valleys. In the 
end, the height of each unit area were statistically organised and presented as a Gaussian 
distribution.  
The result of the control PDMS chip showed a lot of green and flat areas with occasional 
crests, demonstrating that the surface of the PDMS chip was indeed very flat. The Gaussian 
distribution of the height plotted a curve with a small variance (Figure 3.4.4).  
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Figure 3.4.4 Quantitative analysis of topological surfaces from a microfluidic structure fabricated in 
PDMS (left) and the Gaussian distribution of surface roughness (median feature height) (right). Note 
that the relatively smooth surface from the PDMS chip resulted in a small variance in the distribution 
curve. Published in Ref 105. Reproduced with permission from AIP Publishing LLC. 
In contrast to the PDMS chip, the FC chip showed a map with randomly distributed peaks 
and trenches. There are even white (no data) areas in the map, meaning that the height 
variation was too large to detect. The distribution curve was also deformed and had a large 
variation (Figure 3.4.5).  
 
Figure 3.4.5 Quantitative analysis of topological surfaces from a microfluidic structure fabricated in 
Form Clear (left) and the Gaussian distribution of surface roughness (median feature height) (right). 
Note that the rough surface from the FC chip leads to a large variation in the distribution curve.  
Among all 3D printed chips, the VJSL chip showed a similarly flat surface as the control 
PDMS chip, except for a few scratches and ridges. The distribution of the heights was also 
very narrow and tight. The difference in median height between PDMS chip and VJSL chip 
was less than 5% (Figure 3.4.6).  
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Figure 3.4.6 Quantitative analysis of topological surfaces from a microfluidic structure fabricated in 
VisiJet SL Clear (left) and Gaussian distribution of surface roughness (median feature height) (right). 
Despite some scratches, the surface of the VJSL chip was relatively flat as evidenced by the small 
variation in the distribution curve. Published in Ref 105. Reproduced with permission from AIP 
Publishing LLC. 
3.4.3 Atomic Force Microscopy 
To assess the surface properties at an even higher magnification, atomic force microscopy 
was utilised. This technology is able to reveal the surface topological properties as tiny as a 
few nanometres. Because AFM has a very limited imaging depth of field and scanning area 
that are designed for investigating smooth surfaces rather relatively rough surfaces created 
by 3D printing, this experiment was then terminated and was only briefly described and 
discussed here. Nevertheless, the result indicated that 3D printed surfaces are generally too 
rough that beyond the scale of what AFM is capable to measure. Here, I presented the 
result from a relatively flat VJSL chip.  
A representative area of 10 x 10 μm, which is the largest detectable size, from the VJSL chip 
was selected for AFM imaging. The result again proved that the VJSL chip had a flat surface 
with a maximal variation of less than 0.2 μm.  
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Figure 3.4.7 Qualitative analysis of topographic surfaces using atomic force microscopy (AFM). A 
representative image of a 10 x 10 μm section was taken from a microfluidic channel fabricated in 
VisiJet SL Clear (left). Note the maximal roughness variation was less than 0.2 μm.  
 
3.5 Optical properties 
Zebrafish embryo bioassays rely on high resolution images to analyse any phenotypic 
responses. The accessibility of high quality images from lab-on-a-chip devices is thus of the 
utmost important. In this regard, all 3D printed chip devices were made of optically 
transparent or “clear” materials. Moreover, the surface roughness described above also 
played an important role in optical properties. Herein, the imaging performance of the 3D 
printed chips was assessed with several commonly used microscopies.  
3.5.1 Bright field microscopy 
Zebrafish embryos were loaded into the chip devices, imaging under an upright 
stereomicroscope in the bright field (Figure 3.5.1). The result showed that the lab-on-a-chip 
devices fabricated from different materials have dramatically different optical 
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transparencies, though they were all claimed to be transparent. Compared with the control 
PDMS chip, only the VJSL chip had a close transparency that clearly showed embryo sitting 
in the chip device. VJC, WXC, and DFC chips showed transparency to some extent, where the 
shape of the embryos could be seen but no details were readily observable. The DFC chip 
also presented black spots throughout the chip, further obstructing the imaging. The FC chip 
again performed so poorly that the embryo was barely noticeable. The body of the chip 
device also had perceptible “scan line” traces from the fabrication processes. To 
compensate for this problem, the chips lacking of optical transparency were further 
mechanically polished, but the improvement was very limited.  
 
Figure 3.5.1 Comparison of optical transparency of the chip devices in the presence of loaded 
embryos under a stereomicroscope. Only the chips made of PDMS and VisiJet SL Clear allowed an 
unobstructed view of live embryos. Published in Ref 105. Reproduced with permission from AIP 
Publishing LLC. 
3.5.2 Fluorescence microscopy 
Zebrafish and embryos are popular animal models in biomedical applications because they 
allow simple genetic modification and can express fluorescent protein. Therefore, the 
suitability of 3D printed chips for fluorescence imaging of specimens was also examined. In 
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the experiment Tg(fli1:EGFP) transgenic zebrafish embryo (48 hpf) were loaded into the chip 
device and imaged under a popular fluorescence (FITC/GFP Ex 480 nm / Em 535 nm). This 
transgenic strain offers non-invasive observation of the blood vessel development 
expressing in enhanced green fluorescent protein (EGFP) in endothelial cells.  
The result showed that all 3D printed chips bear substantial autofluorescence due to the 
material, interfering with the observation of small features such as the intersegmental 
vessels (Figure 3.5.2). Compared with the control PDMS chip, only the VJSL chip offered an 
acceptable level of visibility. The transparency of WXC chip was fine but contained too much 
background noise fluorescence. The remaining chips were not capable of imaging 
fluorescent zebrafish embryos at all.  
 
Figure 3.5.2 Comparison of optical transparency of chip devices for fluorescent microscopy imaging. 
Epifluorescence imaging (GFP Ex 480 nm / Em 535 nm) of immobilised transgenic Tg(fli1:EGFP) 
zebrafish embryos (48 hpf) inside 3D printed microfluidic chip devices. All 3D printed chips showed 
auto fluorescence that interfered with imaging. Only the image from the VJSL chip was comparable 
with the control PDMS chip. Published in Ref 105. Reproduced with permission from AIP Publishing 
LLC. 
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3.5.3 Focus stacking confocal microscopy 
Because zebrafish embryos are close in shape to spheres, conventional microscopy cannot 
focus on the entire surface of the embryo. Hence, for high resolution imaging, focus stacking 
confocal microscopy is necessary. The confocal microscopy suppresses the signal outside the 
field of focus and only focuses on a very small depth of field. Multiple images were taken at 
different focal distances. Then, the focus stacking technology merges the images from all 
steps into one fully focused image.  
In the experiment, confocal images were taken from the VJSL chip loaded with Tg(fli1:EGFP) 
zebrafish embryos (48 hpf), as well as from the PDMS chip as a control. Two channels i.e. 
bright field and fluorescence were merged together showing GFP highlighted blood vessels 
in the bright field. The VJSL chip once again showed a similar imaging quality as the control 
PDMS chip. Despite some shadows, the key features were reliably presented.  
 
Figure 3.5.3 Comparison of the PDMS chip with the VJSL chip in high-resolution stacked confocal 
imaging of live Tg(fli1:EGFP) zebrafish embryos. The image taken from the VJSL chip was comparable 
with the control PDMS chip.  
 
3.6 Embryo loading and immobilisation 
Next, I investigated the functionality of 3D printed embryo trapping chips. The chip design 
exploited hydrodynamic forces enabling automated embryo trapping and immobilisation 
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(Figure 3.6.1)59.  Hydrodynamic trapping is dependent on the geometry of the microfluidic 
systems, and even small obstructs in the system will affect the loading efficiency. In this 
regard, I tested how quality of fabrication affected the function of the chip devices under 
standard operation procedures.  
In the experiment, wild type zebrafish embryos at 24 hfp were individually loaded into 
embryo trapping arrays at a flow rate of up to 2 mL/min. The trapping efficiency was 
calculated as the number of docked embryos over the number of injected embryos on the 
chip device.  
 
Figure 3.6.1 Embryo loading and immobilisation. Left: CAD rendered cartoon depicting the embryo 
loading principle. Embryos were aspirated from a storage reservoir into the fluidic channel. 
Hydrodynamic force guided the embryo into the trap. Docked embryos act as spacers allowing the 
upcoming embryos to roll over towards the next available trap. Right: A macrograph showing all 
embryos were trapped in a 3D printed chip device.  
The result showed that embryo trapping efficiency was significantly affected by the quality 
of fabrication and surface roughness. Accordingly, trapping efficiencies in PDMS, PMMA, 
VisiJet Crystal, Watershed 11122XC, Dreve Fototec 7150 Clear, VisiJet SL Clear, and Form 
Clear chip prototypes averaged 81 ±3%, 87 ±2%, 48 ±8%, 79 ±1%, 100 ±0%, 98 ±2%, and 25 
±5%, respectively (Figure 3.6.2). Residues and support materials caused a lowered trapping 
performance of VJC chips fabricated by the MJM process. In contrast, a poor trapping 
efficiency from Form Clear chips suggested a low quality of feature fabrication and a rough 
surface due to imprecise layer composition. While, the outstanding embryo trapping 
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efficiency achieved by WXC, DFC and VJSL devices were supported by superior feature 
production and minimised surface roughness as demonstrated by SEM and optical 
profilometry. 
 
Figure 3.6.2 Embryo trapping efficiency on 3D printed devices. Loading experiments were conducted 
at different flow rates as indicated. Note that the embryo trapping efficiency was significantly related 
to feature finish quality and surface roughness. 
 
3.7 Biocompatibility 
In the last phase of assessment, the biocompatibility of the 3D printed chips for long term 
culture was investigated under a microperfusion environment. Zebrafish embryos are 
considered to be one of the most sensitive organisms to environmental deteriorations and 
can be readily applied to test chemical toxicity of solid substrata39, and the 3D printed chip 
devices were indeed designed for zebrafish embryo bioassays.  
In the experiments, wild-type zebrafish embryos at 6 hour post fertilisation (hpf) were 
loaded onto the chip devices and cultured under continuous microperfusion at a flow rate of 
400 µL/min for up to 72 hours. The perfusion was performed in a closed loop circuit with a 
40 mL reservoir contained fresh embryo medium. Embryo viability was observed every 24 
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hours, however, due to the limited visibility of some 3D printed chips, detailed 
characterisation of embryo developmental stages was not accessible. Therefore, at the end 
of the exposure experiment, embryos were unloaded from the chip devices onto Petri 
dishes for phenotypic analysis.  
 
Figure 3.7.1 Viability of zebrafish embryos cultured on microfluidic chip devices at 72 hour post 
fertilisation (hpf) under a continuous microperfusion of 400 µL/min. Note that only one 3D printed 
chip, the one made of VJSL polymer, showed a similar embryo viability to the control PDMS and 
PMMA chip devices.  
The result showed significant toxic effects for most 3D printed chips (Figure 3.7.1). 100% 
mortality was observed in VJC, WXC, and FC chips. The DFC chip was less toxic to the 
zebrafish embryos, but caused sublethal effects such as oedema. Compared with control 
PDMS and PMMA chips, only the VJSL chip was biocompatible with the embryos.  
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Figure 3.7.2 Biocompatibility of microfluidic chips for long-term living zebrafish embryo bioassays 
under a continuous microperfusion of 400 µL/min. Matrix chart depicts cumulative teratogenic 
effects during a standard zebrafish embryo toxicity (FET) test. CTR – control; MJM – multi-jet-
modelling; SLA – stereolithography; HI – hatching inhibition; TA – trunk abnormalities; PO – 
pericardial oedema; HR – heart rate abnormalities. Published in Ref 105. Reproduced with permission 
from AIP Publishing LLC. 
For the first 48 hours of the experiment, no embryo mortality was observed on any chip 
device. Lethal and sublethal effects were expressed between 48 and 72 hours of the 
experiment, suggesting a cumulative chronic toxicity effect rather than an accurate 
response (Figure 3.7.2). In survived embryos, different developmental abnormalities among 
different 3D printed chips were observed (Figure 3.7.3), indicating different toxic ingredients 
contained in different 3D printing materials.  
 
Figure 3.7.3 Critical developmental abnormalities in cultured zebrafish embryos observed in chip-
based devices fabricated using 3D printing. 
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3.8 Summary and discussion  
The implementation of lab-on-a-chip (LOC) technologies for in situ analysis of small model 
organisms and their embryos is attracting an increasing amount of interest from the 
biomedical community. However, the development of microfluidic lab-on-a-chip devices for 
small model organisms is rather limited compared with other burgeoning fields. This is due 
to the difficulty of rapid prototyping and manufacturing millilititre scale LOC devices with 
complex three dimensional structures that can accommodate large organisms in flow-
through conditions. I postulate that the advanced 3D printing technology is capable of 
solving this problem. However, so far no reports have investigated the biological 
implications of small model organisms or embryo culturing in 3D printed devices.  
Despite the rapid developing of 3D printing technology on the market, the printing 
resolution and quality varies dramatically. Materials suitable for making biomicrofluidic lab-
on-a-chip devices are so far limited to photoresist resins, as they are the only optically 
transparent materials used by current 3D printers. However, most photoresist resins were 
not initially designed for applications in aqueous environments because they tend to swell 
significantly when in contact with water, and they were found being toxic to aquatic 
organisms77.  Nevertheless, few commercially available materials, such as DSM Somos 
WaterShed XC11122, were reported to be biocompatible77, 93.  
In this study a range of 3D printing systems and their associated materials were selected to 
fabricate a zebrafish embryo trapping array. A comprehensive side-by-side evaluation of all 
prototypes was performed to test printing accuracy, surface roughness, and optical 
transparency. I also focused on the material biocompatibility by conducting zebrafish 
embryo bioassays, and found only one material that was nontoxic to the embryo over the 
testing period. It can be concluded that current 3D printing technology, especially 
stereolithography (SLA) and multi-jet modelling (MJM), provide a convenient and 
inexpensive way to fabricate complex lab-on-a-chip devices. However, one has to be very 
careful when choosing the printing system and materials. Many challenges remain in the 
current 3D printing technologies.  
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Fabrication of 3D printed chips  
All the devices presented in the thesis were printed horizontally. During the prototyping, the 
FC chips had been attempted to be printed vertically. In general, printing vertically took 
much more time; and it resulted in a similar optical performance but a reduced accuracy in 
building the microfluidic channels. For these reasons, only the horizontally printing 
configuration was chosen to print all the chips in this study. 
Although the 3D printing process is simple and so convenient that it can be achieved by one-
click, most of technologies require post-processing procedures. For instance, the MJM 
fabrication process uses wax as a support in building hollow structures such as fluidic 
channels. Removing the support wax required complicated procedures, which are described 
in Chapter 2. During experiments, despite efforts to clean the fluidic channel, residue wax 
could not be completely eliminated (Figure 3.8.1). Wax granules blocked the small fluidic 
channel, which affected embryo loading efficiency; they also accumulated in the embryo 
traps, which prevented embryo docking (white arrows). So far, no solutions were found to 
address this issue.   
 
Figure 3.8.1 Post-processing challenges associated with Multi-Jet modelling (MJM) fabrication of 
microfluidic chip-based devices. Left: Residues of VisiJet S300 Support Wax left behind during the 
fabrication process (white arrows); Right: Magnified view of a single embryo microtrap obstructed by 
significant VisiJet S300 Support Wax residue. Post-processing of MJM prototypes required several 
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subsequent steps to remove Support Wax as outlined in Chapter 2. Complete removal of wax residues 
proved impossible. 
A similar situation occurred during the SLA fabrication processes. To print a structure over 
the hollow spaces, unpolymerised resin (the printing material) were employed as the 
spacer. When finishing, excess resins need to be flushed out to achieve the designated 
structure. In the standard operation protocols, residue resins are cleaned by flushing with 
isopropanol followed by soaking the prototype in isopropanol for 10 minutes. In the end, 
the 3D printed chips needed to be hardened in a UV oven.  
Unlike the support wax, unpolymerised resin is relatively easy to wash out using isopropanol 
(Figure 3.8.2). However, when the structure is complicated, the washing becomes 
ineffective. For example, when the fluidic channel is narrow or has a lot of sharp twists, 
isopropanol is unable to reach the residue. In practice, I found that applying air pressure can 
sometimes blow off the residue. Nevertheless, an overpowered pressure can damage the 
structure, as the 3D printed structures are relatively soft and prone to deform prior to the 
UV curing. 
There are more difficulties when a 3D printed chip had residual resin remaining in the 
channel during UV curing. The UV light would harden the excessive resin and block the 
fluidic manifold permanently. It is necessary to clean the channel very carefully before the 
final curing.  
Figure 3.8.2 Post-processing challenges associated with stereolithography (SLA) fabrication of 
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microfluidic chip-based devices. Left: Non-polymerized SLA resin residues obstructing channels with 
high fluidic resistance (red circle); Right: Removal of non-polymerized SLA resin residues with 
isopropyl alcohol ensures proper geometry of the microfluidic circuitry.  
Autofluorescence  
Autofluorescence is a natural emission of light where the molecules of material absorb 
excitation light without artificial addition of fluorescent markers. Strong autofluorescence 
obstructs observation of fluorescent markers in target specimens, as described above. 
Choosing materials should be done very carefully for experiments using fluorescent 
specimens because different polymers have different autofluorescence intensities at 
different wavelengths. For example, VisiJet SL Clear chip had low to moderate 
autofluorescence from the excitation wavelengths ranging from 458 nm to 514 nm, but it 
had an extremely high response to the excitation wavelength at 633 nm (Figure 3.8.3).  
 
Figure 3.8.3 Detection of autofluorescence across a range of wavelengths on VisiJet SL Clear chip. 
Left: Region of interest (ROI) of the chip is depicted. “Plastic” denotes the solid part of the chip and 
the “Surface” denotes the hollow part (fluidic manifold) of the chip. Right: Intensities detected at 
different wavelengths. Surface areas have significantly higher autofluorescence than the plastic 
areas. The intensity of the fluorescence is dependent on the wavelength of the excitation light.  
Other properties of the 3D printing materials 
To reveal other physical attributes of the 3D printing material, I have applied several 
treatments to the chips. In autoclave testing, the 3D printed prototypes were heated up to 
140 °C under a standard pressure for 20 minutes. As a result, all 3D printed chips were 
cracked and no longer functional. In UV exposure experiments, 3D printed prototypes were 
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exposed to UV light in a standard cell culture hood for 24 hours. In the end of the 
experiment, the 3D printed chips were curved and had become hard and brittle. All 3D 
printed chips were also treated with 50% oxygen plasma twice, each time for 30 seconds. 
No visible damaged was caused. 
The biocompatibility issue 
So far, only a selection of photoresist resins and printing systems were evaluated for one 
biological model (zebrafish embryo), the results nevertheless pointed to serious 
biocompatibility issues for polymers commonly used in high-definition 3D printing. To 
understand the general toxicity profile of 3D printing materials, more ecotoxicological 
assays need to be performed on more 3D printing materials using more animal models. 
Preferably, chemical analysis of the toxic leachates would also be performed. I will continue 
discussing this topic in chapter 4.   
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4 Characterisation of 3D printing material toxicity 
 
4.1 Introduction 
A recent boom in three dimensional (3D) printing technologies has instigated a revolution of 
microfabrication and prototyping in science and engineering. In particular, bioengineering 
has benefited from 3D printing for making medical implants, including bones, ear moulds, 
and exoskeletons. Moreover, development of high-definition 3D printing technologies, such 
as Multi-jet moulding (MJM) and Stereolithography (SLA), has allowed the production of 
features as small as a few micrometres, capable of prototyping and fabrication of 
biomicrofluidic lab-on-a-chip devices. This incentive helped the biomedical researchers to 
close the gap between the need for prototyping bio-devices and their insufficiency in 
engineering expertise.  
As discussed in the previous chapter, although high-definition 3D printing is able to rapidly 
fabricate biomicrofluidic devices for aquatic organism culture, the materials have the 
potential issue of lacking biocompatibility as per our primary test on zebrafish embryos. In 
this chapter, a comprehensive toxicity characterisation of numerous commonly used 
polymer materials in 3D printing applications was performed. Currently, there are dozens of 
materials on the market, and different printing systems use very different printing materials. 
In this study, I carefully selected a few popular materials as representatives for 
biocompatibility tests. For fused deposition modelling (FDM) printing systems, I selected 
acrylonitrile butadiene styrene (ABS) and polylactic acid (PLA); for Multijet moulding (MJM) 
printing systems, VisiJet Crystal (VJC) was picked; and for stereolithography (SLA) printing 
systems, Watershed XC11122 (WXC), Dreve Fototec Clear (DFC), VisiJet SL Clear (VJSL), and 
Form Clear (FC) photoresist resins were chosen.  
 
4.2 Experimental design 
I postulate that the material’s toxicity derives from the leachate that comes from the 
surface of polymerised material, and/or unpolymerised residues left in the 3D printed 
prototypes. In this regard, the potential toxicants need to be extracted from the solid phase 
(3D printed objects) into aqueous phase (organism culture medium). In this experiment, 
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porous blocks fabricated in different 3D printing polymers were used for extraction (Figure 
4.2.1 A). Each block had a surface area of 6,250 mm2. Four 3D printed blocks were added 
into a glass bottle filled with 500 mL of respective organism culture medium for extraction. 
The extraction was conducted in darkness at 22 °C for 72 hours, with the assistance of a 
magnetic stir bar spinning at approximately 240 rpm. The resultant medium was considered 
to be concentrated 100% extract.  
Material toxicity profiles were evaluated by using standardised bioassays according to OECD 
guidelines for testing of chemicals. Test aquatic organisms were selected and ranged from 
plants, invertebrates, and vertebrates. The biotests were conducted immediately after 
material extraction. 
 
Figure 4.2.1 A standardised preparation of water extracts for profiling polymer toxicity (A) CAD 
Design of the extraction structure, each block has a surface area of 6,250 mm2. (B) Extraction 
cartoon. Four 3D printed blocks were added into culture medium with a magnetic stir bar and stirred 
for three days in a dark environment.   
 
4.3 3D printed polymer screening test 
In the first phase of toxicity bioassays, 100% concentrated polymer extract was used to 
explore the toxic effects on a battery of aquatic model organisms.  
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4.3.1 Aquatic plants  
Fresh water microalgae (Selenastrum capricornutum) responsed to the toxicity by a 
reduction in growth. Algae normally grow exponentially over a period of 72 hours106. 
Growth and growth inhibition were quantified from the measurement of algal cell number 
density as a function of time. As a result of testing, all 3D printing polymer extracts exhibited 
toxicity by inhibiting algal growth (Figure 4.3.1 A). In particular, while algae were still 
growing in ABS, PLA, and VJC treatments, algal cell density in all SLA polymer (WXC, DFC, 
VJSL, and FC) treatments decreased or remained unchanged. The result indicated that fresh 
water algae is very sensitive to 3D printing polymer extracts, especially the SLA material 
extracts, which were highly toxic to the algae.  
 
Figure 4.3.1 3D printing polymer toxicity profiling using aquatic plants. 100% concentrated 3D 
printing material extracts were used. A) Toxicity biotest on fresh water algae. Cell numbers of each 
treatment were counted every 24 hours. Algal growth was inhibited in all treatments, including ABS 
and PLA. B) Toxicity biotest on lemna. Growth rates for each treatment were calculated. Lemna died 
in WXC and VJSL treatments after just two days. DFC and FC also showed chronic toxicities.  
Fresh water duckweed (Lemna minor) has been extensively studied as a standard toxicity 
model system. Growth and growth inhibition were quantified from the measurement of 
frond number as a function of time. In this experiment, I observed that ABS and PLA 
treatments were not toxic to the lemna; VJC and DFC treatments showed slight toxicity. The 
FC treatment had a chronic toxic effect on the lemna, whereas the WXC and VJSL killed 
lemna completely within 24 hours (Figure 4.3.1 B).  
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4.3.2 Marine invertebrates   
Toxicity investigations were also performed with marine invertebrates. Brine shrimp 
Artemia franciscana is a commonly used species for ecotoxicological biotest. The artemia, 
however, is known for being less sensitive to many chemicals in comparison to other test 
species.  
During experiments, it was indeed found that artemia were rather resistant to all the 
polymer treatments. By the end of 24 hours, all artemia survived the test (Figure 4.3.2 A). 
Significantly decreased survival rates were observed after 72 hour of exposure.  
 
Figure 4.3.2 Toxicity profiling using marine invertebrates. 100% concentrated 3D printing material 
extracts were used. Viabilities were calculated every 24 hours. A) Test on the marine crustacean 
artemia. Note that artemia was resistant to the toxicity from all the treatments. B) Test on the 
marine crustacean amphipod. Amphipods were very sensitive to DFC and FC extracts.  
Amphipods (Allorchestes compressa) were another marine crustacean species chosen for 
toxicity tests. They are more sensitive to environmental toxicants than artemias. In the 
experiment, amphipods were found very sensitive to two polymer treatments, DFC and FC, 
with 100% mortality within 24 hours of exposure (Figure 4.3.2 B). In other treatments, 
however, no significant toxicity was observed during 72 hours of exposure.  
4.3.3 Freshwater invertebrates 
Following up the marine invertebrates, I also tested the toxicity responses of freshwater 
species. Rotifer (Brachionus calyciflorus) has a favourably comparative sensitivity with other 
invertebrates currently used in aquatic toxicology. The data show that rotifers were found 
being very sensitive to SLA polymer (WXC, DFC, VJSL and FC) extracts (Figure 4.3.3 A). The 
FDM materials (ABS and PLA) and MJM material (VJC) were found non-toxic to this species.  
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Figure 4.3.3 Toxicity profiling using freshwater invertebrates. 100% concentrated 3D printing 
material extracts were used. Viabilities were calculated every 24 hours. A) Tests on rotifer. All SLA 
polymers (WXC, DFC, VJSL, and FC) were shown to be very toxic to this organism. B) Test on daphnia. 
WXC, DFC, and VJSL polymer extracts were very potent toxins to the daphnia, whereas the VJC and FC 
extracts showed moderate toxicities. Published in Ref 107. Reproduced with permission from AIP 
Publishing LLC. 
The freshwater planktonic crustacean Daphnia magna has been developed as a standard 
aquatic toxicity test for many years and has been approved by many international 
organisations, including OECD, ISO, and USEPA. It is one of the most commonly used species 
for determining the effects of xenobiotics in aquatic ecosystems. In this experiment, I 
observed that WXC, DFC, and VJSL treatments were very toxic to the daphnia that they were 
all killed within 24 hours of exposure (Figure 4.3.3 B). VJC and FC polymer extracts were 
moderately toxic to the daphnia, so that nearly 50% of them were dead after 48 hours of 
exposure. The ABS and PLA were inert to this species.  
4.3.4 Freshwater vertebrates 
Next, I investigated the toxicity profiles on vertebrate animal models, i.e. zebrafish embryos 
and larvae. In the primary test performed on a flow-through chip-based system, the 3D 
printing polymers were found to be lethal to the fish embryos after 72 hour of exposure 
(Chapter 4). In this experiment, biotests were performed in a static condition and the 
toxicity was found even higher, so that embryos were dead within 24 hours of exposure, 
except for ABS and PLA treatments, which were not toxic (Figure 4.3.4 A).  
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Figure 4.3.4 Toxicity profiling using freshwater vertebrates. 100% concentrated 3D printing material 
extracts were used. A) Test on zebrafish embryo. B) Test on zebrafish larvae (7 dpf). Only two FDM 
materials (ABS and PLA) were nontoxic to the zebrafish. The toxicants apparently can penetrate the 
chorion of the embryo. Published in Ref 107. Reproduced with permission from AIP Publishing LLC. 
Zebrafish larvae at 7 days post fertilisation (dpf) were also used as a test organism. 
Compared with zebrafish embryos, the larvae are much more mature, with main organs 
developed and are expected to be more resistant to toxicants. On the other hand, hatched 
larvae have lost the protection from their chorion so that they actually might be more 
vulnerable to the toxicants. As a result of biotests, the toxicity response of zebrafish larvae 
was almost identical to the response of embryos. All polymer extracts, apart from ABS and 
PLA, were highly toxic to the zebrafish (Figure 4.3.4 B).  
4.3.5 Zebrafish larvae behaviour 
All aforementioned biotests were based on the mortality observed at the endpoint of the 
experiments.  There is an alternate way to assess the toxicity by looking at animal 
behavioural parameters. Behavioural test using zebrafish larvae have been well developed 
on both the scientific side and the technological side. In particular, it has been established 
that behavioural parameters, such as travelled distance and active duration, precisely reveal 
animal’s locomotion and response to the toxicants. Recently, a few innovative imaging 
systems have been developed for automated animal behaviour tracking and analysis. In this 
experiment, Zebrabox was used for video recording and analysis.  
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Figure 4.3.5 Toxicity profiling based on zebrafish larvae behaviour studies. 100% concentrated 3D 
printing material extracts were used. A) Tracking of zebrafish larvae trajectories in test chambers. B) 
Total distance of larvae travelled in the test chambers. After just five minutes of exposure, the 
moving ability of the larvae were significantly inhibited in MJM (VJC) and SLA (WXC, DFC, VJSL and 
FC) material extracts. Published in Ref 107. Reproduced with permission from AIP Publishing LLC. 
In the 3D printing material toxicity tests, zebrafish larvae (7 dpf) were exposed to polymer 
extracts for one hour, during which their movement trajectories were recorded. In fact, 
after just 5 minutes of exposure, while all the zebrafish larvae were still alive, their 
locomotion activity were significantly inhibited in most treatments, except for ABS and PLA 
(Figure 4.3.5 A). The locomotion activity is directly related to the total travelled distance as 
shown in Figure 4.3.5 B. This result was in line with the mortality test results, demonstrating 
that only FDM materials (ABS and PLA) were inert to the zebrafish larvae.  
 
4.4 Form Clear toxicity test 
In the last section, I performed a comprehensive screening test on a range of model animals. 
The toxicity profiles of seven popular 3D printing materials were investigated. However, as 
an ecotoxicology study, the information was still insufficient because only one 
concentration was tested for each polymer. A dose response curve is required for 
understanding the potential effects on the test organisms and finding remediation methods.  
An in-depth study of all polymers was impossible because the time input and cost would be 
considerably high. In this regard, I selected one material, Form Clear. The reason was that 
the Form Clear is specifically used by the Form series 3D printers. They are desktop 3D 
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printers that are markedly lower in cost than other 3D printing systems. Therefore, I expect 
that this material would be largely manufactured, and the waste material would hence also 
be extensively produced, causing potential environmental issues.  
4.4.1 Acute toxicity test  
In the Form Clear acute toxicity test, concentrated extract media were further diluted to 
20%, 40%, 60%, 80%, and 100% fractions. Lemna, daphnia, zebrafish embryos and larvae 
were chosen as model organisms for mortality test. Toxicity curves and half-maximal 
response concentrations (EC50) of each test organism were plotted and calculated using the 
Toxrat software.  
In the lemna test, concentrated Form Clear extract caused a maximal 70% of growth 
inhibition, with the EC50 at 77.4% dilution of the extract. Similarly, concentrated Form Clear 
caused only 50% mortality in daphnia. The dose response curve was relatively flat, meaning 
the daphnia were not very sensitive to the toxicants in the FC extract. To the contrary, 
zebrafish embryo and larvae were very sensitive to this polymer, as evidenced by their steep 
dose response curves. 100% mortalities were observed at 30% and 35% dilution of extract 
for embryo and larvae, respectively (Figure 4.4.1).  
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Figure 4.4.1 Toxicity tests of Form Clear extract on model organisms: A) Lemna, B) Daphnia, C) 
zebrafish embryo and D) zebrafish larvae. Concentrated Form Clear extract was diluted for the test. 
Toxicity curves depicted the response of each test organism to different concentrations of the extract. 
Half-maximal response concentrations were calculated using the Toxrat software. Note that 100% 
mortality could not be achieved in the tests using Lemna or Daphnia. In the tests with zebrafish 
embryo or larvae, 100% of mortality was observed at a mere 40% dilution of the concentrated 
extract.  
4.4.2 Zebrafish larvae behaviour test  
In addition to the mortality tests, zebrafish larvae behaviour tests were performed to reveal 
sublethal locomotor activity responses to lower concentrations. The experiment was 
performed by tracking the movement of each larvae during alternating periods of light and 
dark. After 64 minutes of exposure, the polymer extract was shown to be toxic to the fish 
larvae by inhibiting their moving ability, even in a the low concentration of 20% dilution 
(Figure 4.4.2 A). Zebrafish larvae normally are more active during the dark period than the 
light period. As the the concentration of the toxicant increased, the difference in moving 
distance between light and dark became insignificant (Figure 4.4.2 B). The habituation curve 
showed that zebrafish larvae had an instant locomotion change at the very beginning of the 
experiment. The moving distances in each concentation differed significantly during the first 
light/dark cycle. As the fish larvae adaped to the test environment, the behavioural 
differences among different concentrations became trivial (Figure 4.4.2 C). When analysing 
the percentage of change in the moving distance during the experiement, compared to the 
control, significant locomotion changes were found at concentrations higher than 40% 
dilution (Figure 4.4.2 D). The threshold of the toxicity is around 20% of dilution, which is in 
line with the result from the mortality test.  
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Figure 4.4.2 Larval behaviour tests of Form Clear extract. 100% concentrated Form Clear extract was 
diluted for the tests. The behaviour test lasted for 64 min with a 4-min-light-4-min-dark cycle applied 
during the tests. A) Total distance travelled by larvae in the test chamber. B) Comparison between 
the distances travelled during the light and the dark. Zebrafish larvae were more active during the 
dark environment. C) Habituation curve of the larvae in every light/dark cycle. Zebrafish larvae had 
an instant response immediately after being exposed to the toxicants. However, they tended to 
recover over the exposure time. D) Percentage of change in total movement distance during the 
experiment. Significant changes were observed even at the lowest conentration.  
As a vision assistant, the record of larvae trajectories was presented in Figure 4.4.3. The 
trajectory lines were in three colours. Green lines are large movements with a burst speed 
larger than 20 cm/s. Red lines represents small movements with a burst speed between 7 
and 20 cm/s. Black lines are trivial movements with a burst speed smaller than 7 cm/s. It is 
clear that embryo activity is negatively related to toxicant concentration. The embryo 
locomotion also decreased over the period of time.  
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Figure 4.4.3 Tracking of zebrafish larvae trajectories after exposure to the Form Clear material 
extract at different concentrations. Each circle depicted the larvae travelling trajectory in 16 minutes. 
Zebrafish larvae showed an instant behaviour change to the toxicant at different concentrations.  
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4.5 Chemical analysis  
So far, I have investigated the toxicity effect of 3D printing materials on aquatic model 
organisms, but the specific chemical compounds contributing to the toxicity have not yet 
been identified. Therefore, in the next phase of toxicity profiling, a chemical analysis was 
performed using gas chromatography (GC) with associated mass spectrometry (MS).  
Generally, in GC-MS analysis, all compounds are injected into to a separation column. As the 
temperature ramps up, constituents with smaller molecular weight exit the column and are 
detected first, followed by heavier molecules. Peaks are then recorded on the graph 
according to their respective retention time. Afterwards, the separated compounds enter an 
MS detector, where compounds are electronically impacted and decomposed into smaller 
fragments. The molecular weights of all fragments work like a finger print for the original 
compound and can then be identified through comparison to compound libraries.  
 
 
85 
 
 
Figure 4.5.1 Qualitative chemical analysis of Form Clear extract using GC-MS. Form Clear extracted 
water sample was further extracted into dichloromethane (DCM) for GC experiments. Two major 
peaks were detected. From the compound library, one compound was identified as methyl 
methacrylate (MMA) and the other one as 1-hydroxycyclohexyl phenyl ketone (1-HCHPK).  
During these experiments, I again used Form Clear polymer as an example. Before sampling, 
constituents existing in FC water extract were further extracted into a solvent 
dichloromethane (DCM). As a result of GC-MS analysis, apart from some small peaks that 
were actually the impurities from the solvent, two major peaks were found in the sample 
(Figure 4.5.1). The first one, with a retention time of 7.23 min, was identified as methyl 
methacrylate (MMA) and the second one, at a retention time of 15.92 min, was 
characterised as 1-hydroxycyclohexyl phenyl ketone (1-HCHPK) (Figure 4.5.1). The 
similarities of identified compounds compared with the compound library were 72% for 
MMA and 94% for 1-HCHPK.  
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Although the MMA is one of the major compounds in the raw material (unpolymerised 
resin), its MS identification score was only 72% which was not reliable enough to confirm its 
existence. Furthermore, I compared the unknown compound’s MS spectrum with that of a 
standard MMA. As a result, their retention times were different under the same GC 
condition, and their MS spectra did not match each other. Based on this result, MMA was 
then excluded in the further study. Therefore, the actual compound responsible for this 
peak remained unknown. On the other hand, 1-HCHPK, with 94% similarity to the library, 
can be identified with high confidence. To confirm the presence of this compound in the 
sample, I again compared the retention times of the sample and the pure 1-HCHPK 
compound. Their retention times were found to match, as expected.  
 
Figure 4.5.2 Calibration curve of 1-hydroxycyclohexyl phenyl ketone (1-HCHPK) for GC quantitation. 
The concentration of the 1-HCHPK in the extract was determined to be 137 mg/L.  
Following up the qualitative analysis, a quantitation was performed to determine the 
concentration of 1-HCHPK in the water extract. A series of standards were prepared to 
generate a calibration curve. Excellent linearity was achieved, as shown in Figure 4.5.2. I 
then analysed the FC polymer extraction sample again and found the concentration of 1-
HCHPK in the extract was 137 mg/L.  
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4.6 Identified compound verification 
In the last section of the toxicity profiling, the toxicity of the identified compound (1-HCHPK) 
was tested to see if it was as effective as the original Form Clear extract. This is to verify 
whether the chemical analysis was properly performed. If the toxicity of 1-HCHPK was the 
same as the polymer extract, it could be concluded that the 1-HCHPK was the very 
compound that causes toxicity. Otherwise, it indicates that the chemical analysis was 
incomplete and that one or more unidentified toxicants existed in the sample, or that 
several chemicals have a synergetic effect on the overall toxicity.  
4.6.1 Acute toxicity test 
Toxicity verification biotests were performed on a few selected model organisms. In the 
mortality tests, lemna, daphnia, zebrafish embryos and larvae were chosen, identical to the 
Form Clear extract tests. Half-maximal response concentrations (EC50) and toxicity curves of 
each species were calculated and plotted (Figure 4.6.1). For organisms that were not 
sensitive to the Form Clear extract, i.e. lemna and daphnia, they were also not very sensitive 
to 1-HCHPK. The maximal responses (100% mortality) were found at nearly 200 mg/L. 
Likewise, zebrafish embryo and larvae were very sensitive to the Form Clear extract, and 
they are also sensitive to 1-HCHPK. Toxicity curves for both embryo and larva were steep 
and the EC50 value was around 45 mg/L.  
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Figure 4.6.1 Toxicity test of 1-HCHPK on model organisms. Toxicity curves depicted the response of 
each test organism to different concentrations of 1-HCHPK. Half-maximal response concentrations 
were calculated using the Toxrat software. Four model organisms A) lemna B) daphnia C) zebrafish 
embryo, and D) zebrafish larvae were used for the tests, same as the Form Clear extract tests, for 
comparison (Figure 4.4.1). The 1-HCHPK was indeed toxic to all test organisms at relatively low 
concentrations.  
4.6.2 Zebrafish larvae behaviour test 
Zebrafish larvae behaviour tests were also performed for the toxicity verification test. 
Similarly, zebrafish larvae at 7 dpf were exposed to different concentrations of the toxicant 
for 64 min with a 4-min-light-4-min-dark cycle. Zebrafish larvae again displayed sensitive 
responses to the toxicant. Larval locomotor activity was significantly inhibited at 30 mg/L, in 
both light and dark environments (Figure 4.6.2 A&B). The habituation curve demonstrated 
an instantaneous response of larval fish to the toxicant exposure. Compared with the 
control, 1-HCHPK at 15 mg/L and 30 mg/L inhibited larvae mobility by more than 50%; the 
inhibition was close to 100% at higher concentrations (Figure 4.6.2). Comparing the 
percentage of change in travelled distance, I postulate that the toxicity threshold of toxic 
response is between 15 and 30 mg/L.  
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Figure 4.6.2 Zebrafish larval behaviour test of 1-HCHPK. The behaviour tests were performed for 64 
min with a 4-min-light-4-min-dark cycle. A) Total distance travelled by larvae in the test chamber. B) 
Comparison between the distances travelled during the light and the dark. C) Habituation curves of 
the larvae in every light/dark cycle. D) Percentage of change in total movement distance during the 
experiment.  
 
4.7 Summary and discussion  
A recent revolution in high-definition 3D printing technologies has greatly facilitated 
fabrication of biomicrofluidic lab-on-a-chip devices. While fused deposition modelling 
(FDM), multi-jet moulding (MJM), and stereolithography (SLA) provide the capabilities to 
rapidly prototype miniaturised devices for small model organism culturing, the 3D printing 
material toxicity has not yet been extensively studied. In this chapter, a significant toxicity 
profiling was performed on a selection of widely used 3D printing materials by using 
biotests. In the first stage, the toxicity profiles of 7 selected materials were screened 
through the use of 8 model organisms. Secondly, I focused on one particular polymer, Form 
Clear. Standard bioassays were conducted according to OECD protocols and behavioural 
bioassays were carried out using zebrafish larvae. Thirdly, a chemical analysis was 
conducted to identify the compounds existing in the polymer extract and determine their 
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concentrations. Lastly, I verified the toxicity of the identified compound by performing 
biotests again. In summary, it was found that significant toxic effects were exhibited by a 
vast majority of MJM and SLA polymers, causing both lethal and sublethal (behaviour) 
effects on a range of aquatic organisms.  
Attribute of 1-HCHPK 
The toxic compound identified in the 3D printed polymer water extract was 1-HCHPK. It 
exists in the raw material (monomer resin) as a photo initiator which absorbs photons and 
initiates the polymerisation reaction. Photo initiators are being used in a broad range of 
plastic products, including food, biological and medical applications. In particular, Yamaji 
and co-workers found the presence of 1-HCHPK in the injection solution from polyethylene 
ampoules from three brands; and the MTT assay demonstrated that concentration of 1-
HCHPK in the injection solution was cytotoxic108. This result is in line with the finding from 
this study.  
Limitation of the biotest 
Although eight model aquatic species, ranging from plants to vertebrates, were selected for 
the toxicity characterisation, it is probably still insufficient to understand the general toxic 
effects on the ecological system, especially after knowing that there is a huge variation 
among the response of all tested organisms to the toxic polymer extracts. For example, 
lemna was not very sensitive to DFC and FC polymers, but very sensitive to WXC and VJSL 
polymers; whereas amphipods were delicate with regard to DFC and FC polymers, but very 
resistant to WXC and VJSL polymers.  
The number of tested polymers in this study was limited at seven, which was restricted by 
the funding, time, and printing facility availability. Provided that there are dozens of 3D 
printing materials on the market and new materials are being produced every year, the 
material coverage of the study was also inadequate. Therefore, caution is required for 
bioengineers who are willing to use MJM or SLA 3D printing to fabricate devices for 
biological utilities.  
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Limitation of the chemical analysis  
In this study, chemical analysis was performed by GC-MS and two major peaks were 
detected from the extraction sample. One of the peaks hit the compound library and was 
successfully identified. However, the analysis had many limitations. To start with, GC-MS is 
only ideal for detecting polar and volatile (molecular weight < 300 Da) compounds. Any 
larger constituents existing in the sample would not be detected. Moreover, polymer 
extracted in water (aqueous phase) could not be injected into the instrument for direct 
analysis, they need to be extracted further into an organic solvent phase. Herein, I used 
dichloromethane (DCM) as the solvent because it is a widely used polar solvent. As water is 
also a polar solvent, any compounds dissolved in water theoretically should also dissolve in 
DCM. Nevertheless, there could have exceptions, resulting in the loss of some analytes. 
Furthermore, the further extraction was a liquid-liquid extraction. Analytes could easily be 
lost during this procedure, making the quantitation inaccurate. Finally, a better separation 
method like high pressure liquid chromatography (HPLC) could be utilised together with a 
more precise detection method like nuclear magnetic resonance (NMR) to identify trace 
compounds in the extract.  
Remediation and challenges  
Given the 3D printing principle and the material properties, I postulate that the toxicity 
came from unpolymerised residual resins left in the channels, and/or leachate from the 
surface of the polymerised material. In both cases, the biocompatibility issue could be 
remediated by iterative washing using fresh water and solvents. In the standard operating 
protocol, isopropanol was recommended to clean the residual resins through soaking and 
flushing for a short time. That was apparently not enough to wash away all the toxicants.  
To prove this point, I have 3D printed a few single-well organism culture chambers (Figure 
4.7.1). The size of the well was designed to be exactly same as the wells on a conventional 
24-well microtitre plate. Zebrafish embryos were used as a test organism and cultured in the 
wells after a standard post-fabrication cleaning of the chamber. Not surprisingly, all 
embryos were died after 24 hours of exposure.  
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Figure 4.7.1 CAD design of single-well organism culture chamber. (A) Cross-section view of the single 
well culture chamber. Note that the lid only loosely covered the chamber for air exchange. (B) Single 
well with the lid. The size of single-well was designed to be exactly same as the wells on conventional 
24-well microtitre plate.  
In the test of washing, I soaked the 3D printed chip devices in 99% isopropanol for 24 hours 
each wash (Figure 4.7.2). After 24 hours of soaking, the zebrafish embryo viability increased 
dramatically from 0% to 75% in the devices fabricated by Dreve Fototec Clear resin. The 
toxicity was completely gone after three wash interactions and no further toxicants were 
released.  
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Figure 4.7.2 Viability of zebrafish embryos cultured on prototypes made of Dreve FotoTec polymer 
resin at 72 hour post fertilisation (hpf). 
However, this remediation method has its drawbacks. Overly soaking the printed parts in 
isopropanol will soften the 3D printed material and damage delicate 3D printed structures, 
such as small channels and pillars. Thus, it is not ideal for lab-on-a-chip fabrication purposes. 
In experiments using other solvents, 99% ethanol increased the washing efficiency, but it 
caused more damage and the Watershed XC11122 material even completely dissolved after 
24 hours.  
Apart from washing, some other remediation methods was attempted including subsequent 
UV exposure of printed objects, plasma treatment of the surface of printed objects, and 
autoclave of the polymer extract. However, none of the methods were able to address the 
issue. Thus, to fabricate a biocompatible microfluidic lab-on-a-chip device for zebrafish 
embryos, a new manufacturing approach needs to be explored. This is demonstrated in the 
next chapter.  
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5 ZebraTox Chip: A lab-on-a-chip device for automated fish embryo 
toxicity assays 
 
5.1 Introduction 
This chapter describes the design, validation, and application of a pioneering lab-on-a-chip 
technology for automated zebrafish embryo toxicity bioassays utilised in drug discovery and 
ecotoxicology. The main objective was to develop a biocompatible and miniaturised embryo 
trapping array to load, isolate, and immobilise single embryos in a flow through 
environment. The chip device was made of optically transparent materials with no structural 
obstacles for a broad adaption of imaging systems and was suitable for high-throughput 
imaging. The microfluidic module facilitated continuous medium exchange and/or toxicant 
delivery under microperfusion during the period of embryo development.  
To validate the microfluidic system, computational fluid dynamics simulations were 
performed, followed by experimental validations. For a proof-of-concept drug delivery test, 
two antiangiogenic compounds were tested on transgenic zebrafish embryos. To investigate 
the applicability of the microfluidic fish embryo toxicity test (μFET) in ecotoxicity testing, six 
reference toxicants were tested as model chemical stressors. I provide evidence that 
miniaturised μFET analysis opens a brand new alternative for inexpensive automation in 
aquatic ecotoxicity protocols. For innovative applications, I demonstrate that microfluidic 
devices with immobilised embryos offer great convenience for embryonic activity analysis in 
a flow through environment. Moreover, by integrating oxygen sensors onto the chip, a new 
function for the device was explored for visualised fish embryo metabolic analysis. 
Furthermore, I demonstrate that by expanding the embryo trapping array into a high 
density plate-like device, it can fulfil the requirement of high-throughput screening. 
 
5.2 Design of the linear embryo trapping array    
Zebrafish embryos are protected by an elastic spherical chorion with a diameter of 1 mm to 
1.2 mm. They also bear a substantial amount of mass, 850 µg to 1050 µg, that leads to rapid 
gravitational-induced sedimentation and high translational and rotational momentum when 
moving. These features were initially considered as obstacles for manipulation in a 
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microfluidic system, but in this study, these very characteristics were utilised for embryo 
loading and immobilisation.  
 
Figure 5.2.1 Overview of miniaturised zebrafish embryo trapping arrays. The chip devices are made of 
optically transparent and biocompatible thermoplastic poly(methyl methacrylate) (PMMA). The size 
of the chips is identical to standard microscope glass slides.  
The size of the chip was designed to be to identical to standard microscope glass slides (75 
mm x 25 mm, Figure 5.2.1). Each chip contained a microfluidic system consisting of five 
major components: an inlet port, a loading channel, an embryo array, a suction manifold, 
and an outlet port (Figure 5.2.2). The 21 embryos traps were clustered into 7 groups of 
three traps. Each group of three traps is positioned within a single well from a 96 well plate 
for high-throughput imaging (red dotted circle, Figure 5.2.2).  
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Figure 5.2.2 Microfluidic manifold on the chip device. All main modules depicted. Embryo traps were 
clustered in seven groups. Each group consisted of three traps and featured a total circumference 
and distribution equal to the wells on standard 96-well microtitre plate. Published in Ref 109, 
Reprinted with permission from ©  2015 American Chemical Society.  
The chip device comprised of five PMMA layers (Figure 5.2.3), with a total thickness of 7.3 
mm. The top layer contained the inlet and the outlet of the chip; both of which were circular 
cuts with a diameter of 2.9 mm. The second layer held a loading channel (68 mm × 1.8 mm × 
2.0 mm). This channel is not only for embryo loading, but also for toxicant delivery and post-
culture embryo recovery. The third layer carried the top half of 21 embryo traps (ϕ 1.5mm × 
0.7 mm); the fourth layer contain the bottom half of 21 embryo traps (ϕ 1.5mm × 0.5 mm) 
and the suction manifold. The suction manifold included a main suction channel (63 mm × 
2.5 mm × 0.5 mm) and interconnection channels (0.3 mm × 1.6 mm × 0.5 mm) linking each 
embryo trap and the main suction channel. A suction force was created from the small 
channels to help embryo docking, immobilisation, and toxicant perfusion. To support 
unobstructed imaging capabilities from both upright and inverted cameras, the suction 
manifold was located on the side panel of the traps. The bottom layer was simply a sealing 
of the entire fluidic domain.  
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Figure 5.2.3 Exploded view of the chip device. The chip comprised of 5 layers. The functions of each 
layer is depicted. Each layer was fabricated separately on a laser cutting machine. The five layers 
were then thermally bonded together in a fan assisted oven.  
After bonding all five layers together, a fluidic domain was then created as depicted in 
Figure 5.2.4. The total volume of the fluidic domain was 324 µL and the total surface area 
was 1012 mm2.  
 
Figure 5.2.4 CAD rendering of the fluidic domain of the chip device. The fluidic domain is the hollow 
part of the chip device. All features are depicted.  
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The microfluidic system was designed for automatically trapping embryos with the one-
embryo-in-one-trap concept. The trapping principle exploited both gravitational-induced 
sedimentation of embryos and low-pressure suction at the bottom of the device (Figure 
5.2.5). When loading, a low pressure suction force from a peristaltic pump was applied 
constantly at the outlet of the chip. Embryos were first aspirated one by one at certain 
intervals from a reservoir to the inlet of the chip. As the embryos enter the chip, they were 
pulled to move forward along the loading channel because of the hydrodynamic force from 
the suction channel. When the embryos flowed over the embryo trap, they were deflected 
by the combination of gravitational force and suction force and hence sank into the embryo 
trap. As the docked trapped embryos were immobilised, they behaved as spacers occupying 
the trap, allowing subsequent embryos to roll freely across the trapped embryos and 
towards the next available trap. The process was repeated until all traps were occupied and 
the loading process was discontinued. Toxicant solutions could then be introduced via the 
flow inlet.  
 
Figure 5.2.5 3D cartoon depicting the principle of embryo trapping and immobilising on the chip. i) 
The system took advantage of combined gravitational-induced sedimentation and low pressure 
suction at the bottom of the embryo trap. Embryos fall into the embryo trap as they pass over. ii) and 
iii) Trapped embryos are immobilised, acting as spacers for following embryos to roll over the 
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occupied traps and toward next available trap. iv) After all embryos are trapped, drugs or toxicant 
can be introduced for on-chip bioassays. Published in Ref 109. Reprinted with permission from ©  
2015 American Chemical Society. 
In the case that one extra embryo is loaded into the microfluidic device, the embryo will 
stay in the end of the loading channel without being immobilised. However, this embryo will 
not interfere the embryo on-chip culture, nor the imaging of the embryos. 
 
5.3 Simulation and validation  
To predict the embryo trapping performance, the mass transfer uniformity, and the on-chip 
culture feasibility, computational fluid dynamics (CFD) simulations were performed followed 
by experimental validations.  
5.3.1 Embryo trapping 
The simulated fluidic streamlines demonstrated the flow velocities at different regions of 
the fluidic domain under a constant flow rate of 400 µL/min. The flow velocity was uniform 
at 4.3 mm/s along the embryo loading channel up to trap number 18. At the fluidic region of 
the last three embryo traps the flow velocity plummeted to nearly zero though the flow 
velocity elevated to 10 mm/s at the suction microchannel (Figure 5.3.1). This indicated that 
the embryo trapping could be difficult in the last three traps. 
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Figure 5.3.1 Computational fluid dynamics (CFD) simulation predicting streamlines when flowing 
across the trapping array. Flow trajectory and the velocity along the fluidic domain are depicted. At 
the flow rate of 400 µL/min, most of main loading channel achieved a flow velocity of around 4 
mm/s. Note that the flow velocity is dramatically decreases towards the last three embryo traps (trap 
number 19 to 21). Published in Ref 109. Reprinted with permission from ©  2015 American Chemical 
Society. 
The Lagrangian particle tracking (LPT) model was applied to predict the embryo trapping 
trajectory. This model is often used to analyse small particles, such as dust, aerosol, or small 
bubbles, but here this model was used to predict zebrafish embryo behaviour under 
hydrodynamic and sedimentation forces. Simulated embryos were set as rigid spherical balls 
with a diameter of 1 mm, which is slightly smaller than the depth of the embryo trap (1.2 
mm). As a result, the simulation indicated that when passing through the occupied wells 
embryos would roll on top of the trapped embryos, bounce, and continue rolling until they 
101 
 
dock into the next available trap (Figure 5.3.2). On top of that, LPT also predicted a 
sequential trapping of embryos.  
 
 
Figure 5.3.2 Implementation of Lagrangian particle tracking simulation model to predict the trapping 
characteristics of the design. Embryos traps were numbered in sequence from the flow inlet. Embryo 
The red line depicts the trajectory of embryo movement along the loading channel. Published in Ref 
109. Reprinted with permission from ©  2015 American Chemical Society. 
In experimental validation, zebrafish embryo at 6 hour post fertilisation (hpf) were first 
stained with trypan blue for a better observation. To begin with, the chip device was primed 
with 99% ethanol to eliminate any visible air bubbles, followed by a thorough flushing out 
with embryo medium E3.  Embryos were then aspirated from a reservoir into the chip one 
after another at an interval of 15 seconds. Although the embryo trapping did not occur in 
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the sequence predicted by the simulation, it indeed achieved 100% of trapping efficiency 
(Figure 5.3.3).  
 
Figure 5.3.3 Experimental validation of the particle tracking model. Embryos were stained with 
Trypan blue to highlight the embryo locations. The full loading took approximately 7 minutes 
depending on the flow rate and embryos aspiration gap. Note the excellent agreement of 
experimental embryo docking as compared with CFD simulations. Published in Ref 109. Adapted with 
permission from ©  2015 American Chemical Society. 
The embryo trapping efficiency was tested under different flow rates (Figure 5.3.4). At low 
flow rates, the hydrodynamic force was insufficient to lead embryos through the channel 
due to the substantial mass of the embryos (sedimentation force >> hydrodynamic force). In 
contrast, when the flow rates were too high, all the embryos skipped the traps and were 
flushed into the end the loading channel (sedimentation force << hydrodynamic force). 
Eventually, an optimal flow rate of 400 µL/min was found to constantly achieve 100% 
trapping efficiency. 
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Figure 5.3.4 Trapping efficiency at various flow rates (n ≥ 4).100% trapping efficiency can be achieved 
at flow rates between 300 and 700 µL/min. Trapping efficiency deteriorated at higher flow rates. This 
phenomenon was attributed to excessive velocity and momentum of the embryos that could not be 
compensated for by the suction manifold when trapping. Published in Ref 109. Reprinted with 
permission from ©  2015 American Chemical Society. 
This chip device also allowed recovery of immobilised embryos. In practice, the chip can be 
turned upside down to release trapped embryo into the loading channel. A positive pressure 
could then be applied from the suction port to push all the embryo to leave the chip device.  
5.3.2 Mass transfer 
Mass transfer on empty chip 
Constant delivery of toxicants with a uniform distribution to the immobilised zebrafish 
embryos is essential for long-term microperfusion studies in drug discovery and 
ecotoxicology. CFD simulations were performed to predict the uniformity of the mass 
transfer across the chip device (Figure 5.3.5). Trypan blue was set as the simulated dye. The 
simulation indicated that the medium exchange rate reached 100% in the embryo traps 
after 60 seconds of perfusion at a flow rate of 400 µL/min. It also predicted a unique 
perfusion pattern in the suction manifold, as the medium exchange rate at some part of the 
suction channel was very slow.  
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Figure 5.3.5 CFD simulation predicted uniformity of mass transfer across the empty array. Trypan 
blue was chosen as a modelling compound. After 60 seconds of continuous perfusion at the flow rate 
of 400 µL/min, the medium exchange rate in the main loading channel reached 100%. Note the 
unique fluidic pattern in the suction manifold after 60 seconds of perfusion.  
During experimental validation, the chip was again primed with ethanol to eliminate air 
bubbles followed by flushing with embryo medium E3. Afterwards, 0.04% Trypan blue 
solution was perfused from the loading port at a flow rate of 400 µL/min. Images were 
taken every 15 seconds as a comparison of the simulation. In spite of a few seconds delay in 
medium exchange, the medium exchange rate was fast and the microperfusion pattern was 
in excellent agreement with the CFD prediction (Figure 5.3.6).  
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Figure 5.3.6 Experimental validation of mass transfer in the empty chip. Chip was perfused with a 
0.04% Trypan Blue at a volumetric flow rate of 400 µL/min. Images were taken at 15, 30, 45, and 60 
seconds of perfusion. After 60 seconds of perfusion, 95% of the embryo traps achieved full medium 
exchange with trypan blue. The exception was the very last embryo trap. Note the fluidic pattern was 
identical between the simulation and the experiment.  
Mass transfer on loaded chip 
The CFD simulations were also performed to predict the perfusion uniformity with docked 
embryos (Figure 5.3.7). Here, simulated embryos were set as rigid spherical balls with a 1 
mm diameter. Trypan blue was used as a simulated solution perfusing at 400 µL/min. The 
prediction indicated that the medium exchange rate was rather fast that after 60 seconds, 
the surface of the embryos achieved more than 90% of medium exchange. It is worth noting 
that the upper hemisphere received more medium exchange than the lower hemisphere 
due to the suction microchannels locating in the bottom of the embryo traps. However, the 
exchange rate could still achieve 100% over the time.  
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Figure 5.3.7 Time-resolved CFD simulations of toxicant perfusion in the chip with fully loaded fish 
embryos, detailing traps numbered 20 and 21. Trypan blue was predicted to cover most of the 
embryo surface after 60 seconds of perfusion at flow rate of 400 µL/min. 
In experimental validation, zebrafish embryos at 6 hpf were loaded onto the chip device, 
followed by a microperfusion of 0.04% Trypan blue solution for 5 minutes. The Trypan blue 
was then washed out by embryo medium E3. As a result, all loaded embryos were stained 
by the blue dye with a relatively uniform intensity across all the traps (Figure 5.3.8). In some 
embryo trap however, higher staining intensities were observed because of variation in the 
size in the embryo population.  
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Figure 5.3.8 Experimental validation of toxicant perfusion on the fully loaded chip device. Trypan Blue 
was perfused in the chip device at a flow rate of 400 µL/min for 300 seconds, followed by a washout 
with E3 embryo medium. Most trapped embryos remained in the traps and show uniform labelling of 
embryos across each cluster. 
5.3.3 Embryo on-chip culture 
In the next stage, the biocompatibility of the chip microenvironment for embryo culture was 
evaluated under a continuous flow over an extended period of time. CFD was performed to 
predict the water pressure and shear stress exerting on the surface of immobilised embryos. 
Here, simulated embryos were set as rigid spheres with a 1 mm diameter sitting in the 
bottom of the embryo traps under a continuous flow rate of 400 µL/min.  
As shown by calculations, the water pressure was evenly exerted onto the embryos, with a 
maximum pressure of 4.1 Pa at the top section and a minimum pressure of 3.5 Pa at the 
bottom section (Figure 5.3.9-A). The water pressure was mainly attributed to the flow from 
the loading channel, and was slightly compensated for by the flow from the suction 
microchannel. In contrast, the shear stress exerting on the embryos originated from the 
suction microchannel (Figure 5.3.9-B). The section directly facing the suction microchannel 
received a maximal shear stress of 0.1 Pa.  
108 
 
 
Figure 5.3.9 CFD simulation of embryo microperfusion culture on the chip at flow rate of 400 µL/min 
A) Contours of water pressure exerted on immobilised embryos inside the trap. B) Contours of shear 
stress exerted on immobilised embryos inside the trap. Calculations were based on the embryos from 
the last two embryo traps. Published in Ref 109. Reprinted with permission from ©  2015 American 
Chemical Society. 
It is rather difficult to physically measure water pressure and shear stress exerted on the 
zebrafish embryos in the chip microenvironment. Hence, experimental validation was 
performed by a long-term culture of zebrafish embryos in a microperfusion condition from a 
very early developmental stage until 48 hours post fertilisation (hpf) (Figure 5.3.10). 
Developing embryos reached all developmental staging criteria, including somite formation 
(12 hpf), eye buds formation (18 hpf), tail detachment (24 hpf), and pigmentation (48 hpf).  
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Figure 5.3.10 Time-lapse images of developing zebrafish embryos over the duration of the 
experiment. Embryos were loaded on a chip at the flow rate of 400 µL/min, followed by on-chip 
culture under the same flow rate for up to 48 hours. Published in Ref 109. Reprinted with permission 
from ©  2015 American Chemical Society. 
A normal and uniform development of embryos was observed across the living embryo 
array. Furthermore, a cumulative embryo survival test was conducted at different flow rates 
ranging from 0 to 1000 µL/min. Embryo survival rate during microperfusion experiments 
were statistically comparable with static Petri dish control experiments, except for those 
with extremely low flow rates (Figure 5.3.11). The decreased survival rates were due to the 
oxygen depletion inside the chip when the flow rate was too low to carry sufficient oxygen 
for the embryo in a chip that is made of gas non-permeable PMMA.  
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Figure 5.3.11 Cumulative survival (72 hours) of zebrafish embryos perfused on chip at varying 
volumetric flow rates. Embryo viability on microperfusion experiments were comparable with static 
experiment on Petri dish. Low viability occurred in low flow rate experiments due to the oxygen 
depletion. Published in Ref 109. Reprinted with permission from ©  2015 American Chemical Society. 
 
5.4 Imaging from the chip 
The accessibility for imaging is one of the most important considerations when design lab-
on-a-chip devices because, currently, the zebrafish embryo assays rely greatly on 
microscopy. In this regard, the chip device was designed to facilitate both upright and 
inverted imaging systems by assigning all fluidic channels to positions with no obstacles for 
imaging (Figure 5.4.1). The thickness of the chip device was also minimised for high 
magnification imaging. In particular, the minimum distance from the lens and the embryo 
was 1 mm from the bottom and 5 mm from the top. Hence the imaging from the bottom of 
the chip was preferred.  
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Figure 5.4.1 Bright field image from the top of the chip device with immobilised zebrafish embryos at 
48 hpf. There is no physical obstacles blocking imaging from either sides of the chip.  
Images from the chip device could to be taken, per cluster of three embryo traps, at a 
magnification of at least 30x. An image of the whole chip with detailed embryo features was 
also possible by stitching all sections together as shown in Figure 5.4.2.  
 
Figure 5.4.2 Bright field image from miniaturised Dino-Lite 5 MP USB microscope. Images of embryos 
were taken at a group of three and then stitched together and shown as an image of the whole chip.  
The chip device also fully supported fluorescence imaging from different imaging systems 
(Figure 5.4.3). In experimental validations, transgenic zebrafish Tg(fli1:EGFP) embryos with 
highlighted intersegmental vessels (red arrows) at 48 hpf were loaded onto the chip device. 
The blood vessel pattern of zebrafish embryos is highly characteristic during embryogenesis 
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and can be stained or genetically modified to allow visualisation under fluorescence 
microscopes 36, 37. Fluorescence imaging were performed by i) Dino-Lite miniaturised 
fluorescent microscope ii) Trophos high-throughput image cytometer iii) Nikon SMZ1500 
upright microscope, and iv) Nikon Eclipse TiE epifluorescence microscope. The features 
highlighted by green fluorescent protein (gfp) were all clearly present, even at low 
magnifications (with three embryos); and the intensity of autofluorescence from the PMMA 
chip was at an acceptable level.  
 
Figure 5.4.3 Comparison of different fluorescence imaging systems on zebrafish embryo array with 
loaded Tg(fli1:EGFP) embryos. A) Miniaturised Dino-Lite 1.3 MP fluorescent USB microscope. B) 
TROPHOS plate RUNNER image cytometer. C) Upright microscope Nikon SMZ1500. D) Inverted 
microscope Nikon Eclipse TiE epifluorescence. Note that the intersegmental vessels (red arrow) were 
all clearly visible.  
 
5.5 On-chip anti-angiogenesis assays 
Following the preliminary validation of the lab-on-a-chip fish embryo trapping array, I tested 
a couple of small molecular drugs as a proof-of-concept drug toxicity screening. Zebrafish 
embryos are protected by chorion (a layer of membrane surrounded the body) that resists 
large molecules, however, small molecular drugs are able to penetrate the chorion and 
affect embryos, causing mortality or developmental abnormalities36. In this experiment, two 
anti-angiogenesis drugs i.e. VEGFR1-3 inhibitor AV951 (Tivozanib) and VEGFR2/PDGFRβ 
inhibitor Sunitinib were selected for testing with transgenic zebrafish Tg(fli1a:EGFP) 
embryos on the chip device. 
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Prior to the experiment, 0.003% 1-phenyl-2-thioures (PTU) was added into the standard 
embryo culture medium E3. This compound not only inhibits the natural pigmentation of 
the embryo without any effects on their health, but also delays the embryo hatching time, 
allowing the embryos to be encapsulated within their chorion for an extended period of 
time110. At the endpoint of experiment, 0.2 mg/mL of Tricaine mesylate (TMS) was added 
into the culture medium to temporarily anaesthetise the embryo from spontaneous 
movement inside the chorion. This process was essential to obtain a better imaging quality 
with fluorescent images when the exposure time was very long. 
 
Figure 5.5.1 Chip-based angiogenesis assay performed on Tg(fli1:EGFP) zebrafish embryos. Images 
were taken at 72 hours into the experiment with z-stack imaging. Embryos were anesthetised with 
Tricaine mesylate (0.1 mg/mL) when imaging. Vehicle control was DMSO. Microscopic visualisation 
of intersegment vessel (ISV) showed no inhibition, partial inhibition, and full inhibition of AV951 at 
1.0, 0.5 and 0.1 µM respectively. 
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Embryos at 16 hpf were loaded into the chip device under continuous perfusions of anti-
angiogenesis drugs. At 72 hours post fertilisation (hpf), non-stimulated (control) zebrafish 
embryos developed normally in the chip device as evidenced by the presence of 
characteristic patterns of intersegmental vessels (ISV). Embryos treated with AV951 
achieved 100% inhibition of ISV at 1 µM, partial inhibition at 0.5 µM, and no inhibition at 0.1 
µM (Figure 5.5.1). Sunitinib showed no inhibition of ISV up to 50 µM, but showed 100% 
inhibition at 100 µM (Figure 5.5.2). By using TMS, using focus-stacking imaging technique, I 
was able to generate fully focused images on spherical embryos by merging multiple images 
taken at difference focus distances.  
 
Figure 5.5.2 Chip-based angiogenesis assay performed on Tg(fli1:EGFP) zebrafish embryos. Images 
were taken at 72 hours of experiment with focus-stack imaging. Embryos were anesthetised with 
Tricaine mesylate (0.1 mg/mL) when imaging. Microscopic visualisation of intersegment vessel (ISV) 
showing vehicle control (DMSO), no inhibition, and full inhibition of Sunitinib at 0, 50 and 100 µM, 
respectively. 
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5.6 Microperfusion fish embryo toxicity (µFET) assays  
Following the proof-of-concept drug toxicity screening test, the applicability of using 
microfluidic embryo array was investigated by performing fish embryo toxicity (FET) test 
based on a standard toxicity test protocol (OECD TG 236). This experiment was aimed at 
demonstrating that the fish embryo toxicity test performed on the microfluidic chip device 
is equal to, if not better than, the standard toxicity tests performed in static multiwell 
plates. I expected to see the microfluidic chip device overcome the limitations of standard 
toxicity tests.  
To compare the performance between testing methods, medium lethal concentration (LC50) 
by using FET protocol and half maximal response (EC50) by using the iFET scoring criteria 
were calculated. To demonstrate the microfluidic system is applicable for a wide range of 
chemical compounds, I selected several commonly used reference toxicants to represent 
major classes of chemicals.  
5.6.1 Test using FET protocol 
I first used the standard fish embryo toxicity test (FET, OECD TG 236) protocol to test toxic 
compound. This protocol outlined four lethal endpoint of the experiment i.e. coagulation of 
embryo, lack of somite formation, non-detachment of tail, and lack of heartbeat (Figure 
5.6.1). There are, however, no scoring criteria for sub-lethal effects and therefore the utility 
of this protocol is rather limited. In experiments, copper sulphate pentahydrate 
(CuSO4·5H2O) was used as a reference toxicant for toxicity tests. Copper is known to be toxic 
to aquatic organisms at low concentrations. It causes mortality without significant sub-lethal 
or teratogenic effects.  
 
Figure 5.6.1 Lethal endpoints of zebrafish embryo toxicity tests at 24 hpf compared with a viable 
embryo. Lethal endpoints of coagulation of embryo, lack of somite formation, and non-detachment 
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of tail were illustrated. Note that the fourth lethal endpoint. i.e. lack of heartbeat, was not applicable 
for embryos at 24 hpf.  
As a result of the biotest, embryo mortality in the microperfusion chip was in line with the 
mortality in the static culture plate (Figure 5.6.2). In particular, the LC50 value was 0.8 mg/L 
on the chip device and 1.3 mg/L in the static wells.  
 
Figure 5.6.2 Comparison between zebrafish embryo biotests performed in a microfluidic chip-device 
and conventional static culture plates. Chip experiments were performed under continuous 
microperfusion at a flow rate of 400 µL/min for 48 hours. Copper sulphate pentahydrate 
(CuSO4·5H2O) was used as a reference chemical to cause mortality with no sublethal effects in the 
fish embryos. The FET index was calculated based on the standard FET assessment criteria. The FET 
index indicates the mortality of the test embryos. Published in Ref 109. Reprinted with permission 
from ©  2015 American Chemical Society. 
5.6.2 Test using iFET protocol 
Organic reference toxicants, such as phenol and caffeine, induce significant developmental 
abnormalities, but are not lethal to zebrafish embryos. Using FET endpoints in these cases 
are not appropriate. In this regard, the iFET protocol was used to improve the FET protocol 
to be able to test compounds causing sub-lethal effects on fish embryos. Apart from the 
four lethal endpoints from the FET protocol, iFET further introduced nine sub-lethal 
endpoints during the embryo development104. Those parameters are: i) pericardial oedema, 
ii) lack of pigmentation, iii) head abnormalities, iv) yolk abnormalities, v) tail abnormalities, 
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vi) abnormal eye development vii) spine abnormalities viii) defects in blood circulation, and 
ix) heart abnormalities (Figure 5.6.3).  
 
Figure 5.6.3 Sub-lethal (iFET) endpoints of zebrafish embryo toxicity test at 48 hpf compared with a 
viable embryo. iFET endpoints of pericardial oedema, lack of pigmentation, head abnormalities, yolk 
abnormalities, tail abnormalities, abnormal eye development, and spine abnormalities are 
illustrated. Note that two of the iFET parameters, defect in blood circulation and heart abnormalities, 
were not depicted here because they require demonstration via video clips.  
In the tests with organic compounds, four reference toxicants, dimethyl sulfoxide (DMSO), 
ethanol, phenol and caffeine, were used. Comparing EC50 values determined from 
microperfusion chip experiments with EC50 from static plate experiments, the values are 
rather close between two experiments. This result confirmed that the zebrafish embryos 
cultured in a microperfusion condition on the lab-on-a-chip device are suitable for fish 
embryo toxicity test with a broad range of chemical compounds and toxicants (Figure 5.6.4).  
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Figure 5.6.4 Comparison between zebrafish embryo biotests performed in a microfluidic chip-device 
and conventional static culture plates. Chip experiments were performed under continuous 
microperfusion at a flow rate of 400 µL/min for 48 hours. DMSO, ethanol, caffeine, and phenol were 
used as reference chemicals that not only cause mortality, but also provoke sub-lethal effects on the 
fish embryos. The iFET method was used to score both lethal and sub-lethal effects based on the 
relevant criteria. Note that the EC50 values were close between perfusion experiment and static 
experiment. Published in Ref 109. Adapted with permission from ©  2015 American Chemical Society. 
5.6.3 iFET test with unstable compound 
Despite the agreement with toxicity results in the above experiments, the model 
compounds selected were considered “easy” compounds that are very polar or moderately 
hydrophobic and they are likely to provide stable exposure concentrations both in a static 
exposure setup and in a microperfusion system. However, the static FET is particularly 
limited when the exposure concentrations at static conditions cannot be stably maintained, 
e.g. in case of hydrolysis, volatilisation, or absorption of the test compound to surfaces of 
exposure vessels. For these conditions, a pulse exposure is required and a microfluidic 
device could provide great advantages. To demonstrate that the microfluidic chip device 
provides more stable and reliable exposure, I chose nicotine as a representative compound.  
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Nicotine represents a challenge for toxicological assays due to the following reasons: Firstly, 
it is a common drug with an unquestionable and well-established toxicity. Secondly, its 
aromatic structure makes it prone to light degradation and oxidation, and, lastly, it is non-
polar and not hydrated below 60 °C, which poses the challenge. 
When testing the effects of nicotine in the microperfusion system, the iFET EC50 obtained 
was 112 mg/L. In comparison, the iFET EC50 for conventional systems was 185 mg/L, which is 
1.65 times the detection limit observed using the microperfusion system (Figure 5.6.5). This 
result demonstrated that microperfusion system can have lower detection thresholds due 
to increased availability of non-polar and unstable compounds. This increase in sensitivity 
from using the microfluidic device as a testing platform presents strong advantages and is 
therefore a contribution to the advancement of the toxicological technology currently 
available.  
 
Figure 5.6.5 Comparison between zebrafish embryo biotests performed in a microfluidic chip-device 
and conventional static culture plates. Chip experiments were performed under continuous 
microperfusion at a flow rate of 400 µL/min for 48 hours. Nicotine was used as an example of a class 
of unstable compounds. The iFET (lethal and sub-lethal/teratogenic) index was calculated based on 
the scoring criteria. Note that the EC50 value was significantly lower in the perfusion experiment than 
in the static experiment. Published in Ref 109. Reprinted with permission from ©  2015 American 
Chemical Society. 
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5.7 Embryonic activity detection 
The application of the embryo trapping array in embryonic behaviour studies was also 
explored. One of the greatest advantages of using zebrafish embryos is that their chorions 
are completely transparent, revealing the embryonic movement inside the chorion. 
Movements such as tail flicks, coilings, and convulsive behaviour starting as early as 17 
hours post fertilisation (hpf) are important measurements in toxicology and pharmacology 
because they reflect the development of the nervous system and are highly susceptible to 
pharmacological manipulation. 
To study the embryo behaviour, a video analysis software is required. In this study, 
DanioScope was used, as it is a non-invasive video analysis tool that investigates zebrafish 
embryo and larvae activity, cardiology, and morphology. For embryo activity study, 
DanioScope detects tail coils or convulsions.  
 
Figure 5.7.1 Comparison of the embryo detection windows using DanioScope 1 software in video 
acquisition. A) A standard setup in a Petri dish. B) A setup using the lab-on-a-chip device. Embryos 
were positioned and immobilised on the chip device. The software successfully detected the region of 
interest (yellow circles) in the chip device without overlapping.  
Compared with a standard experimental setup in a Petri dish, embryos were spatially 
separated on the chip device (Figure 5.7.1). This accelerated the detection of the embryo 
chorion and reduced the error from overlapping embryos. Furthermore, the chip device 
provided a continuous microperfusion environment that prevented the evaporation of 
embryo medium during video acquisition. Moreover, because embryos were immobilised in 
the chip device, it minimised the external movements of the embryos that lead to a shift in 
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position, and allowed spatial encoding of each embryo during an extended period of time 
(Figure 5.7.2).  
 
 
Figure 5.7.2 User interface of the Danio Scope 1 in data analysis, plotting the charts of embryo 
activity over the period of 1 min. The software generated embryonic activity results based on every 
single detected embryos for the period of the video.  
In a proof-of-concept experiment, 5% dimethyl sulfoxide (DMSO) was used to stimulate the 
embryo activity over 24 hours, as DMSO is known to be mildly toxic to zebrafish embryos. 
Embryos at 24 hpf were loaded into the chip device under a continuous microperfusion at 
400 µL/min. In comparison, a negative control (E3 medium, non-toxic embryo medium) and 
a positive control (Form Clear extract) experiment were also conducted in parallel (Figure 
5.7.3).  
A rapid stimulation in embryo activity was observed after just one hour of exposure to 5% 
DMSO solution, and the stimuli affected the embryonic activity over the next six hours.  The 
embryo activity plummeted after 12 hours into the experiment. In comparison, in the 
negative control experiment the embryo’s bursts of activity fluctuated around 3% in the 
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duration of the experiment; while in the positive control experiment, the embryo activity 
was constantly decreasing after an elevation in the first hour of perfusion.  
 
Figure 5.7.3 Comparison of embryonic burst activities after toxicant exposure on chip-based device. 
Note the rapid activity stimulation in 5% DMSO after just one hour of exposure. Also note that a 
continuous activity decrease over the time occurred in the positive control experiment.  
 
5.8 Visualisation of metabolic activities in zebrafish embryos  
Oxygen gradient is a physiological parameter for measuring the metabolic activity of the 
specimen. Progress in development of oxygen sensors has allowed visualised detections by 
luminescence as a result of excited molecular oxygen. However, all the tests were still 
conducted in small glass vessels containing a single organism, and, therefore, were not 
convertible to high-throughput screening assays.  
A new technology named Fluorescence Ratiometric Imaging (FRIM) has recently been 
reported. It is based on real-time quantification of fluorescence signals sourced from a 
fluorescence sensor foil placed approximate to the specimen. This miniaturised system is 
capable of observing the patterns of aqueous oxygen gradients in real-time. In this section, a 
proof-of-concept microfluidic technology was demonstrated that integrated an oxygen 
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sensor foil into the fish embryo trapping array. Such a combination represents a new 
method to measure the oxygen gradient in a flow-through condition.  
5.8.1 Design of the microfluidic device 
A microfluidic chip-based device for zebrafish embryo metabolic activity detection was 
fabricated in poly(methyl methacrylate) (PMMA). PMMA is not only biologically compatible 
and optically transparent, but also gas impermeable which prevents passive oxygen 
exchange between the atmosphere and the fluidic environment. The oxygen sensor foil was 
fabricated by coating fluorescing substances onto a plastic sheet. The reference dye emits a 
constant green fluorescence signal; whereas the indicator dye emits fluorescence in 
response to reaction with oxygen. The sensor foil was capable of indicating the partial 
pressure of oxygen in an aqueous environment111-113. Therefore, to make the sensor fully 
functional, it needs to be in direct contact with the specimen.  
The design concept of the chip device was very similar to the device described earlier, 
however, an extra layer was added to hold the oxygen sensor foil (Figure 5.8.1). The fluidic 
manifold was also slightly modified because of the restriction of the oxygen sensor foil size 
provided by the manufacturer. In particular, the chip device consisted of five modules: (i) a 
loading manifold (52 mm × 1.8 mm × 1.0 mm) for embryo loading, toxicant perfusion, and 
specimen recovery, (ii) an array of 18 miniaturised embryo traps (ϕ 1.5 mm × 1 mm) for 
individual embryo trapping and immobilisation, located beneath the loading channel, (iii) a 
suction manifold including a main suction channel (53 mm × 2.5 mm × 0.5 mm) and 
interconnection channels (0.3 mm × 1.6 mm × 0.5 mm) for each embryo trap, (iv) 
connection ports (ϕ 2.9mm) as inlet and outlet for direct tubing (1/16” OD) connections, 
and (v) a sensing manifold holding oxygen sensor foil sheets. Despite having an additional 
layer of oxygen sensor foil, the rational for embryo loading, immobilising, and on-chip 
culture remained the same as described in chapter 3 (Figure 5.8.1).  
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Figure 5.8.1 Design of the microfluidic chip-based device. A) An exploded view of the chip device 
depicting all layers and features. The chip comprised six layers. Each layer was fabricated separately 
on a laser cutting machine. The second layer was a holder for fitting the oxygen sensor foil. All six 
layers were then thermally bonded together in a fan assisted oven. B) Macrophotograph of the chip-
based device. All features are depicted. C) Cross-section view of the chip device, depicting embryo 
trapping and immobilising principles. Note that the oxygen sensor foil was located beneath the 
embryo traps, making all loaded embryos sit on it. Published in Ref 114. Reproduced with permission 
from John Wiley and Sons. 
Oxygen detection was achieved by using the Presens® VisiSens™ system that captures the 
signals from the sensor foil using a miniaturised digital microscope (Figure 5.8.2). Signals 
were then transformed in the analysis software (VisiSens Analytical 1) that calculates the 
oxygen level by comparing the values from the calibration with the readings from detected 
signals.  
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Figure 5.8.2 Experimental set-up for real-time oxygen detection. A) Photograph of the experimental 
set-up showing the Presens VisiSensTM system associated with a microfluidic lab-on-a-chip device. The 
detection unit included a portable USB microscope with a 1.3MP camera, capable of imaging at 10x 
or greater magnifications. B) Magnified view of the microfluidic chip device loaded with 40 hour post 
fertilisation (hpf) zebrafish embryos. Note that the clear bright field view was effected by the oxygen 
sensor foil, but it has no effect on the experiment as the oxygen detection is based on fluorescence 
signals. Published in Ref 114. Reproduced with permission from John Wiley and Sons. 
5.8.2 Experimental validation 
During the calibration of the detection system, air-saturated water (water bubbled with air) 
and anoxic water (Na2SO3, 5 g/L) were used to create an anoxic/normoxic boundary. In the 
bright field, the anoxic region and normoxic region can be clearly seen as orange and green 
areas, respectively. The contrast was greatly improved under a fluorescence view (Figure 
5.8.3).  
As a proof-of-concept experiment, I investigated the changes in oxygen gradient by 
adjusting the supply of oxygen under the demands of zebrafish embryo metabolism. 
Embryos at 40 hour post fertilisation (hpf) were loaded onto the chip device, followed by a 
continuous flow for on-chip culture. By altering the flow rate, the oxygen concentration 
changed in the approximate contact zones (region of interest, ROI) of the zebrafish 
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embryos. ROI was determined by direct observation of embryo position from bright field 
images, followed by outlining the entire chorion area in the fluorescent images (Figure 
5.8.3). It was observed that in the absence of a continuous supply of oxygen, the oxygen 
level quickly plummeted around the embryo (Figure 5.8.3).  
 
Figure 5.8.3 Oxygen gradient detection using embedded sensor foils on a microfluidic chip-based 
device. (Left) Comparing image taken from bright field (upper panel) and fluorescence view (lower 
panel) in respond to a drop of anoxic water on the oxygen sensing foil. The boundary of normoxic 
(green) and anoxic (orange) regions can be clearly observed in the bright field, however, the 
boundary can be more clearly to observe using fluorescence. It is worth noting the excessively high 
fluorescence signals on the bottom left image, indicating an unfavourably high oxygen diffusion rate 
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from air to water. This phenomenon indicated that calibration of the oxygen sensor is not possible in 
the atmospheric environment. (Right) Real-time images (top- bright field, middle- fluorescence, and 
bottom- calculated oxygen level) of a zebrafish embryo with oxygen gradients due to a reduced flow 
rate. Published in Ref 114. Reproduced with permission from John Wiley and Sons. 
Next, I characterised how oxygen gradients could be affected by the presence of fish 
embryos during the halt and reintroduction of oxygen saturated water. In the experiment 
the flow of oxygen saturated water was halted and then continued through perfusion after 
two minutes. As a result, oxygen levels kept decreasing steadily over time until nearly 
depleted. After the perfusion restarted, it was found that oxygen level slowly recovered in 
the first minute and then rapidly jumped back to saturation (Figure 5.8.4 A).  
 
Figure 5.8.4 Relationship between the fluidic flow and the oxygen gradient in the air impermeable 
microfluidic chip. A) Oxygen level (% air saturation) as a function of time (seconds) during the halt 
and reintroduction of water flow to zebrafish embryos at 40 hpf. Flow rate for water reintroduction 
was 0.4 mL/min. B) The effect of flow (0.4, 0.2, and 0.1 mL/min) on oxygen levels over the time in 
approximate (contact) zones of 40 hpf zebrafish embryos. Published in Ref 114. Reproduced with 
permission from John Wiley and Sons. 
Lastly, I investigated the oxygen gradient as a function of different flow rates. At the flow 
rate of 0.4 mL/min, oxygen levels were relatively constant over the period of 120 second. In 
comparison, when the flow rate was reduced to 0.2 or 0.1 mL/min, oxygen levels declined 
from nearly 100% to 60% or 20%, respectively (Figure 5.8.4 B). This result indicated a 
demand of oxygen required by on-chip culturing embryos.  
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5.9 Interfacing with a high-throughput imaging cytometry 
As zebrafish embryo bioassays are gaining an increasing amount of interest, a high-
throughput and automated experimental system is urgently demanded. Current zebrafish 
embryo assays are low throughput because a standard zebrafish embryo biotest is an 
image-based analysis. The changes in embryonic phenotypes during the experiment are 
usually recorded as images and then proceed to image analysis. Therefore, the acquisition 
of high quality images is one of the most important steps in the assay. Yet this is not an easy 
task, as zebrafish embryos are spherical and their body trunks are curled inside the chorion, 
making the imaging extremely difficult and time-consuming.  
Recently the TROPHOS® Plate Runner HDTM (Trophos, Inc., Marseilles, France) - a high-speed 
multichannel imaging cytometer - was developed for this purpose. It equipped with a high 
speed camera capable of acquiring images at a resolution of up to 67 mega pixels with a 
depth of field of 40 µm. The imaging cytometer is thus able to acquire images for each well 
of 96-well plates in three fluorescent channels within 25 minutes. Because of the high 
resolution, changing objective lenses become unnecessary for imaging and magnifications 
can be conducted digitally in post-imaging steps without loss of information. 
This equipment is a very desirable accompaniment to the lab-on-a-chip embryo trapping 
array for high-throughput screening. With all outstanding capabilities, the imaging 
cytometer, however, is only adaptable with standard multiwell plates. Hence, in this section, 
I modified and expanded the previous chip device to be compatible with the cytometer.  
5.9.1 High density fish embryo trapping array 
The expanded version of the embryo trapping array was designed to fit the exact same 
space as a conventional 96-well microtitre plate (127 mm × 85 mm). Each chip consisted of 
12 independent microfluidic manifolds for zebrafish embryo loading, immobilising, and 
culturing, as described in chapter 3. Herein, the embryo traps were designed to feature a 
total circumference and distribution of the wells on standard 96-well microtitre plate for 
any plate readers that accept multi-well plates (Figure 5.9.1 A). In particular, each image 
taken from a well from a 96-well plate covered three embryos immobilised in the traps 
(Figure 5.9.1 B).  
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Figure 5.9.1 Lab-on-a-chip technology for high-throughput zebrafish embryo immobilisation, 
microfluidic flow-through culture and time-lapse imaging. A) The high-speed multichannel imaging 
cytometer TROPHOS Plate Runner HD (Trophos, Inc.). Inset: A high-throughput zebrafish embryo 
trapping array adaptable to the imaging cytometer. B) Photograph depicting the high-throughput 
chip-based device. It contained 12 independent fluidic manifolds. Inset: Overlay of a 96-well plate 
with a chip-based device. 
5.9.2 Experimental validation 
To validate the technology, an experiment was performed to test the quality of images 
taken from the fluidic device. Transgenic Tg(fli1a:EGFP) embryos were loaded onto a chip-
based system at the 16 hpf before the development of intersegmental vessels (ISVs). The 
developing embryos were then continuously perfused in a close-loop cycle at a continuous 
flow rate of 0.4 mL/min with E3 media. On the chip, ISVs were fully developed at 40 hour 
post fertilisation, in line with the control experiment where the embryos were cultured in 
standard Petri dishes.  
The presence of ISV can be clearly viewed in the images taken from the imaging cytometer, 
with a minimum amount of autofluorescence from the chip device (Figure 5.9.2). Acquired 
images were further digitally magnified five times and the details of the embryo could still 
be seen clearly, thanks to the chip device that immobilised the fish embryos. This result 
proved that the chip device fit well with the high-resolution image cytometer and was ready 
to perform zebrafish embryo bioassays.  
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Figure 5.9.2 Assessment of imaging quality of the cytometer, taken images from the chip-based 
device and depicting Tg(fli1a:EGFP) zebrafish embryos cultured under continuous microperfusion. 
High-resolution visualisation of patterns of intersegmental vessels (ISV) was conducted using 
multichannel imaging cytometer TROPHOS Plate Runner HD. Transgenic embryos were arrayed and 
immobilised at 16 hpf. ISV can be clearly viewed at 40 hpf. Digitally magnified images also showed 
high definition.  
5.9.3 3D printed fluidic interface 
During the experiment, I realised that the high-throughput chip device was very difficult to 
use because of the increased effort necessary for tubing connections and leakage 
prevention. This issue is in fact not only apparent in this particular case, but also is a 
common issue experienced by many lab-on-a-chip devices.  
 
Figure 5.9.3 Photo realistic rendering images of the fluidic interface. All functional features depicted. 
It sandwiches the high-throughput chip device in the middle interfacing between the culturing chip 
and the external tubing.  
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To address this problem, a proof-of-concept 3D printed fluidic interface was prototyped for 
convenient chip positioning, tubing connections, and image acquisition.  The interface 
comprised of a hinge-based cradle to fix the chip device and two arrays of integrated barb 
connectors that extend the inlets and outlets of the chip for tubing interconnections. Each 
connector was surrounded by a notch that held a rubber O-ring to seal the gap between the 
cradle interface and the chip device. To secure the sealing of the fluid interconnection, a 
mechanic locking system was integrated into the device. The bottom layer of the cradle was 
bundled with two small hinge holders carrying two screws together with two wing-nuts. To 
use the cradle device, simply place the chip device onto the holder, close the hinge and 
tighten the two wing-nuts. Image acquisition could be accessed via the top and bottom 
surface that were left empty (Figure 5.9.3).  
 
Figure 5.9.4 Macrophotograph of 3D printed fluidic interface with the HTS chip device. The interface 
was fabricated by Stereolithography (SLA) 3D printing technology using VisiJet SL Clear material. 
Published in Ref 112. Reprinted with permission from ©  2015 American Chemical Society. 
The prototype was 3D printed using Stereolithography, allowing a high quality finish of all 
small features (Figure 6.3.4). The smallest feature was the wall of the connection nozzles 
with only 0.2 mm thickness, nonetheless, it was accomplished successfully without any 
imperfections. Although 3D printing materials are toxic to the aquatic organism and are not 
suitable for fabricating lab-on-a-chip devices directly, as discussed in chapter 4, they can still 
contribute to the device manufacture as long as they are not directly or largely in touch with 
the fluids. The contact of the material in the connection nozzles is neglectable, as evidenced 
by the validation test, showing no mortalities throughout the experiment (Figure 5.9.2).  
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5.10 Summary and discussion 
In this project, I present a microfluidic lab-on-a-chip device for zebrafish embryo toxicity 
assays. The automated arraying and immobilisation of embryos on the chip-based device 
simplified specimen handling and accelerated image acquisition. The chip device allowed 
embryo on-chip culturing on a one-embryo-in-one-trap basis, which improved time-lapse 
imaging for tracking every single embryo. The toxicity test can be performed under 
continuous flow-through conditions over 48 hours without disturbing the development of 
the specimens. 
The further developments and modifications were performed for advanced applications of 
the chip device. Firstly, an additional layer holding an oxygen sensor foil was integrated to 
the embryo chip, enabling a visualised measurement of oxygen level in real-time. Secondly, 
a high-throughput chip was fabricated by integrating 12 individual fluidic manifolds onto a 
plate-based device that was the exact size of a 96-well multititre plate. The device 
seamlessly fit to a high-resolution image cytometer that can screen up to 252 embryos in 
less than 10 minutes. Thirdly, a 3D fluidic interface was prototyped for a rapid and leak-free 
experimental set-up for the high-throughput device. This made the use of the microfluidic 
system increasingly user-friendly and effortlessly. 
Design of the lab-on-a-chip device 
The viability of the embryos under a microperfusion condition is of utmost concern in the 
chip design. Computational fluid dynamics (CFD) simulations were performed to show that, 
under a constant flow rate of 400 µL/min, the embryos were exposed to a low water 
pressure and a very low shear stress. According to previous work by Wlodkowic and co-
workers, the maximum shear stress value from the simulation was at least two orders of 
magnitude lower than the value reported to damage cells115.  
Another concern when using microperfusion fish embryo toxicity test (µFET) is that all 
embryo culture chambers are mutually connected, which opens up the possibility of cross 
contamination. This situation is, in fact, minimised by having individual suction 
microchannels for each of the embryo trap. When a dead embryo releases waste, the waste 
would be directly flushed out of the chip device via the suction manifold (Figure 5.10.1).  
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Figure 5.10.1 Automatic clearance of embryo waste during the microperfusion culture. Each embryo 
culture chamber was connected to a suction microchannel. Any waste produced from unhealthy 
embryos would be flushed out of the culture chamber without cross contamination.  
Comparison between FET and iFET 
Most of the toxicity results in the experiment were scored using both the FET method (LC50) 
and the iFET (EC50) method. Compared with the standard FET method, the iFET not only 
focuses on lethal endpoints, but also includes sub-lethal endpoints. Therefore, the iFET is a 
more sensitive scoring method for identifying the effects of toxicants. Compared with the 
LC50 values, EC50 values were at least 20% higher (Figure 5.10.2). The difference becomes 
significant for compounds that cause few mortalities, but severe developmental 
abnormalities. For example, xanthine alkaloid caffeine, known to be a potent antagonist of 
adenosine receptors, induced iFET EC50 value 3.5 times higher than the FET LC50 value.  
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Figure 5.10.2 Comparison of scoring methods between FET (lethal) and iFET (lethal and sub-
lethal/teratogenic) endpoints after exposure to several compounds. Experiments were performed on 
chip-based devices for 48 hours. Note that iFET calculations include FET mortality parameters and 
introduces nine sub-lethal parameters. It increases the sensitivity of a standard fish embryo toxicity 
test. 
Comparison between microperfusion and static experiment 
The results confirmed that the microperfusion fish embryo toxicity assay (µFET) obtained 
comparable results to conventional FET assays performed in multi-well plates when testing 
reference toxicants. Linear correlation analysis between the two experimental setups 
yielded R2 value of more than 0.9 (Pearson and Lee linear correlation test (p<0.01)) (Figure 
5.10.3). When testing compounds that are unstable in static conditions, such as nicotine, the 
microperfusion system displayed a higher toxicity than the static system. This result 
indicated that the chip-based microperfusion system is more reliable in these toxicity tests 
than static conditions.  
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Figure 5.10.3 Linear correlation analysis between chip-based microperfusion experiments and plate 
based static experiments. Lab-on-a-chip experiments were performed under continuous 
microperfusion at a flow rate of 400 µL/min for 48 hours. Note the excellent agreement between the 
two experiments when testing standard reference chemicals. Also note a bad correlation when 
testing unstable compound (nicotine) where chip-based device showed higher toxicity. Published in 
Ref 112. Adapted with permission from ©  2015 American Chemical Society. 
 
Limitations 
The major limitation of using the microfluidic embryo array in toxicity tests is the maximal 
test duration. To perform chip-based experiments, the test duration was reduced from a 
standard 96 hours to 48 hours. Some compounds, in particular non-polar and highly 
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hydrophobic compounds, may not reach internal equilibrium concentrations within 48 h of 
exposure. However, the reduced exposure duration was necessary because the embryo 
array was designed to immobilise fish embryos within the chorion. Zebrafish embryos 
normally hatch between 48 hpf and 72 hpf, and hatched embryos would swim out of the 
device and deteriorate the experiment.  
Nevertheless, the necessity for 96 h of toxicant exposure is debatable. To start with, it is 
believed that the ideal time point for toxicant penetration of zebrafish embryo is shortly 
after 24 hpf. After this time point, the chorion of the embryo hardens and it becomes 
increasingly difficult for compounds to penetrate the developing embryos. There is no solid 
example of slowly penetrating and equilibrating drugs in zebrafish. Generally, they 
penetrate well early or very poorly. The early developmental processes are easier to perturb 
than late processes.  
Secondly, in many countries outside the EU, complex and prohibitive Animal Ethics permits 
are required for any tests performed on hatched embryos. Animal Ethics is not required only 
for unhatched embryos. This profoundly limits deployment of OECD TG 236 test protocols 
that must often be modified to adhere to Animal Ethics regulations. 
Thirdly, key responses, lethal and sub-lethal endpoints can be already observed in 
unhatched embryos cultured with toxicants for up to 48 h, as evidenced by the previous 
work (Table 5-1)39. 
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Table 5-1 Lethal and sub-lethal endpoints of zebrafish39 
 
  
24 h 48 h 96 h 120 h
Lethal endpoints
 Coagulation √ √ √
 Tail not detached √ √ √
 No somite formation √ √ √
 No heartbeat √ √
 Lack of hatching √
Sublethal developmental endpoints
 Completion of gastrula
 Formation of somites √
 Development of eyes √ √ √
 Spontaneous movement √ √ √
 Heartbeat/blood circulation √ √
 Heartbeat frequency √ √
 Pigmentation √ √
 Formation of edemata √ √
Teratogenicity endpoints
 Malformation of the head √ √ √
 Malformation of sacculi/otoliths √ √ √
 Malformation of tail √ √ √
 Malformation of heart √ √ √
 Modified chorda structure √ √ √
 Scoliosis √ √ √
 Rachitis √ √ √
 Yolk deformation √ √ √
 General growth retardation √ √ √
 Length of tail √
Exposure time
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6 Development of a highly integrated and automated microfluidic 
total analysis system (µTAS) 
 
6.1 Introduction  
The emerging microfluidic lab-on-a-chip technologies have addressed many issues in cell-
based and organism-based pharmaceuticals and toxicant screening. The technologies are 
based on two major concepts: by miniaturising the test vessels, the consumption of samples 
is greatly reduced; and by applying a flow throughout the fluidic system, a more accurate 
test result is achieved. Nevertheless, using lab-on-a-chip technology is not as popular as 
expected116. The major obstruction is actually the difficulty in operation. This is ironic 
because lab-on-a-chip technology is meant to be convenient to use, but it is not the case in 
most current designs. Many lab-on-a-chip prototypes can be rather referred as chips-in-the-
lab, because the chips themselves cannot stand alone, they require many associated sensors 
and actuators to operate the entire system (Figure 6.1.1). More attention should be focused 
on developing a miniaturised analysing system with integrated functions.  
 
Figure 6.1.1 A standard experimental set-up for using a microfluidic lab-on-a-chip device. Although 
the chip itself is miniaturised, it requires bulky detectors and fluidic actuators to be operated. There is 
little automation involved and the throughput is very low.  
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In this chapter, a series of miniaturised pumps and valves were developed to efficiently and 
effectively actuate the high-throughput system. And finally, I integrated all the units, 
together with the chip device described in the previous chapter, and presented a prototype 
of a microfluidic total analysis system.  
 
6.2 Miniaturised microfluidic actuators  
To operate a high-throughput microfluidic device requires a substantial amount of technical 
support, especially for the fluidic actuators. For example, the device described in section 5.9 
had 12 individual fluidic manifolds, meaning an array of 12 pumps is needed. Currently, 
there is a lack of pumps for microfluidic high-throughput screenings, which need to be 
inexpensive, reliable, and capable of running with low volumes. In this regard, I customised 
a series of peristaltic pumps and valves by using robotic servo motors combined with 3D 
printing technologies.  
6.2.1 Miniaturised peristaltic pump 
Selection of pumps is one of the most important considerations in running a microfluidic 
system. Commonly used pumps for lab-on-a-chip devices include peristaltic pumps, syringe 
pumps, and piezoelectric pumps. Their difference in terms of performance was the 
pulsation intensity and the range of flow rates. In this section, I designed and manufactured 
a series of customised peristaltic pumps because they are relatively simple: simple to make, 
simple to use, and simple to maintain. The pump design was based on using Dynamixel 
servos (Robotis Ltd.) as the actuator of the pump, using metal bearings as the rollers, and 
using 3D printing to fabricate a pump head.  
A range of Dynamixel servos, i.e. AX-12A, AX-18A, MX-28T, and MX-64T, was investigated. 
Each servo has a different size, max torque, and max speed, which enables the pump series 
to be very versatile for broader applications. Taking the pump design using AX-12A, as an 
example, the pump comprised of four major components: i) a servo actuator, ii) a 3D 
printed pump head, iii) a 3D printed roller holding a number of metal bearings, and iv) 
tubing and connectors (Figure 6.2.1).  
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Figure 6.2.1 Computer aided design (CAD) of the miniaturised peristaltic pump based on a Dynamixel 
AX-12A servo motor. The customised pump head and the roller holder were 3D printed.  
The pumping speed and pulsation were restricted by the servo actuators, but they can be 
tuned and compensated for by the design of the pump head. The number of rollers is an 
important parameter in this regard. Many small rollers can reduce the pulsation, but will 
also reduce the maximum flow rate, while a few of large rollers increase the flow rate but 
introduce substantial pulsations. In the design, the pump head and rollers were 
interchangeable, as to fit into extensive applications. Figure 6.2.2 presented a few examples 
of the pump designs using different combinations of servo actuators and pump heads.  
Thanks to the powerful servo actuators and the associated microcontroller (CM-530, 
Robotis), the pump is fully controllable and programmable under a PC software 
environment.  
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Figure 6.2.2 Variant designs of customised pumps. From left to right: 1) Four-roller pump head with 
Dynamixel MX-64T servo, 2) eight-roller pump head with Dynamixel MX-64T servo, 3) six-roller pump 
head with Dynamixel MX-28T servo, and 4) six-roller pump head with Dynamixel AX-12A or AX-18A 
servo.  
The reliability of the pumps was assessed and the linear range between the flow rate and 
rolling speed was determined for each actuator (Figure 6.2.3). The pump using AX-18A had 
the highest maximum flow rate with a widest linear range, followed by MX-64T, AX-12A, and 
MX-32T. However, both AX-18A and AX12A could not achieve a low flow rate because they 
do not have enough torque at a low speed. On the contrary, MX-64T and MX-32T do not 
have a fast speed, but they are high in torque and powerful enough to achieve a flow rate as 
small as 75 µL/min. 
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Figure 6.2.3 Calibration curves of pumps using different servos, depicting the relationship between 
flow rate and pump speed (revolution per minute, RPM). All pumps had a linear correlation from at 
least 0.1 mL/min to 1.5 mL/min, which is sufficient for most applications in perfusion experiments.  
6.2.2 Pinch valve 
Valve is one of the commonly used fluidic actuators in microfluidics. However, a 
programmable pinch valve is currently still rare. In this regard, I prototyped a pinch valve 
based on the Dynamixel AX-12A servo actuator. Similar to the pumps, the valve consisted of 
four major components: i) a servo actuator, ii) a 3D printed head, iii) a 3D printed pinch arm 
with a metal bearing as a pusher, and iv) tubing and connectors (Figure 6.2.4).  
The valve was actuated by a CM-530 microcontroller (Robotis, Ltd). Like the pumps, the 
valve is also fully programmable under a PC software environment. The only difference was 
that the valve was operated in a “servo mode” instead of a “wheel mode” for the pump. In 
servo mode, the movement of the actuator could be more finely controlled. Note that AX-
12A was a weak actuator that has a relatively low torque. However, in this experiment I 
found that it was enough to hold up to the pressure, until the tubing connector failed first. 
Hence, no further designs using other servo actuators were attempted.  
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Figure 6.2.4 Customised two-way pinch valve based on Dynamixel AX-12A servo. The pusher arm and 
the cover lid were 3D printed.  
 
6.3 Microfluidic total analysis system (µTAS) 
To wrap up the study, I set out to design and manufacture an affordable and highly 
customisable analysis platform for zebrafish embryo bioassays. By integrating innovative 
technologies, such as microfluidics, robotics, and 3D printing, the microfluidic total analysis 
system miniaturised and automated all experimental procedures, including sampling, long-
term flow-through culture, and detection.  
The system was separated into two parts. The first part was the organism culturing system, 
which included a high-throughput chip with a fluidic interface, arrays of fluidic actuators, 
and an auxiliary miniaturised microscope (Figure 6.3.1). The utility and function of the chip 
and interface device were described above. Note that the fluidic actuation system was 
highly customisable and can be expanded to include additional pumps as required. A rack 
for pumps and fluidic reservoirs was prototyped using thermoplastic PMMA.  
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Figure 6.3.1 Microfluidic pump array associated with a high-throughput chip interface and a 
miniaturised microscope. A) A photo realistic rendering image B) A macrophotograph depicting the 
experimental set-up.  
The second part of the system was an automated analysis platform. The core of the 
platform was a servo actuated rack-and-pinion stage, mounting the fluidic interface 
together with the chip device for automated image acquisition. As a proof-of-concept 
prototype, a simplified version of the stage that only moved alone one-dimension was 
manufactured. As such, the fluidic interface was also simplified to cradle one chip with one 
fluidic manifold. The rack-and-pinion system was actuated by an AX-12A servo. Two 
microcontrollers (CM-530, Robotis) were embedded on to the stage for controlling the 
moving system and fluidic actuators. Finally, a high-resolution miniaturised microscope 
(DinoLite, Taiwan) was placed under the stage, imaging the chip device from the bottom 
(Figure 6.3.2). The prototype was fabricated using thermal plastic PMMA. 
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Figure 6.3.2 Photo realistic rendering images of the microfluidic total analysis system (µTAS). The 
system comprised of a one dimensional rack-and-pinion moving stage, an embedded peristaltic 
pump, an embedded two-way valve, and a miniaturised microscope. A miniaturised fluidic interface 
was fit to the moving stage together with the lab-on-a-chip device. The system was controlled by two 
CM-530 microcontrollers (Robotis Ltd.).  
In the primary experiment, the moving stage was set to move at an interval of two seconds, 
each time covering three embryo traps, throughout the entire chip device. Afterwards, the 
stage moved to the original spot for the next imaging task. The system performed with great   
reproducibility in positioning the imaging regions after iterative tests (Figure 6.3.3).  
 
Figure 6.3.3 Prototype of the microfluidic total analysis system (µTAS). All features are depicted. 
Inset: a window from a computer running the image capturing software, showing a real-time view of 
the chip device.  
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6.4 Summary and discussion 
In this chapter, more advanced technologies for automated and high-throughput zebrafish 
embryos bioassays were presented. To be able to actuate a high-density microfluidic 
system, a series of highly customised peristaltic pumps were manufactured. Robotic servo 
motors were selected as actuators that are powerful and accurate to provide continuous 
flows to the system. Lastly, I prototyped a microfluidic total analysis system that integrated 
all the aforementioned features into a platform, together with a moving stage and an 
imaging system, allowing automated image acquisition for high-throughput zebrafish 
embryo bioassays.  
Although using microfluidics for high-throughput screening has garnered an increasing 
amount of interest, the development of the fluidic actuators was falling behind demand. 
Currently commercialised pumps were either not accurate enough or extremely expensive, 
which are unsuitable for batch experiments. In this regard, a cost-effective and miniaturised 
pump array was presented. It used robotic servos as the actuators, which are robust and 
precise. The pump head was customised and fabricated using 3D printing and was 
interchangeable among different servos for a variant of flow control requirement. 
Unfortunately, the prototypes were still very primitive, as the durability of the pumps were 
limited by the plastics used in 3D printers. A pump head made in rigid materials, such as 
metal or alloy, would be ideal.  
There is also a lack of an automated, high-throughput and inexpensive total analysis system 
for zebrafish embryo biotests. Letamandia and co-workers present a system, but it was 
expensive and not user-friendly68. Currently, The Union Biometrica system based on work 
from Pardo-Martin and co-workers was commercialized. However, it was designed mainly 
for zebrafish larvae analysis69. This system is not broadly adapted because of significant cost 
and limited scope of use. As far as I know no real units have yet been delivered and only 
demo units are currently available after five years of development. Under this circumstance, 
the advantage of this study with a miniaturised and customisable device will be exploited.  
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7 Conclusions 
 
The development of zebrafish embryo as a model organism for bioassays has attracted a 
great amount of interest in the biomedical and environmental research communities. 
However, there is a lack of available technology that allows automated and high-throughput 
screenings under flow-through conditions. The main objective of this thesis is to address this 
problem. I first I explored the use of 3D printing to rapidly fabricate lab-on-a-chip devices for 
zebrafish embryo assays and found a potentially underestimated biocompatibility issue in 
3D printing materials. Following up, I investigated the toxicity profiles of a range of 3D 
printing materials by using standardised biotests. Next, I developed and fabricated a 
biocompatible lab-on-a-chip device for automated embryo loading, arraying, and culturing 
on a microperfusion chip. Finally, I modified and expanded the chip device for high-
throughput screening purposes; I prototyped a microfluidic total analysis system using a 
miniaturised and automated imaging platform for zebrafish embryo bioassays. 
 
7.1 Achievement and impact 
In chapter 3, the feasibility of using 3D printing to accelerate the fabrication of microfluidic 
lab-on-a-chip devices was investigated. Compared with conventional rapid prototyping 
technologies, I demonstrate that selected stereolithography technologies can achieve 
superior feature production, comparable levels of optical transparency, and user-friendly 
manufacture of prototypes. However, I for the first time, reported that caution needs to be 
exercised because most of the tested 3D printing materials were found to be toxic and 
cause significant developmental abnormalities, as evidenced by zebrafish embryo biotests. 
This work suggested that using 3D printing technologies enables us to rapidly prototype 
innovative devices for related research, but current 3D printing materials should not be 
directly exposed to aquatic biological specimens in the long-term. As 3D printing 
technologies attract an increasing amount of interests in scientific research, this preliminary 
work created instructive information for potential users when choosing 3D printing systems.  
As a follow up, chapter 4 presented an extensive toxicity profiling on a panel of common 
polymers used in 3D printing applications. This work, for the first time, conducted an in-
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depth and multispecies toxicity test, indicating potential dangers and limitations in 
fabrication of biocompatible devices using the FDM, SLA, and MJM 3D printing systems. 
Moreover, a pioneering chemical analysis successfully revealed two chemical compounds 
existing in the materials and causing the toxicities. This research provided guidance to the 
scientists selecting biocompatible 3D printing materials and it also established an effective 
and efficient method to assess the toxicity of unknown materials.  
To avoid using toxic 3D printing material in making lab-on-a-chip devices, chapter 5 
presented the design and validation of an innovative lab-on-a-chip technology for 
automated zebrafish embryo biotests performed on immobilised fish embryos cultured 
under a continuous microfluidic perfusion. It is acknowledged that a microfluidic lab-on-a-
chip systems, such as this work, where the most tasks are conducted automatically without 
disturbing the test specimens or causing sudden changes to their environment, will perform 
more productively than conventional static and manual bioassays. Moreover, the 
application of the technology developed in this thesis is not limited to manipulation of 
zebrafish embryos. With simple modifications in size and dimension, the device should be 
suitable for other aquatic small model organisms, including Xenopus oocytes and sturgeon 
embryos. On top of that, a few more advanced lab-on-a-chip devices were prototyped with 
customised equipment for automated and high-throughput zebrafish embryo screening 
tests. A proof-of-concept microfluidic living embryo array system was fabricated to enable in 
situ Fluorescence Ratiometric Imaging (FRIM) on developing zebrafish embryos for kinetic 
quantification of oxygen gradients. It is reasonable to envisage that integration of 
microfluidic chip-based technologies with FRIM represents a noteworthy direction to 
miniaturise and revolutionise research on metabolism and physiology in vivo. Moreover, a 
high-throughput microfluidic device was presented for zebrafish embryo bioassays. The 
device was conceptually designed to seamlessly interface with a fluorescent imaging 
cytometer for rapid and high-resolution imaging. I hope this work will pave the way for the 
next generation of microfluidic bio-instrumentation for real-time and high-throughput 
whole-organism analysis, with broad applications in drug discovery and ecotoxicology. 
In chapter 6, a miniaturised microfluidic total analysis system was customised that 
integrated a lab-on-a-chip device, a fluidic interface, an array of fluidic actuators, a camera, 
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and a programmed moving stage. This prototype will prospectively become a highly 
customisable and cost effective bio-instrument for zebrafish research communities.  
 
7.2 Limitation and future work 
An extensive study on 3D printing material toxicity profiling was performed using standard 
biotests on aquatic model organisms. The result showed that 3D printing materials are very 
toxic in the aquatic environment, but how would they affect soil or vegetation remains 
unknown. More tests should be conducted in this direction.  
A primary chemical analysis was performed to identify and quantify the compound existing 
in the polymer water extract using GC-MS. Although few compounds were identified, I 
believe that more substances exist in the water sample, as the current extraction method 
was restricted by the solvent used for the liquid-liquid extraction. Future studies should be 
conducted using more or a combination of solvents for extraction. More detection 
technologies, including LC-MS or NMR, could be used for identification.  
A microfluidic zebrafish embryo trapping array was demonstrated to be capable of loading, 
immobilising, and culturing live embryos in a microperfusion environment. It was also 
designed to be able to unload all the embryos from the chip device at the end of 
experiment. However, the unloading performance was not very consistent in the validation 
experiment. Embryos were found clogged at the inlet of the channel and torn after 
recovery. As the unloading function was required by many of our collaborators, a 
modification in the fluidic inlet and loading channel will be conducted in future work.  
A prototype of a microfluidic total analysis system was fabricated. It has a rack-and-pinion 
moving stage that could be programmed for automated imaging. The prototype is, however, 
very primitive in that the stage can only move along one dimension. In future work, a 
robotic system with two or more servo actuators could be integrated to the stage to allow 
the positioning to occur freely on the X-Y plane for imaging of high-throughput chip devices.  
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